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Part I
Overview of Sperm Maturity, 
Oxidative Stress and Apoptosis

Chapter 1
Introduction
A clinical-pathology review of apoptosis 
and oxidative stress in reproduction
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Introduction
Assisted reproductive techniques (ART) have offered the possibility of treatment in 
many infertile couples with male factor infertility. However, success is not guaranteed 
and success rates for ART procedures still remain suboptimal 1. Originally developed 
to combat female infertility, ART practice is increasingly important in andrology. 
The use of spermatozoa from ejaculates with poor spermiogram or from non- 
physiological sources such as the epididymis and testis raises a number of concerns. 
It is for instance possible that some sperm selected for ART will display features of 
damage at the molecular levels despite they appear normal, which may be partially 
responsible for low blastocyst development rates (BDR), pregnancy rates (PR) and 
recurrent pregnancy loss (RPL) 2, 3. The negative effects of sperm damage, specifically 
DNA fragmentation appear during genome activation after fertilization 4. 
Programmed cell death (apoptosis) is a cascade of cellular events that are under genetic 
control and leads to a series of cellular, morphological and biochemical changes away 
from healthy homeostasis culminating into cellular suicide 5 (Figure 1a-c). Reports link 
the presence of apoptotic markers in human sperm with the failure of in-vivo as well 
as in-vitro fertilization 3, 6, 7. Externalization of phosphatidylserine (PS) from the inner 
leaflet (its normal location) in the sperm plasma membrane to its outer surface is one 
of apoptotic reversible changes observed in human spermatozoa which becomes 
irreversible when it is accompanied with extensive DNA damage 8, 9. Origin of sperm 
DNA damage can be explained mainly by defective spermatogenesis and OS 
mechanisms 10. Sperm DNA fragmentation is a critical apoptotic feature that has 
been identified in ejaculated spermatozoa 11, 12.  Reports showed the link between OS- 
induced sperm damaged and the presence of apoptotic changes especially as to DNA 
damage 13, 14. Developing new protocols for sperm diagnostic assays based on the 
early detection of OS markers and/ or apoptosis-like changes should be considered as 
tools to improve ART success rates and to optimize reproduction lab services. 
In order to better comprehend the different aspects of OS impact in spermatozoa 
damage and clinical results described in this thesis, a general description of sperma-
togenesis, OS and apoptotic markers in mature sperm, the tools used to measure 
them and potential laboratory applications, are addressed in this chapter.
1. Spermatogenesis overview
Spermatogenesis is the complex process of highly organized self renewal/ proliferation 
and cyclic maturation leading to germ cells differentiation. It includes specific morpho - 
logical cellular associations of the seminiferous epithelium, and actions of FSH/ testosterone 
to control the continuous differentiation of the germ cells to mature haploid motile 
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spermatozoa 15, 16. Impaired spermatogenesis accounts for male factor infertility which 
approximately forms 50% of all causes in infertile couples 17, 18. This impairment 
translates into defective sperm function.  Molecular changes, may start even in the 
early maturation stages the spermiogenesis, which result in production of functionally 
unhealthy spermatozoa19. Concomitantly, there can be partially arrested spermato-
genesis, depending on severity, type, or level of the affected molecular pathways. 
Environmental factors such as infections 20 life style stresses 21, 22 and varicocele 23, 24 
may interfere with normal and impaired spermatogenesis by causing or aggravating 
OS. This type of damage may occur in early and late stages of sperma togenesis 25, 26.
Figure 1  (A) Gross structure of testis shows distribution of the seminiferous tubules collecting 
together to end in the epididymis, then vas deferens. Spermatic vessels plexus forms the main 
components of spermatic cord. Tortuous spermatic venous plexus observed in infertile men and 
is considered the most common pathologies in male infertility. Magnified cross section in a 
seminiferous tubule is to show the diameter and its lining of the anatomical unit of spermato-
genesis. Seminiferous tubules as further studied longitudinally to show its lining layer of Sertoli 
cells with differentiating germ cells maturation stages (B) Morphological changes of germ cells 
which occur in response to injurious agents such as apoptosis.
A
B
CCF©2010
CCF©2010
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2. Sperm integrity in male reproduction 
Sperm chromatin integrity is an important factor as male gametes are main contributors 
in embryonic development 4, 27. In normal spermatogenesis, sperm chromatin is a 
highly organized, compact structure consisting of DNA and nucleo proteins 28. Human 
sperm chromatin is different from other animal species as they have a higher 
proportion of histones and percents of high heterogeneity within the same specimen. 
Sperm chromatin is condensed in an organized way to protect and facilitate a safe 
transport of the paternal genome to the ready mature oocyte through fertilization 
process 29. Integrity of sperm chromatin is a result of multiple molecular and 
morphological maturation steps completed with production of healthy sperm. 
Reports showed that protamination status, zinc, vitamin A, disulphide bonds and 
DNA breaks may collectively or individually have a role in sperm chromatin quality 
30-32. Sperm chromatin integrity has been extensively studied recently to explore its 
significance in clinical reproduction laboratory 33 .
Figure 1  (C) Activation of the most common pathways for oxidative stress (OS) and apoptosis 
in somatic cells which may get activated in response to external or internal cellular injurious 
stimuli. There may be activation of interacting pathways which favor OS induced damage with 
apoptotic machinery activation. These interactions cause energy failure and augment DNA 
fragmentations and suppression of DNA repair. (ETS, electron transfer system; MMP, mitochondrial 
membrane potential; GR, glutathione reductase; GPx, glutathione perioxidase; SOD, superoxide 
dismutase; Bax/Bak, proapoptotic proteins essentials for mitochondrial induced apoptosis; 
eNOS, endothelial nitric oxide synthase; CAD, caspase activated DNase; ApoF1, apoptosis 
inducing factor; PARP, poly (ADP)-ribose polymerase; Cas, caspase)
C
CCF©2010
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The presence of (faulty) DNA repair in early embryonic development is related to the 
origin of gene mutation. The human cellular genome is almost by default protected 
by mechanisms collectively known as DNA repair activity. DNA damage is critical in 
early human life, especially during fertilization as well as in early embryonic 
development.DNA repair activity in the zygote is mandatory in order to avoid 
mutation induction in the germ line 27.The current viewpoint is that DNA  repair is a 
maternal trait. DNA repair activity may be affected by the transcripts stored during 
maturation processes of the oocyte 34, 35. 
3. Oxidative stress (OS) and apoptosis in human spermatozoa
The main sources of DNA damage in sperm are either apoptosis or reactive oxygen 
species (ROS) 36, 37. Sperm DNA damage is indicated to be of concern in male infertility 
and/ or ART 33, 38, because of the genetic anomalies that can be induced in embryos 39, 40.
3.1  Oxidative Stress (OS)
OS reflects a status which results from the imbalance of generating ROS beyond the 
available antioxidant capacity within gametes, their progenitors or embryonic cells 13, 41. 
In sperm, there is an inability to readily detoxify the reactive intermediates and/ or 
to repair the resulting OS induced damage within limited capabilities. The affected 
cells may show markers for damage of their protein, lipids, or DNA molecular 
compounds 13, 42. 
The presence of non-physiological high levels of ROS generation in male reproductive 
tract are potentially toxic to sperm quality and function 43. Human spermatozoa are 
particularly susceptible to OS-induced damage because their plasma membranes 
contain large quantities of polyunsaturated fatty acids (PUFA) while their scanty 
cytoplasm contains low concentrations of scavenging enzymes 44. High levels of 
seminal ROS are reported in 25% to 40% of infertile men 45. Although the source(s) by 
which human spermatozoa generate intra-cellular ROS remain to be clarified, there 
may be a significant role for the enzyme β-nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase in generating ROS 46.
Two factors protect the sperm DNA from oxidative insult: the characteristic packaging 
of the DNA by protamines and the available TAC in seminal plasma 47. However, OS 
may develop as a result of an imbalance between ROS generation and scavenging 
activities 48. Strong evidence suggests that high levels of ROS mediate the occurrence 
of high frequencies of single- and double-strand DNA breaks commonly observed in 
the spermatozoa of infertile men 49. Studies in which the sperm was exposed to 
artificially high ROS conditions showed a significant increase in DNA damage Further - 
more, ROS play an important role in mediating apoptosis by inducing cytochrome c 
17
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and caspases 9 and 3 activation, which in turn result in a high frequency of single and 
double stranded DNA strand breaks 50. 
3.1.1  Markers of OS Induced Damage
OS markers include seminal ROS, seminal plasma TAC, and sperm damage markers. 
These markers reflect oxidative damage to the lipid, protein or nucleotide components 
of spermatozoa which impair their function 51. Teratozoospermia occurs as a result of 
defective spermatogenesis and is characterized by an abundance of spermatozoa 
carrying surplus residual cytoplasm. The retention of residual cytoplasm promotes 
spermatozoa to generate endogenous ROS via mechanisms that may be mediated 
by the cytosolic G6PD (Glucose 6-phosphate dehydrogenase) enzyme 52. Therefore, 
patients presenting with teratozoospermia are at greater risk of developing pathogenic 
levels of ROS, and subsequently sperm DNA damage.
In general, ROS production is highest in immature spermatozoa from males with 
abnormal semen parameters and appears to be associated with high levels of DNA 
damage 53. However, spermatozoa with cytoplasmic retention are not the only 
abnormal cells that are associated with high levels of DNA damage and high ROS 
production. Spermatozoa with abnormal head morphology, midpiece defects and 
tail defects also display the same characteristics. Production of ROS positively 
correlates with sperm deformity index (SDI), which is calculated by dividing the total 
number of deformities observed by the number of sperm evaluated 54. Similarly, 
spermatozoa with large nuclear vacuoles were shown to present with higher levels of 
DNA fragmentation 55.
3.2 Apoptotic pathways during spermatogenesis
Mature human spermatozoa result from unique differentiation/ maturation processes 
of germ cell progenitors. Germ cell progenitors are supported and nourished by Sertoli 
cells. Testicular blood barrier protects early germ cell progenitors from being attacked 
from external injurious agents or their own immune system 56. Disruption of this 
barrier by trauma, surgery or infection may induce germ cell stresses 57. Depending 
upon the repair capacity and severity of injurious factors will be de degree of the 
affection on spermatogenesis. To directly or indirectly evaluate apoptotic effects on 
sperm quality, a number of molecular markers were proposed to detect in (aberrant) 
spermatozoa 10. They include structural changes in surface (e.g. phosphatidyl serine 
(PS) externalization), cytoplamsic proteins (e.g. caspases) or nuclear markers (e.g. DNA 
breaks) which could be detected through specialized assays that may help in 
detecting spermatogenesis abnormalities in some infertile men 58. Figure 1a shows 
testis, anatomical sections with germinal epithelium differentiation in normal conditions. 
The most common apoptotic pathways which may be activated in germinal epithelium 
(and the involved molecules) in response to injuries are demonstrated in Figure 1 C. 
18
chapter 1
Apoptotic pathways in mature spermatozoa remain not fully understood because of 
almost absence of cytoplasm and reduced nuclear functional activities. The most 
accepted theory is “abortive apoptosis by Sakkas”59. Other possible pathway for DNA 
damage is activation of endonucleases by external DNA 60.
3.3 Apoptotic Markers in Sperm 
The use of non-apoptotic spermatozoa for reproduction is imperative for achieving 
successful fertilization that should be followed by subsequent good embryo quality. 
As compared to somatic and testicular germ lines, the significance of apoptosis 
phenotype in ejaculated spermatozoa remains controversial 61. Apoptosis-related 
features, reported in human spermatozoa, may indicate anomalies in the regulation of 
apoptosis in the testis 11. Abortive apoptosis is a theory which proposes failure to 
eliminate abnormal spermatozoa during spermatogenesis differentiation stages 
which may explain their presence in ejaculated semen 59, 62. The use of these damaged 
spermatozoa may compromise the fertilization potential (however, damaged sperm 
may fertilize oocyte), affecting the early embryo development 4, 27. Depending upon 
the degree of damage, early apoptosis can be reversible when the plasma membrane 
is only affected and shows a repairable damage. Late apoptosis is considered when 
damage becomes un-repairable following extensive or nuclear damage 63. 
The cellular changes that may be present in sperm, which are induced by apoptosis or 
OS induced damage, are associated with molecular markers which can be used for 
diagnostic or therapeutic applications. In the next paragraph, the most used 
molecular markers are described.
A. Early apoptotic markers
i.  Externalization of phosphatidylserine (PS)
PS is a phospholipid located on the inner leaflet of the plasma membrane. PS has a 
high and selective affinity for annexin V, a 35-36 kD phospholipid binding protein 
Annexin-PS binding occurs after translocation of PS from inner to outer leaflets of 
plasma membrane resulting in externalization of PS (EPS) on the surface. Translocated 
PS is one of the earliest detectable features of cells undergoing apoptosis 64. EPS 
negatively correlates with the sperm quality.  Reduced integrity of sperm membrane 
is more frequently seen in spermatozoa from infertile men that contribute to 
childlessness 65.
ii.  Mitochondrial dysfunction
Sperm mitochondria are susceptible to injurious agents’ apoptotic stimuli due to their 
compartmentalization within the midpiece region. Intact mitochondrial membrane 
potential (MMP) is determined to be essential for sperm motility 66. MMP disruption is 
considered as a key marker for apoptosis signaling cascade which is observed in 
human spermatozoa. A strong correlation could be found between MMP and DNA 
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fragmentation levels in human spermatozoa 67. In support of the implication of 
apoptosis in human reproduction, EPS, mitochondrial dysfunction, and nuclear DNA 
damage were detected in significantly higher levels in infertile men and those with 
varicocele 68.
B. Late Apoptotic Markers
i.  Caspase (s) activation
Caspase (CP) activation is believed to be a well-defined point of no return for apoptosis 
progression, and a number of apoptotic events downstream of caspase activation 
have been characterized among which DNA fragmentation stands as a critical 
apoptotic event 69. Evidence supports that within the testicular cells, caspases play a 
central role in the apoptotic process that leads to DNA fragmentation of Sertoli cells 
70. Activated CP-3 induces activation of caspase-activated deoxyribonuclease (CAD; 
also called caspase-activated nuclease), which is integrally involved in degrading 
DNA. Therefore, CP-3 executes the final disassembly of the cell by generating DNA 
strand breaks 71 (Figure 1c). 
Samples from infertile patients are characterized by high numbers of cells with 
activated caspases, especially in those with cytoplasmic droplets, with a strong 
positive correlation to EPS. Presence of precursors and activated forms of CP-8 and 
CP-9 in conjunction with CP-3 in human spermatozoa has also been confirmed 72.
ii.  DNA fragmentation
Sperm DNA fragmentation was found to be prevalent in fractions of sperm with 
positive immunostaining for CP-3, suggesting a relation between them 12. Further, a 
significant positive correlation was seen between activated CP-3 levels in the sperm 
midpiece and DNA fragmentation in specimens with low motility, suggesting that 
caspase-dependent apoptotic mechanisms could originate in the cytoplasmic droplet 
or within mitochondria and function in the nucleus 73 (Figure 1). In addition, DNA 
damage seems to be correlated with abnormal sperm morphology and low motility 
74. DNA damage can be directly measured by TUNEL or Comet assays which have 
been discussed below (Figure 2).
4. Laboratory role in human reproduction
Management of infertile couples requires an accurate diagnosis for optimizing the 
chances to pregnancy and overcome repeated treatment failures 75. Infertility/
sub-fertility is a common health problem that can be addressed successfully with a 
number of interventions. The physician must be careful when concluding male 
infertility diagnosis based only on the routine sperm parameters as concentration, 
motility, and especially morphology 76. Idiopathic infertility, where no abnormalities in 
20
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neither male nor female investigations are found, might in part caused by molecular 
OS-induced damages. Improvement of the quality of andrology lab preparation 
techniques such as sperm selection and cryobiology procedures for future use of 
cryopreserved gametes or embryos is imperative. Iatrogenic damage to spermatozoa 
by sperm preparation techniques should be avoided when possible 47.
4.1  Routine Semen Analysis
Semen is a reflection of the functional capacity of different components of the male 
reproductive system. The standard semen analysis will remain the corner stone for 
male infertility diagnosis. Standard semen analysis includes measurement of semen 
volume, pH, sperm concentration, motility percentage (and total motile, and 
progressive motile), leukocytes and sperm antibody assessment 76, 77. Two main 
systems are recommended for sperm morphology assessment, WHO and Strict’s 
criteria. Although sperm morphology has little prediction on the ART outcome, 
pregnancy rate/cycle with ART reported to decline from 30% in patients with normal 
sperm morphology to 20 % with the use of compromised sperm morphology 
according to WHO guidelines 78 (Figure 2-A show routine sperm examination in 
healthy and infertile men).
4.2  Additional Assays for Semen Quality
There are several assays that may have the merit to be used for detecting the sub 
fertile male. A short description is given for each below.
4.2.1  Reactive oxygen species (ROS) 
a) Global seminal ROS
Global ROS, i.e. measure both extra- and intra-cellular ROS by chemiluminescence 
assay using a luminal or lucigenin probes. Luminol is more sensitive and reacts with a 
variety of ROS at neutral pH. Free-radicals oxidize luminol/ lucigenin to produce a 
luminescence signal which is converted to an electrical signal by the luminometer. 
Level of free radicals produced is measured as relative light unit per second (RLU/sec) 
per million sperm 79.
b) Specific intra-cellular ROS
Intracellular generation of ROS can originate from a specific defect in number of 
potential sources, including NADPH oxidase and complex III within the mitochondrial 
electron transport chain. Dichlorofluorescin (DCF) can detect intra-cellular H
2
O
2 
and 
dihydroethidium (DHE) can detect intracellular O
2
 80. Mean fluorescence intensity and 
percentage of positivity will be reported for each specimen.
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Figure 2  (A) Routine sperm parameters in healthy (Right) and infertile (Left); Opacity with pH 
and ejaculate volume in the same time, Sperm morphology by diff quick staining method, 
Sperm viability stained with one step Eosin-Negrosin method, Cytospin preparation stained with 
Nuclear-Fast Red and picroindigocarmine staining (NF-PICS) that stain sperm heads in red. 
(B) Sperm Chromatin cytochemical staining developed earlier such as acridine orange test, 
Aniline blue test, and toluidine blue assay. Comet assay with either neutral or alkaline buffer, 2-tail 
Comet assay when both alkaline and neutral buffers used. Flowcytometry based assays were 
developed to assess sperm DNA fragmentations as
A Routine Examinations
B Chromatin Histochemical Staining
22
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4.2.2  Seminal plasma antioxidant capacity (TAC)
Detection of seminal plasma available TAC is an indirect assay for OS and may provide 
the clue for sub fertile male diagnosis and management 81. 
Figure 2  (C) sperm chromatin structure assay (SCSA®) and (D) Terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) assay. 
C SCSA Assay
D TUNEL Assay
23
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4.2.3  Lipid perioxidation
OS can have major detrimental effects on sperm lipid membranes, which are rich in 
polyunsaturated fatty acids. Thus, by increasing the level of membrane lipid 
perioxidation, they diminish the membrane fluidity and its functions. These peroxides 
decompose the Fe(2+)-promoted thiobarbituric acid (TBA) assay, stimulating a lipo-
peroxidative chain reaction and resulting in malondialdehyde formation 82. 
4.2.4  Sperm Integrity
The assumption is that defective sperm chromatin (mainly due to DNA breaks) will 
impair embryo development and implantation 83. Assays available to measure directly 
the sperm DNA damage are e.g. TUNEL in situ nick labeling and Comet (Figure 2 B and 
D). Indirectly measurements of DNA damage are aniline blue, toluidine blue (TB), 
SCSA®, CMA3, and halo test among others (Figure 2 B, C and D). Some data showed 
negative effect on fertilization and IUI success in samples with poor sperm quality 33 
but no clear negative impact on implantation with IVF or ICSI in males who had DNA 
fragmentation index (%DFI) of > 30% and increased miscarriage rate 84. All these assays 
may provide different prediction levels for abnormal sperm chromatin or sperm DNA 
fragmentation (Figure 2-C to 2-D). However, they are still in need of more standardization. 
a) Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL)
This assay is used to detect fragmented DNA which utilizes a reaction catalyzed by an 
exogenous TdT and is termed as ‘‘end labeling’’ or terminal deoxynucleotidyl 
transferase dUTP nick-end labeling (TUNEL) assay. It has been reported to be a specific 
and reproducible test for sperm DNA damage detection 85(Figure 2-D).
b) Sperm Chromatin Structure assay (SCSA®)
SCSA is a flow-cytometric assay based upon the fact that abnormal sperm chromatin 
is highly susceptible to physical induction of partial DNA denaturation in situ 86. The 
extent of DNA fragmentation index (DFI) following  acid treatment is determined by 
measuring the metachromatic shift from green fluorescence (acridine orange 
intercalated into double-stranded nucleic acid) to red fluorescence (acridine orange 
associated with single-stranded DNA) 87. Mean green fluorescence reflects DNA 
content and/or degree of sperm chromatin condensation, of which the latter inhibits 
DNA stainability. Percentage of high DNA-stainable (%HDS) sperm identifies the cells 
with immature nuclei due to lack of nuclear condensation 88 (Figure 2-C).
c) Sperm Chromatin Dispersion (SCD) Test
SCD assay has the ability to diagnose different degrees of DNA fragmentation with 
severe damage being characterized as degraded DNA. SCD test is based on the 
principle that sperm with fragmented DNA fail to produce the characteristic halo 
when fixed in low melting agarose microgel then acid denaturation and removal of 
nuclear proteins 89. 
24
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Sperm with intact DNA form chromatin loops (halo). DNA strand breaks prevent this 
looping; the degree of DNA damage is proportional to the decreasing size of the 
loops ranging from normal big and medium halos down to mild or no halo. Degraded 
cells are counted for calculation of DNA degradation index (the nuclear core).
d) Comet Assay
The single cell gel electrophoretic assay (Comet assay) was applied for sperm 90. This 
method may be done with high alkaline conditions (pH 12.5) that denatures all DNA 
or with neutral pH (not causing DNA denaturation). Two tails comet assay was 
proposed for detecting single and double stranded DNA breaks simultaneously 91 
(Figure 2-B).
e) Chromomycin A3 (CMA3)
CMA3 is a glycosidic anti-neoplastic antibiotic isolated from the bacterium Streptomyces 
griseus. CMA3 reversibly binds to guanine-cytosine (G-C) base pairs in the minor 
groove of DNA. This agent is used as a fluorescent chromosome dye. The binding of 
CMA3 is an indication of poor chromatin condensation 92( Figure 2-B).
f) Toluidine Blue (TB) staining
TB staining was described as an alternative to sperm chromatin structure assay. TB 
staining positivity can be categorized as: normal (light blue, LB %), abnormal (dark 
violet, DV %) and two intermediate chromatin conformations (blue, B %; and Violet, 
V %) 93( Figure 2-B).
4.3 Suggested Techniques for the future Reproductive Laboratory 
4.3.1  Flow Cytometry (FCM)/ Cytometrics (Figures 2-C and D)
Accurate detection of a sperm marker depends on the ability of FCM to precisely 
orient the spermatozoa at the time of measurement in the flow cell of the analyzer or 
sorter. The sperm wave generated after exposure to the laser beam shows a 
characteristic pattern due to the presence of the tail following the head for each 
spermatozoon. Sperm may be stained by single or multiple markers for accurate FCM 
detection of sperm characteristics (Figure 3). The staining quality for each sperm 
compartment can be examined by flowcytometry and should always be verified by a 
fluorescent microscope 94. 
Sperm membrane, cytoplasmic or nuclear markers can be examined by the 
flowcytometry (Figure 3). These assays may be used for diagnostic and/ therapeutic 
purposes. Sperm sorting can be based upon markers such as surface markers e.g. 
membrane damage by using annexin V fluorescence labeled antibodies or intracellular 
markers such as DNA contents 95, 96. New FCM assays were proposed to play a major 
role for detection of sperm pathologies 97. Apoptosis detection methods should be 
analyzed in light described recently as well as sperm gating 98.
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4.3.2  Molecular Biological Based Techniques
a) Proteomics
Proteomics technologies have improved its sensitivity in protein detection in matured 
sperm and it has therefore driven a better insight in the normal proteome 99. The key 
challenge is to move from lists of identified human sperm proteome to informed 
understanding of biological function or application 100. 
Figure 3  Flowcytometry (FCM) is a rapidly growing technology in andrology lab. (Upper part) 
FCM is basically composed of laser source that hits a single cell at one time (sheath fluid hydro 
focusing, fluidics). The reflecting signals are collected through a series of dichroic mirrors and 
filters (Optics) and amplified by photomultiplier tubes (PMT) to provide a digital information on 
physical (FSc, forward scatter), granularity (SSc, side scatter) and chemical cellular properties 
(fluorescent light, FL). Multiple sperm properties and markers can be examined through surface, 
intra-cytoplasmic and/ or nuclear staining of spermatozoa (Lower part).
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b) Metabolomics 
Metabolomic is also an emerging technique for the profiling key biomarkers of living 
cells. This is a promising assay that can be beneficial in the management of male-factor 
infertility and ART in general. Metabolomics is a non invasive analysis in the 
investigation of infertile men. Unique metabolomic profile of oxidative stress 
biomarkers (-CH, -NH, -OH and ROH) has been reported to be of characteristic pattern 
using semen plasma from healthy men vs. patients with idiopathic infertility, varicocele 
and vasectomy reversal 101.
c) Genomics
Observations have demonstrated that the environmental agent has the ability to 
induce genetic and epigenetic changes in the sperm genome. Such changes might 
induce trans-generational changes, expressed  in adults onset to diseases 102. 
Epigenetic modifications, gene sequences and gene expression may play a growing 
role in male infertility and reproduction laboratories although they still require more 
standardization 99, 103.
Scope of the thesis
The current pregnancy and live-birth rates in ART remain to be improved. Continuous 
efforts are designed to increase the likelihood that a couple undergoing IVF will have 
a healthy baby. The increase in andrology applications associated with suboptimal 
success rates has mandated the development of a laboratory approach for a more 
accurately diagnose in order to protect the quality of gametes and their resulting 
embryos after fertilization. A clinical pathology approach includes evaluation of 
semen samples by the most common laboratory techniques, and introducing novels 
assays which cover examination of additional markers in gametes that could be used 
in ART applications. While the role of spermatozoa in ART failure has been overlooked, 
strong evidence suggests that proper use of healthy spermatozoa will result in 
improvement of ART success rates. 
Aim of the thesis
In this thesis, our aims were to: 1) examine the role of OS in male infertility, specifically 
intracellular ROS in the occurrence of spermatozoa-mediated damage with apoptotic 
features which compromise male fertility potential; 2) examine the clinical value of 
novel markers for diagnosis and 3) apply these novel markers on clinical setting for 
male factor management.
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Our main motivation is to develop new protocols for clinico-pathological diagnosis 
based on OS or apoptosis-like damage markers and manifestations. Such an approach 
represents the future of laboratory diagnostics that expands to include molecular 
characterization of spermatozoa in addition to the routine examination.
Outline of the thesis
This doctoral thesis consists of three main parts:
Part I: Sperm maturity, OS and apoptosis
Spermatogenesis is controlled by combined genetic and microenvironmental effects. 
Sperm maturation requires physiological levels of ROS. Defective spermatogenesis 
may be related to OS and apoptosis. Immaturity may be associated with OS and 
apoptotic changes which affect the quality of male gametes (reviewed in the general 
introduction, Chapter 1). It is difficult to define healthy mature spermatozoa only on 
basis of routine sperm parameters in infertile men. There is an increased need for 
novel markers and accurate tools for optimization of diagnostic or prognostic services 
for andrology laboratory.
Part II: Novel markers for OS and apoptosis 
This part includes studies which cover evaluation, adaptation and validation of novel 
assays of OS damage and apoptosis which can be used to characterize (healthy) 
spermatozoa along with routine sperm parameters. Recently, expression of poly 
(ADP-ribose) polymerase (PARP) homologues has been reported to differ with fertility 
potential as well as with sperm maturation. In chapter 2 we reviewed any potential 
biological role of of this novel marker, PARP-1, the most important protein in DNA 
damage repair, in male gametes. In chapter 3: we examined PARP cleavage (cPARP) in 
ejaculated human spermatozoa as an earlier marker for DNA damage especially after 
OS- or chemical- induced sperm stresses. In chapter 4: we examined the incidence of 
a single nucleotide polymorphism (SNP) of endothelial nitric oxide synthase (eNOS) 
gene (Glu298asp variant) in infertile men with asthenozoospermia. Idiopathic asthe-
nozoospermia may carry a genetic defects of certain enzymes involved in free radicals 
metabolism. Chapter 5: we have examined the relationship of sperm viability, 
apoptosis, with intracellular ROS levels in human spermatozoa within immature and 
mature sperm fractions. We aimed also to examine the effect of OS on sperm viability 
with high levels of intracellular ROS.
Part III: Applications of Apoptotic Markers in Andrology
In this section we applied our in-vitro studies to clinical settings. In chapter 6 we 
studied the diagnostic value of TAC in human seminal plasma. We used receiver 
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operating curve (ROC) analysis for determining cutoff values and ranges of seminal 
plasma TAC in infertile and healthy donors. In chapter 7, in a comparative study, we 
have evaluated flowcytometry and chemiluminescence as measures for ROS in 
human semen. We compared the detection limitations of both methods in a 
pre-clinical study for assay development. In chapter 8: we studied semen character-
istics and sperm DNA fragmentation in infertile men with low and high levels of 
seminal ROS. We examined the possibility of the presence of extensive sperm DNA 
fragmentation with high ROS levels in infertile men. In chapter 9; we demonstrated 
the relationship of seminal ROS levels with sperm concentration, motility and 
abstinence time. In a longitudinal study, we followed up sperm concentration, total 
motile sperm and seminal ROS over 21 months in a normozoospermic sperm donor. 
We aimed to examine any fluctuation in these parameters over time.
Finally, the findings of this thesis are discussed chapter 10.
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Abstract
Maintaining the integrity of sperm DNA is vital to reproduction and male fertility. 
Sperm contain a number of molecules and pathways for the repair of base excision, 
base mismatches and DNA strand breaks. The presence of Poly (ADP-ribose) 
polymerase (PARP), a DNA repair enzyme, and its homologues has recently been 
shown in male germ cells, specifically during stage VII of spermatogenesis. High PARP 
expression has been reported in mature spermatozoa and in proven fertile men. 
Whenever there are strand breaks in sperm DNA due to oxidative stress, chromatin 
remodeling or cell death, PARP is activated. However, the cleavage of PARP by 
caspase-3 inactivates it and inhibits PARP’s DNA-repairing abilities. Therefore, cleaved 
PARP (cPARP) may be considered a marker of apoptosis. The presence of higher levels 
of cPARP in sperm of infertile men adds a new proof for the correlation between 
apoptosis and male infertility. This review describes the possible biological significance 
of PARP in mammalian cells with the focus on male reproduction. The review 
elaborates on the role played by PARP during spermatogenesis, maturation, ejaculated 
spermatozoa and the potential role of PARP as new marker of sperm damage. PARP 
could provide new strategies to preserve fertility in cancer patients subjected to 
genotoxic stresses and may be a key to better male reproductive health.
Keywords: PARP, infertility, spermatozoa, spermatogenesis, oxidative stress, DNA 
Repair, apoptosis, PARG.
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parp in male gametes
Introduction
Male fertility is affected by a variety of environmental, behavioral, and genetic factors 
that can alter spermatogenesis at various levels 1-3. Male germ cells are exposed to a 
wide variety of endogenous and exogenous genotoxic agents. Endogenous agents 
include reactive oxygen and nitrogen species generated during the metabolic 
activities of cells 4, 5. Exogenous agents include various environmental factors that can 
inflict damage to genomic DNA. These genotoxic agents can introduce DNA lesions 
in the form of DNA single and double strand breaks, abasic sites, base damage, 
inter-and intra-strand cross links and DNA-protein cross links 6, 7. Origin of DNA damage 
in human spermatozoa can occur by abortive apoptosis, abnormal chromatin 
packaging, generation of reactive oxygen species and premature release from Sertoli 
cells 8-12. During spermatogenesis, germ cell nucleus is nicked by topoisomerases in 
order to relieve the torsional stresses created when DNA is compacted into the dif-
ferentiating sperm head. Persistence of DNA strand breaks during different stages of 
spermatogenesis contribute to DNA damage detected in mature spermatozoa 13, 14. As 
spermatids are haploid, they must resolve double stranded DNA breaks by an 
error-prone DNA repair mechanism 15. An interest in male germ cell DNA quality has 
increased in recent decades especially in the era of assisted reproductive technologies 
(ART). As natural selection of spermatozoa for fertilization is bypassed in procedures 
such as intracytoplasmic sperm injection (ICSI), awareness has been raised regarding 
the possibility of congenital anomalies. Many reviews have dealt with the origin of 
sperm DNA integrity, evaluation of available technologies to assess sperm DNA 
integrity and its impact on the ART outcome 16-24. Environmental, life style and 
occupational hazards in male infertility have also been extensively studied 25-33. These 
factors may affect DNA repair pathways and impact male fertility and subsequent 
embryo development. 
In this review we will discuss the role of Poly (ADP-ribose) polymerase (PARP) as one 
of the DNA damage repair proteins and highlight its role in ejaculated human 
spermatozoa. Recently the focus of PARP’s role in malignancy has intensified to 
include use of PARP inhibition as an adjuvant therapy with chemotherapeutic drugs 
34. As our interest lies primarily in male reproductive health, in this review we will focus 
on the biological role of PARP in general as well as in male gamete and highlight 
possible role of PARP in modulating DNA damage in male germ cells. 
Poly (ADP-ribose) polymerase (PARP)
Poly (ADP-ribose) polymerase (PARP), a nuclear enzyme has a particularly well-re-
searched role in base excision repair; it is one of the primary repair mechanisms to 
resolve DNA lesions caused by endogenous processes as well as those caused by 
exogenous chemical exposure and irradiation 35, 36. PARP also has a well-documented 
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role in testicular germ cells 37-39, including a role in DNA damage repair of germ cells 40. 
However, a similar role for PARP in human ejaculated spermatozoa is still being 
investigated. The last decade has seen increasing interest in the relationship between 
DNA integrity in mature ejaculated spermatozoa and male infertility 16, 25, 41-43. Focus on 
the genomic integrity of the male gametes has been further intensified by the 
growing concern about the transmission of genetic diseases through intracytoplasmic 
sperm injection (ICSI) 44-49.
Proteins involved in the major repair pathways have been shown to be expressed in 
the testis 50. PARP proteins are involved in detection of strand breaks and signaling in 
both the base excision repair and nucleotide repair pathways 51, 52. PARP catalyzes poly 
(ADP-ribose) (PAR) polymerization from donor NAD+ molecules into target proteins. 
PARP1 is the prototype and most abundantly expressed member of a family of PARPs. 
The PARP family consists of 18 homologues (PARP 1-18) with a conserved catalytic 
domain made up of 50 amino acid residues that serve as the ‘PARP signature’ 53. This is 
the site where poly(ADP-ribose) (PAR) chains are initiated, elongated, and where 
branching of the chains can occur 54. Besides this catalytic domain, PARP family 
members may also have other domains including DNA binding domains, macro- 
domains, breast cancer-1 (BRCA-1) C-Terminus (C-T) domain, ankyrin repeats and a 
domain associated with protein-protein interaction called WWE. BRCA-1 C-T domains 
are characteristic of proteins responding to DNA damage at cell cycle checkpoints 
while WWE domains are found in proteins associated with ubiquitination. All of 
these special types of domains contribute to the unique functions of each family 
member 53, 55, 56.
PARP family members can be divided into several subcategories or groups based on 
each protein’s established functional domains and precise functions into: 1) DNA 
dependent PARPs (PARP1 and PARP2) that are activated by DNA strand breaks 
2) Tankyrases (tankyrase-1 and tankyrase-2) that serve diverse functions such as 
telomere regulation and mitotic segregation 3) CCCH-type PARPs (PARP12, PARP13) 
which contain special CCCH type zinc fingers and 4) PARP9, PARP14, and PARP15 
consisting of macro PARP’s which have 1-3 macrodomains connected to a PARP 
domain. They also have WWE domain and PARP catalytic activity. PARP6, 8, 11 and 16 
do not have any recognized domains or functions  and therefore they have not been 
assigned proper nomenclature 56.
Recent classification system by Hassa and Hottiger groups PARPs on the basis of their 
catalytic domain sequences54. PARP family is divided into 3 separate groups: 1) PARP1, 
PARPb (short PARP1), PARP2, and PARP3, 2) PARP4 and 3) 2 PARP members, Tankyrase-1, 
tankyrase-2a, and its isoform tankyrase-2b (also known as PARP5 and PARP6a/ b) 54. 
The various PARP enzymes can also have different subcellular localization patterns. 
PARP1 and 2 are considered nuclear enzymes and are found in the nucleus of cells. In 
contrast, tankyrases and PARP3 are found in both the nucleus and cytoplasm 54, 57. 
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Perhaps the best studied member of the PARP family is PARP1, a 113 kD enzyme 
encoded by the ADP-ribosyl transferase (ADPRT) gene in humans located on 
chromosome 1 58, 59. 
PARP1 has been reported to be involved in regulation of chromatin structure and 
transcription processes in response to specific signaling pathways 55. The protein 
structure of PARP1 is well characterized. Figure 1 represents the PARP1 structure 
domains with clarification on the sites of the zinc fingers, PAR acceptance, and 
cleavage site with short and long cleaved PARP1 fragments. PARP1 is made up of 3 
functional domains including DNA binding domain (DBD), automodification domain 
(AMD) and catalytic domains (CD). The DNA binding domain contains zinc fingers that 
can bind to breaks in DNA and contains the nuclear localization signal (NLS), which 
ensures the translocation of PARP1 into the nucleus and also forms a site of cleavage 
by caspase 3. The AMD is responsible for addition of ADP-ribose polymers to PARP1 
itself. The catalytic domain is responsible for the PARP activity 60 (Figure 1). 
Figure 1  Structural domians of PARP and its fragments showing A: DNA binding domain 
containing Zinc fingers (F1-F3) for nucleosome binding and nuclear localization (NLS) segment; 
Automodification domain responsible for adding ADPR (ADP-ribose) polymers through 
binding with Lysine (K) amino acid and catalytic domain has the PARP signature and PARP 
enzymatic activity. B: Full length PARP1 113 KDa molecule with a mark on the site of cleavage 
(214/215 amino acids) C: PARP cleavage by caspase showing short (24 KDa) and long (89 KDa) 
cleaved PARP fragments.
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The DNA binding domain extends from the initiator methionine (M) to threonine (T) 
373 in human PARP1, and contains 2 well known structurally and functionally unique 
zinc fingers (FI: amino acid 11–89; FII: amino acids 115–199) 61, 62. A recently discovered 
third and thus far an unrecognized zinc-binding motif, (FIII: amino acid 233–373) has 
been reported 63, 64. DNA binding domain contains a bipartite nuclear localization 
signal (NLS) of the lysine (K) rich form KRK-X -KKKSKK (amino acid 207–226) that targets 
PARP1 to the nucleus 65. Zinc fingers FI and FII are thought to recognize altered 
structures in DNA rather than particular sequences. These zinc fingers have been 
reported to be involved in protein – protein interactions 66. PARP1 strongly associates 
with single and double strand DNA breaks generated either directly by DNA damage 
or indirectly by the enzymatic excision of damaged bases during DNA repair processes. 
Several studies suggest that the first zinc finger is required for PARP1 activation by 
both DNA single and double strand breaks, whereas the second zinc finger may 
exclusively act as a DNA single strand break sensor 61, 62, 67. Additional studies are 
necessary for further identification of interactions/localization of PARP or different 
mutation/ polymorphisms of PARP in the pathophysiology of oxidative stress, 
apoptosis and malignancies 68.
The major PAR acceptor protein is PARP1 itself, which appears to accumulate roughly 
90% of cellular PAR via PARylation of its auto-modification domain. Binding of NAD 
(monomer of ADP-ribose) with PARP1 is mainly through hydrogen bonds and other 
with the oxygen molecule from glutamic acid residue on the c-terminus mainly the 
automodification domain 53. Interestingly, Altmeyer et al (2009) showed that glutamic 
acid residue in the automodification domain of PARP1 is not required for PAR 
formation. Instead they identified lysine residues to be the PAR acceptor sites in 
PARP167. 
Role of PARP in metabolic pathways 
The real challenge and the difficulty in understanding PARP interaction and PAR 
metabolism is the lack of structural information that can be provided by X-ray crystal-
lography or by nuclear magnetic resonance (NMR). Prior to the recent findings by 
Altmeyer et al 67, the intense research on PARP was unable to confirm the presence of 
glutamic acid residue in the AMD that may be functioning as the PAR acceptor of 
amino acid in PARP1 69. This was mainly due to the lack of mutational studies for PARP. 
Figure 2 explains the possible PARP interaction with the main proteins involved in 
DNA repair during DNA damage/ repair process. The primary catalytic function of 
PARP enzymes is to transfer ADP-ribose groups to the glutamate, aspartate and car-
boxy-terminal lysine residues of proteins. With NAD serving as a cofactor, PAR 
polymerization begins by breaking the glycosidic bond between ADP-ribose and 
nicontinamide. PARP can elongate the amino acid chains of recipient proteins in a 
linear or branched manner by the addition of up to 200 ADP-ribose groups 70. 
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PARP attaches ADP-ribose groups to a variety of protein substrates. Perhaps the most 
common target of (ADP-ribosyl)ation is PARP1 itself, termed auto-modification 71. 
PARP enzymes commonly modify nucleosome proteins in order to restructure 
chromatin. While both histone H1 and H2B are acceptors of poly ADP-ribose, histone 
H1 is the major acceptor recipient 72, 73. Histone H1t, a major H1 variant in testis, is the 
main H1 target of PARP during spermatogenesis 74. PARP activity is not restricted to 
nuclesome proteins; the well-known tumor suppressor protein p53 is also modified 
by PARP1. This modification transcriptionally inactivates p53 75. DNA polymerases 
modified by PARP have also been inhibited during in vitro studies 76. Toposiomerase II 
can also be modified by PARP activity 77. Similarly, the transcription nuclear factor 
kappa β (NFk-β) can also be modified by ADP-ribose group attachment 78. 
Regulation of PARP activity is important for exploring the therapeutic options of this 
enzyme. Several types of molecules have been identified as activators of PARP activity 
including histones, a common target of PARP. Though histones H1 and H2B are 
modified by PARP1, histones H1 and H3 reciprocally activate PARP1 79, 80. Apart from 
ribosylation, the structure of histones is regulated by acetylation and silent information 
regulator gene (SIRT1), a histone deacetylase, involved in the maintenance of histone 
structure. SIRT1 has a regulatory action on PARP1 activity and in the absence of SIRT-1, 
PARP remains unregulated resulting in apoptosis inducing factor (AIF) regulated cell 
death 81. PARP activity is also activated by a number of metal ions (like magnesium and 
calcium) and polyamines. Incidentally, calcium ions also play an important role in the 
pathophysiology associated with oxidative stress and could provide a link to explain 
the effect of oxidative stress on PARP activity 82-86. 
There are a number of inhibitors used to study PARP activity such as endogenous 
purines (hypoxanthine and inosine) or exogenous molecules like caffeine derivatives 
or tetracycline derivatives 80, 87. PARP1 phosphorylation by ERK1/2 is required for 
maximal PARP1 activation after DNA damage 88. Furthermore DNA-dependent protein 
kinase (DNA-PK), a protein involved in the repair of double strand breaks results in 
suppression of PARP activity probably through direct binding and/or sequestration of 
DNA-ends which serve as an important stimulator for both DNA-PK and PARP 89.
PARP in mammalian cells
The most important role of PARP is its capacity to repair DNA, especially in resolving 
single strand breaks. PARP1 and PARP2 have been shown to function in the repair of 
base excision 60. Additionally, PARP1 may play a role in an alternate version of double 
strand DNA break repair involving the DNA repair protein XRCC1 (X-ray repair 
complementing defective repair in Chinese hamster cells 1) along with Ligase III and 
DNA-dependent protein kinase involved in resealing DNA breaks 90, 91. PARP interactions 
and its role in the DNA repair process is explained in Figure 2. PARP1/ PARP2 get 
activated with DNA breaks and interact along with other main DNA repair proteins 
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(XRCC1, DNA polymerase, DNA ligase III, and other DNA binding proteins to repair the 
damaged DNA strand. Heat shock protein may provide additional activation for the 
PAR formation early in the DNA repair 92 (Figure 2).
PARP1 binds to broken strands of DNA and automodifies itself. It then dissociates from 
the single DNA strand due to the negative charge it acquires from the ADP-ribose 
group. After dissociating, PARP associates with DNA Ligase III alpha, which is involved 
in the resealing of DNA breaks, and XRCC1. XRCC1 then recruits other repair factors 
(such as DNA polymerase β, apurinic-apyrimidinic (AP) endonuclease, and poly-
nucleotide kinase) to complete the repair process 93. Thus, PARP1 is part of an 
important signaling pathway for DNA damage repair due to its ability to recruit other 
Figure 2  PARP interactions in DNA damage/ repair showing A: DNA damage caused by 
genotoxic agents activates PARP with HSP70 (heat shock protein 70) providing further 
activation B: activation of PAR formation with further help from other DNA repair proteins such 
as XCCR1 (X-ray repair complementing defective repair in Chinese hamster cells) that help DNA 
polymerase to start sealing the damaged DNA strand C: DNA polymerase and ligase seal the 
DNA nicks releasing PARP and other DNA binding proteins and D: repaired DNA.
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repair enzymes necessary to preserve DNA integrity of a cell. The role of PARP1 in base 
excision repair (BER) was recognized by its interaction with DNA polymerase β and its 
interaction with DNA Ligase III and XRCC1. It was also shown that PARP1 deficient cells 
demonstrated significantly inhibited BER activity 94. 
Similarly, PARP2 has also been shown to participate in BER pathways, associating with 
DNA polymerase β, XRCC1, and DNA Ligase III 51. PARP2 deficient mice showed 
significant delays in resealing single strand DNA breaks similar to those seen in PARP1 
deficient mice. This is interesting because PARP2 activity is 10 times less than that of 
PARP1. PARP1 and PARP2 also appear to homodimerize and heterodimerize as a part 
of DNA repair 51. PARP not only serves as part of a signaling pathway in DNA damage 
repair but it is also involved in the repair process. In particular, the binding of PARP1 to 
the broken ends of DNA may protect it from degradation by nucleases 95. NBS1 
(Nijmegen Breakage Syndrome 1) has been recently reported to be required for base 
excision repair (BER) 96.
A model put forth recently suggests that the involvement of PARP in DNA damage 
repair is regulated by a feedback mechanism 97. PARP1 is first recruited to the DNA 
break site and then binds to this site through its DNA binding domain. The addition of 
poly (ADP-ribose) (PAR) units enables the recruitment of more PARP1 moieties through 
the AMD of PARP1. The aggregation of PARP molecules then creates a signal that 
recruits other repair factors and forms the positive feedback mechanism of PARP. 
Interestingly, PARP activity is subject to a negative feedback mechanism that prevents 
excessive accumulation of poly (ADP-ribose) and cell death 98, 99. 
PARP in cell cycle and Cell death 
In addition to being involved in the rescuing function of DNA repair, PARP1 is also 
directly involved 100 in both programmed cell death as well as necrosis 101-103 (Figure 3). 
PARP is part of the caspase-dependent pathway of apoptosis and as part of this 
caspase mediating pathway; PARP1 is cleaved by Caspase-3 into a 25 kDa N-terminal 
and an 85 kDa C-terminal fragment. The 25 kDa fragment consists of the DBD and the 
85 kDa fragment consists of the AMD and CD (Figure 1). The detachment of the 
DNA-binding domain from the automodification and catalytic domains inactivates 
PARP1 and allows apoptosis to occur 104. Meanwhile, the N-terminal fragment inhibits 
any uncleaved PARP1 molecules that are still present. Thus, PARP1 cleavage effectively 
inhibits PARP activity that could result in energy depletion as a result of consumption 
of a significantly large number of Nicotinamide adenine dinucleotide (NAD) molecules 
and lack of ribosylation 105. PARP1 is also involved in a caspase-independent cell death 
pathway. When PARP1 is activated by exposing fibroblast cultures to hydrogen perox-
ide-induced damage, it triggers caspase-independent pathway. PARP activation 
triggered the release of AIF from the mitochondria and caused it to relocate to the 
nucleus resulting in chromatinolyis 55, 106-108. 
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PARP is also involved in a less organized version of cell death-necrosis. Originally 
Berger et al proposed that depletion of NAD caused an over-activation of PARP and in 
the milieu of excessive DNA damage can cause necrosis 109. Heeres and Hergenrother 
proposed that over-accumulation of poly (ADP-ribose) are cytotoxic to cells and 
induce them to undergo necrosis. Thus PARP appears to be a two-sided coin. It has 
the potential to respond to threats to DNA integrity, but its over-activation can lead to 
cell death 101. Figure 3 represent a schematic pathways link the ROS and genotoxins 
induced DNA damage with the ATP/NAD levels that may determine the cell death 
pathway depending upon the extent of the DNA damage, caspase activation, and 
ATP/ NAD levels. Modification of PARP activity through inhibition or cleavage may 
lead to apoptosis through preventing DNA repair provided by PARP. However, recent 
Figure 3  Possible role of PARP in cell death in the event of DNA damage caused by ROS or a 
genotoxin, PARP targets the damaged site. If high damage occurs, PARP may become 
over-activated resulting in ATP/ NAD depletion and necrosis. Apoptosis can also occur through 
caspase-3 activation and PARP cleavage. If low damage occurs, PARP can recruit other repair 
enzymes and DNA repair can occur. Recently PARP1 dependent cell death termed as 
parthanatos has been reported, and is distinct from apoptosis, necrosis or autophagy.
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report indicate that PARP may lead to PARP1 dependent cell death that is reported to 
be distinct from apoptosis, necrosis or autophagy and it is called parthanatos 110.
The role of PARP in maintaining genomic integrity could have profound implications 
for cell division. PARP is associated with specific structures important for cell division 
such as centromeres and centrosomes, pointing to its possible role in cell division. 
PARP1 associates with centrosomes during cell division and interphase, which may be 
related to PARP1’s role in maintaining chromosome stability 111. PARP1 is also involved 
in spindle structures necessary for cell division. Poly (ADP-ribosyl)ation of spindle 
structures is essential for normal functioning and assembly of spindles that if disturbed 
could result in defective chromosome segregation 112, 113. PARP3 also demonstrated an 
interaction with PARP1 at centrosomes 57. PARPs also localize to active mammalian 
centromeres primarily during metaphase and prometaphase 114, 115. PARP1 and PARP2 
bind to the same centromere proteins, including the important mitotic checkpoint 
protein and Bub3 (budding uninhibited by benzimidazoles 3) 55.
Chromatin remodeling and transcription
Poly(ADP-ribosyl)ation can be considered an epigenetic modification 116 because its 
modification of histones can remodel chromatin structure in order to provide unique 
information for other proteins involved in not only DNA repair but also in transcription 55, 97. 
The role of PARP in transcription is a result of two important aspects of its function: its 
modification of histones and interaction with other coactivators and DNA binding 
factors to bind to the enhancer promoter regions 117-119.
The chromatin environment is very important for transcription and the role of PARPs 
in chromatin remodeling has been well documented 55, 108. PARP has been found to 
associate with the Facilitates of Chromatin Transcription (FACT) complex, a protein 
complex involved in chromatin remodeling. Poly (ADP-ribosyl)ation of the FACT complex 
prevents the interaction between FACT and nucleosomes in vitro 120. As mentioned 
before, Histone H1 and H2B are major acceptors of PARP modification and this 
modification can also remodel chromatin structure 116. Specifically poly (ADP- ribosyl)
ation of nucleosome structures can cause relaxation of chromatin structure 116, 121, 122. 
In a recent study, PARP1 was shown to be broadly distributed across the human 
genome. Furthermore, PARP1 and histone H1 were shown to have reciprocal roles in 
regulating gene expression. When there is increased presence of PARP and decreased 
presence of H1 at promoter regions of genes, the genes are activated in 90% of the 
cases. When gene promoters had both decreased presence of PARP and H1, less than 
45% of genes were expressed 123. Tulin and Spalding reported that PARP can activate 
the transcription of heat shock proteins in Drosophila by decondensing chromatin 
structure 108. This was in contradiction to the study of Oei et al who showed that poly 
(ADP-ribosyl)ation of transcription factors for TATA-binding protein (TBP) or YinYang1 
(YY1) prevented these transcription factors from binding DNA 124. However, once TBP 
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or YY1 were bound to DNA, they were immune to the action of PARP. Therefore, 
PARP cannot dislodge TBP or YY1 once they are bound to DNA. In this way, PARP can 
prevent transcription in specific parts of the genome without disturbing ongoing 
transcription 60, 125, 126.
PARP interacts with transcription factors at enhancer and promoter regions via its 
involvement with NF-ĸβ, 23, 78, 127, 128. PAPR-NF-ĸβ interactions have important 
consequences for inflammation. PARP1 deficient mice cloned by Oliver et al were 
resistant to endotoxic shock normally induced by exposure to lipopolysaccaride (LPS) 102. 
This could be a result of decreased expression of genes controlled by NF-ĸβ 35, 97, 126, 129, 130.
The epigenetic role of PARP extends to other genomic structures besides histones. 
Poly (ADP-ribosyl)ation of the CCCTC-binding factor (zinc finger protein) CTCF gene, a 
chromatin insulator encoding protein has been shown to affect the ability of this 
protein to interact with over 140 target sites in mice 107, 131-133. The role of PARP in 
controlling the function of the CTCF insulator in the regulation of the transcriptional 
states of various genes further demonstrates the role of PARP in epigenetics 134, 135.
Poly (ADP-ribose) glycohydrolase (PARG) and PARP interactions
Poly (ADP-ribose) glycohydrolase or PARG is an enzyme involved in poly (ADP-ribose) 
metabolism. PARG removes poly (ADP-ribose) units from proteins and thus plays an 
equally important role as PARP in cellular function. Though PARG is found in the 
cytoplasm rather than the nucleus where PARP is found 136, PARG can be transported 
between the nucleus and cytoplasm in order to regulate the breakdown of poly 
(ADP-ribose) 137. It was found that a PARG deficiency in mice was lethal because of an 
accumulation of poly (ADP-ribose) 138. Specifically, PARG maintains chromatin structure 
by depoly (ADP-ribosyl)ation and by acting in opposition to PARP return chromatin to 
its original state. PARG accomplishes this by removing poly (ADP-ribose) groups from 
histones and once again allowing histones to form the nucleosome structure of 
chromatin 137. PARG is involved in DNA repair by regulating the amount of poly 
(ADP-ribose) synthesized in response to DNA damage since excessive poly (ADP-ribose) 
accumulation may result in cell death 101. PARG and PARP work in opposition to each 
other to modify chromatin structure 117, 122. When PARP creates transcriptionally active 
regions of chromatin, PARG restores chromatin to its original state. However, PARP 
does not always transcriptionally activate chromatin regions. For instance, in 
euchromatin regions, PARP is involved in chromatin de-condensation and promoting 
transcription while in heterochromatin regions it could repress transcription 117. PARG 
deficient human A549 carcinomic basal alveolar cells showed a dramatic deficiency in 
their ability to repair DNA single strand breaks in the face of oxidative damage while 
an excess of poly (ADP-ribose) was found to be lethal for these cells 139. Knocking out 
of PARG was found to be lethal in mouse embryonic cells at day 3 of gestation since PARG 
is the primary enzyme involved in breaking down Poly (ADP-ribose) (PAR) in cells 138.
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Due to its abilities to protect against DNA damage, PARG is involved in cellular 
responses to oxidative stress 140. In a recent study by Fisher et al, PARG was found to 
cooperate with PARP1 in responding to oxidative damage by regulating XRCC1 at 
DNA break sites created by oxidative damage 139. PARG has also been shown to protect 
against cell damage caused by genotoxic or oxidative stress even at sub-lethal levels 
by regulating poly(ADP-ribosyl)ation 138.
Role of PARP in germ cell death
Apoptosis is a normal component of mammalian spermatogenesis. It is orchestrated 
spontaneously during the entire stages of spermatogenesis in order to produce 
mature spermatozoa and to eliminate any abnormal spermatozoa. In fact, a very large 
number of spermatozoa die and are eliminated during spermatogenesis. This may be 
due to the ability of the Sertoli cells to maintain only a limited number of germ cells 
and resulting in the elimination of excess germ cells. Apoptosis may also function to 
destroy cells that do not make it past certain cellular checkpoints 141 Evidence seems 
to point to the notion that germ cell death during mitotic and meiotic cell divisions 
may be needed to eliminate problems such as errors in chromosomal arrangement 
during meiosis or un-repaired breaks in DNA. More importantly, apoptosis may be 
needed to prevent genetic abnormalities from being passed onto offspring 142. In a 
recent study, Codelia et al sought to determine which cell death pathway was involved 
in pubertal rat spermatogenesis. Using a caspase-8 inhibitor and a pan-caspase 
inhibitor they detected significantly less cleaved PARP and also a reduction in the 
number of apoptotic germ cells which suggests that germ cell apoptosis occurs via 
the Fas antigen (Fas)-Fas ligand (Fas-FasL) system and that PARP cleavage may play a 
key role therein 143. 
Not only does PARP have a well-defined role in DNA repair, but it is also involved in 
apoptosis. During apoptosis, numerous DNA strand breaks can lead to PARP activation. 
This activation of PARP may be an attempt by the dying cell to repair the DNA damage 
caused by nuclease activation 129, 144, 145. However, this attempt to repair damage proves 
futile as PARP is cleaved by caspase-3 into a catalytic fragment of 89 kDa and DNA 
binding unit of 24 kDa 61, 146. Therefore, this cleaved version of PARP could be a 
biochemical marker of caspase-dependent apoptosis 147, 148.
Deregulation of germ cell death can have important implications for male fertility. 
Patients with contralateral testes exhibit an increased incidence of apoptosis. The 
presence of apoptotic markers is high in these patients especially in spermatocytes, 
early spermatids, late spermatids, and Sertoli cells 149. Infertile men with spermatid and 
spermatocyte maturation arrest and hypospermatogenesis also showed a greater rate 
of apoptosis 150. Specifically, the Fas-FasL pathway and active caspase 3 were shown to 
have increased activity in testes with maturation arrest and Sertoli cell-only syndrome 
(SCOS) 127, 151. The greater rate of apoptosis seen with these infertility cases may be due 
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to elimination of germ cells with extensive DNA damage. Tesarik et al compared men 
with complete spermiogenesis failure to another group of azoospermic men who had 
incomplete failure of spermiogenesis and were able to show that apoptotic DNA 
damage was greater in the latter group when compared to the former. This greater 
extent of DNA damage seen in patients with complete spermiogenesis failure could 
be responsible for the low conception success rates in these cases 152. In a more recent 
study, Maymon et al proposed that the presence of greater levels of poly (ADP-ribose) 
in human spermatocytes during maturation arrest could be correlated with the 
greater occurrence of DNA strand breaks during impaired spermatogenesis 153.
PARP2 has also been implicated in abnormal spermatogenesis. In a recent study by 
Dantzer et al, PARP2 deficient male mice were found to have hypofertility 154. Upon 
examination of infertile PARP2 null mice, an increased incidence of testicular apoptosis 
was found specifically in the spermatocyte and spermatid layers. However, the layers 
containing spermatogonia and preleptotene spermatocytes largely remained normal. 
Chromosome segregation was abnormal during metaphase I and spindle assembly 
was also abnormal in these PARP2 deficient mice. Thus, the decrease in fertility seen 
in these PARP2-null mice could be related to defective meiosis I and spermiogenesis 
81. These results make it increasingly clear that apoptotic markers can be excellent 
diagnostic tools for evaluating fertility potential.
Exogenous agents applied to the testes may also activate caspase-dependent cell 
death pathway. For example, when the scrotal temperature was increased in rats over 
time, the mitochondria dependent cell death pathway in the testis was activated. The 
signaling cascade involved relocation of Bax, translocation of cytochrome C, activation 
of caspases, and the cleavage of PARP 155. Although it is not clear what the precise role 
of PARP is in exogenously induced apoptosis, a study of PARP’s protein targets may 
elucidate this role.  Following exogenous stress, p53 levels increase and are considered 
to be a part of the mechanism that returns spermatogenesis to normal cycles 
following apoptosis. P53 is a downstream protein poly (ADP-ribosyl)ated by PARP 71, 75, 
156, Under conditions of inflammation, PARP poly (ADP-ribosyl)ates and activates 
NF-ĸβ in human Sertoli cells 157. Treatment with anti-inflammatory agents suppressed 
this cell death pathway and validated the involvement of PARP in inflammatory 
responses 158, 159. It remains to be seen if this anti-inflammatory activity of PARP could 
also be applied to germ cells.
PARP and spermatogenesis 
PARP1 has been detected in the nuclei of a variety of tissue types including the brain, 
heart, kidney, and testis 121. PARP2 has been detected in the liver, kidney, spleen, 
adrenal gland, stomach, intestinal epithelium, thymus, brain tissue, and testis. PARP2 
expression is weaker than that of PARP1 and is well distinguished 51. PARP1 has high 
levels of expression in the basal regions of seminiferous tubules of developing mice, 
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but has almost no presence in the luminal region of the seminiferous tubules, 
suggesting that PARP1 is down-regulated during the haploid stage of meiosis 51.
Highest concentration of PARP1 is in rat primary spermatocytes followed by spermatids 
160, 161. In a study by Tramontano et al examining rat primary spermatocytes it was 
found that both PARP1 and PARP2 are present in these germ cells. However, the vast 
majority of poly (ADP-ribose) in these rat primary spermatocytes was produced by 
PARP1 suggesting possibly different roles of PARP1 and PARP2 in spermatogenesis 107. 
Interestingly, PARG has also been detected in the nuclei of rat primary spermatocytes 
160 suggesting the presence of a mechanism to regulate the levels of poly (ADP-ribose) 
in germ cells.
In a recent study using human testicular samples, it was shown that that the strongest 
levels of PARP1 were found in spermatogonia. Presence of poly (ADP-ribose) differed 
slightly with the stage of spermatogenesis. Poly (ADP-ribosyl)ation was strongest in 
human round and elongating spermatids as well as in a subpopulation of primary 
spermatocytes. In contrast, mature spermatids had no PARP expression or poly(ADP-
ribosyl)ation 153.  This is in accordance with a study in rat germ cells where poly 
(ADP-ribose) and NAD levels progressively decreased from primary to secondary 
spermatocytes and to a greater extent in spermatids 74. This decrease in PARP1 levels 
and activity throughout differentiating male germ cells may be correlated with the 
changes in chromatin structure associated with spermatogenesis. The chromatin 
remodeling steps of spermatogenesis include the replacement of histones by 
protamines 162 and a transition from a supercoiled form of DNA to a non-supercoiled 
form 163. It is during these chromatin remodeling steps of spermiogenesis that DNA 
strand breaks can occur. In human testis, an increase in DNA strand breaks occurs in 
100% of elongating spermatids 164. These breaks were later demonstrated to be 
double stranded breaks caused by topoisomerase II as a result of the unique chromatin 
packaging steps that take place during spermatogenesis 14.
Meyer-Ficca et al (2005) demonstrated the presence of poly (ADP-ribose) (PAR) in 
elongated spermatids of rat 39. They showed that during these steps when a high 
number of DNA breaks occur directly preceding nuclear condensation, there is cor-
respondingly a higher amount of poly (ADP-ribose) in rat germ cells. Greater poly 
(ADP-ribose) formation through PARP1 and PARP2 action occurs during this phase of 
spermatogenesis that includes a great deal of chromatin condensation (steps 11-14 of 
rat spermatogenesis), poly (ADP-ribose) levels decrease only when protamines appear 
in the chromatin. Thus, poly (ADP-ribose) formation could be important for repairing 
DNA strand breaks during these crucial chromatin remodeling steps of spermatogen-
esis 39, 165. Furthermore, poly (ADP-ribose) formation could also be important for 
histone modification because not only is there auto-modification of PARP during 
spermatogenesis, but much of PARP activity is targeted towards the testes-specific 
histone, H1t. The activation of Histone 2A (H2AX), a biological marker of DNA breaks, 
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and the poly (ADP-ribose)ylation of histones at break sites may act as markers of such 
damage 166. Thus, the activity of PARP during the chromatin remodeling steps of sper-
matogenesis in terms of repairing double stranded breaks and the poly(ADP-ribosyl)
ation of histones, is critical and disregulation of the chromatin remodeling steps of 
spermiogenesis could have serious consequences for the male gamete 164. PARP2 
knockout mouse was shown to be associated with severely compromised spermatids 
and delays in elongation process 167. Heat stress has been reported to decrease PARP 
expression in the rat testis 50. However heat shock protein was reported to activate the 
PARP and PAR formation 92.
The quest to detect PARP in ejaculated spermatozoa has met with success only 
recently. Taylor et al did not detect the presence of PARP1 in human ejaculated sperm 
samples when analyzing semen for apoptotic markers 168. However, in a recent study 
by Jha et al, 169 several isoforms of PARP were detected in ejaculated spermatozoa 
including PARP1, PARP2, and PARP9. Immunolocalization patterns showed that PARP 
was found near the acrosomal regions in sperm heads. Furthermore, a direct 
correlation was seen between sperm maturity and the presence of PARP, i.e., an 
increased presence of PARP1, PARP2, and PARP9 was seen in mature sperm when 
compared to immature sperm. Just as importantly, the level of PARP1, PARP2 and 
PARP9 was more in ejaculated sperm from fertile men when compared to infertile 
men indicating a possible relationship between PARP and male infertility. PARP 
activity was then modulated to determine its role in the response to oxidative and 
chemical damage in sperm. In the presence of a PARP inhibitor, 3-aminobenzamide, 
chemical and oxidative stress-induced apoptosis increased by nearly two-fold. This 
novel finding suggests that PARP could play an important role in protecting 
spermatozoa subjected to oxidative and chemical damage 169.
PARP and sperm DNA 
Recently the importance of DNA damage to sperm of infertile men has gained 
attention.  It has been shown that that a higher index of DNA damage can possibly 
lead to lower semen quality. In a study involving 322 couples, when DNA fragmentation 
exceeded an index of 15%, there was increased incidence of non-transfer and 
miscarriages after performing intracytoplasmic sperm injection (ICSI) 170. Studies such 
as these warrant the investigation of factors that are responsible for maintaining 
genomic integrity especially in ejaculated spermatozoa. DNA damage repair through 
PARP activity has been demonstrated in rat germ cells. Atorino et al showed that after 
extensive DNA damage in rat spermatids and spermatocytes caused by radiation and 
ROS damage in vivo, a PARP inhibitor caused a delay in DNA damage repair 40. They 
were able to demonstrate up to a 3-fold increase in PARP activation as cells recovered 
from these damaging agents 60, 125, 126. The main difference between spermatids and 
primary spermatocytes was that only spermatids showed detectable poly (ADP- ribose) 
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production after genotoxic stress. Atorino et al hypothesized that primary sperma -
tocytes did not show the same degree of response possibly due to the different 
chromatin states of these two germ cells. Thus, PARP activity in response to genotoxic 
stress may be important for preventing mutations from accumulating and being 
passed on to offspring 40.
Though the role of PARP in repairing DNA damage in ejaculated spermatozoa has yet 
to be thoroughly investigated, it has been found that DNA damage caused by sperm 
cryopreservation can be repaired through PARP activity. In a study by Kopeika et al, 
cryopreserved sperm from loach (fresh water fish related to crab) were used to fertilize 
eggs and the embryos were exposed to a PARP inhibitor 171. It was found that survival 
was significantly decreased in embryos exposed to PARP inhibitors when compared 
to control. This study suggests a possible role for PARP in repairing paternal DNA 
damage and it also showed that it was possible for the oocyte to repair this damage 
even in the face of PARP inhibition 171.
Cryopreservation is not the only threat to genomic integrity. It is still controversial 
whether malignancy itself is the cause of chromatin damage in mature spermatozoa. 
In a study analyzing 75 men with various types of testicular and non-testicular cancers, 
the degree of DNA fragmentation did not differ between types of cancer. But 
surprisingly, the levels of DNA fragmentation in cancer patients were similar to the 
levels found in infertile men 172. Another study found that patients with testicular 
cancer and Hodgkin’s Lymphoma were normospermic, but had increased levels of 
DNA damage along with decreased chromatin compaction 173. However, a third study 
in the same year hypothesized that malignancy alone was not responsible for 
increased DNA damage seen in sperm. This study showed that thawed sperm samples 
from cancer patients had similar levels of DNA fragmentation to that of sperm with 
low freezability collected from healthy donors. Thus, this study attributed the 
increased sperm DNA damage seen in the decreased freezability of these semen 
specimens and not to malignancy 174.
Nonetheless, cancer patients are advised to freeze sperm prior to therapy as an option 
to preserve their fertility potential. Patients undergoing radiotherapy have shown a 
temporary increase in the sperm with DNA strand breaks and a decrease in fertility 
despite having normal sperm concentrations (normozoospermic) 42. Chemotherapy 
does not produce the same deleterious effects as radiotherapy in its initial phase. 
Decrease in sperm DNA fragmentation is generally seen after 3 or more cycles of 
chemotherapy 175. Chemotherapy (especially alkylating agents) and radiotherapy, 
even in low doses, can damage the seminiferous epithelium and impair spermato-
genesis in both children and adults 176.
Apart from treatment by either chemo- or radiotherapy, malignancy itself causes a 
significant threat to sperm DNA damage. This could mean that cryopreservation of 
sperm prior to therapy may not be sufficient to preserve fertility 175. Instead, therapeutic 
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options such as PARP activity modifications could be used in order to retain genomic 
integrity under threats of malignancy and radiotherapy, so that we may get rid of the 
low quality spermatozoa that have DNA damage 177, 178.
Sperm DNA damage repair defects
DNA polymerase activity in non-replicating cells is associated with DNA repair. 
Consequently, increase in apoptotic markers seen in the semen of infertile men may 
also be an indicator of increase DNA repair activity 15. Evidence from the literature 
indicates that DNA repair systems may play a role during spermiogenesis. Elements of 
base excision repair (BER) have been identified in elongated spermatids 179. Mismatch 
repair (MMR) involving the mutS homolog 2 (MSH2) proteins has a role in 
spermiogenesis. Interestingly, in a mouse model for Huntington disease, deletion of 
MSH2 in Huntington disease abolished trinucleotide cytosine-adenine-guanisine 
(CAG) repeat expansion between round spermatids and spermatozoa. CAG, is a DNA 
mutation responsible for causing any type of disorder categorized as a trinucleotide 
repeat disorder. Presence of CAG repeat expansion may explain the earlier onset of 
the disease and the severity of the symptoms through successive generations of an 
affected family due to the expansion of these repeats. Deletion of MSH2 suggests an 
active role for MSH2 during extensive DNA repair 180-183. Quite interestingly, caffeine 
may lead to inactivation of H2AX and non-homologous end-joining (NHEJ) DNA 
repair 184. Impairment in DNA repair during spermiogenesis may result in persistent 
double stranded breaks in mature spermatozoa. Further investigation may provide 
important clues regarding the consequences of the endogenous DNA strand breaks 
and repair in spermatids and mature spermatozoa 185.
Down regulation of DNA repair genes such as Ogg1 (involved in base excision repair), 
Rad54 (involved in double-strand break repair) and Xpg (involved in nucleotide 
excision repair) has been reported using global genome expression by DNA microarray 
following exposure to heat stress at 43oC 30. Heat stress induced by cryptorchidism 
appears to result in decreased expression of DNA polymerase B and DNA ligase III 
both of which are involved in the final stages of DNA repair 186, 187. 
PARP - a new marker in ejaculated spermatozoa
The role of PARP in DNA repair (Figure 2) and its presence during stages of spermato-
genesis suggest that it is involved in maintaining genomic integrity in ejaculated 
sperm. However, the presence of PARP has only recently been shown in ejaculated 
sperm samples. Furthermore, Jha et al have suggested a correlation with the presence 
of PARP and male fertility 169. This study suggested that the decreased presence of 
PARP in the sperm of infertile men could be the cause of increased DNA damage seen 
in poor quality semen samples. DNA damage repair in germ cells as mediated by PARP 
is therefore a hitherto unexplored confounder of male fertility. Further studies are 
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needed to fully explore the role of PARP in DNA repair especially in reproductive 
medicine 50-52, 55, 188.
The existing methods of detecting infertility from semen samples are quantitative 
methods involving the count and observation of sperm and are dubious due to the 
constantly changing ‘normal’ seminal values. A qualitative method would thus serve 
as a more reliable method of detecting infertility 125, 162. In view of this, the detection of 
apoptotic markers such as caspase and phosphatidylserine have been successfully 
correlated with a variety of infertility conditions; however, the use of PARP as an 
apoptotic marker has not been fully explored. 
Taylor et al found greater caspase activity in low motility sperm samples from infertile 
men when compared to those with high motility 168. The active caspase enzymes 
have been localized in the human spermatozoa predominantly in the post acrosomal 
region (caspase 8, 1 and 3) 189-191 or in the mid-piece 192. A significant positive correlation 
between in-situ active caspase-3 in the sperm midpiece and DNA fragmentation was 
observed in the low motility fractions of patients, suggesting that caspase-depen-
dent apoptotic mechanisms could originate in the cytoplasmic droplet or within 
mitochondria and function in the nucleus 193. These data suggest that in some 
ejaculated sperm populations, caspases are present and may function to increase PS 
translocation and DNA fragmentation. Furthermore fluorescence staining of active 
caspases localized the enzymes mainly to the postacrosomal region in sperm from 
donors. This pattern differed slightly from that of patients, in whom additional 
cytoplasmic residues were found to be highly positive 194. 
In an interesting study published by Falerio and Lazebnik in 2000, question as to how 
caspase 3 which is usually cytoplasmic gains access to its nuclear targets was 
examined 195. These investigators suggested that caspase-3 was actively transported 
to the nucleus through the nuclear pores. They found that caspase-9, which is 
activated earlier than caspase-3, directly or indirectly inactivated nuclear transport 
and increased the diffusion limit of the nuclear pores. This increase allowed caspase-3 
and other molecules that could not pass through the nuclear pores in living cells to 
enter or leave the nucleus during apoptosis by diffusion. Hence they suggested that 
caspase-9 contributes to cell disassembly by disrupting the nuclear cytoplasmic 
barrier 195. 
Unlike somatic cells, early studies were not able to detect PARP1 or AIF (which is 
activated by PARP) in ejaculated sperm 106, 168, 196, 197. Similarly, the presence of cleaved 
PARP could not be detected in ejaculated sperm 198; although PARP activity was 
demonstrated in the testis 199. We studied the localization of the PARP in mature and 
immature spermatozoa in fertile and infertile men 169. Mahfouz et al were the first to 
demonstrate the presence of cleaved PARP in ejaculated spermatozoa. When these 
sperm samples were exposed to PARP inhibitors after chemical and oxidative stress, 
there was a decreased incidence of apoptosis 200. These authors did not study PARP 
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and caspase 3 co-localization and they proposed that PARP cleavage may occur by 
activated caspase 3 located in the post acrosomal region. It would be worthwhile to 
replicate these findings in other mammals and investigate the use of cleaved PARP as 
a diagnostic tool to predict/ detect male infertility. 
PARP and oxidative stress 
Oxidative stress (OS) occurs when there is an increase in the levels of reactive oxygen 
species (ROS) and/ or a decrease in the activity of the antioxidant enzymes that 
scavenge these harmful free radicals 201, 202. Such conditions of oxidative stress arise 
when germ cells are faced with biological (such as lipopolysaccharide, LPS) or 
chemical stressors (e.g. environmental toxicants, endocrine disruptors etc.) 20, 31, 203-205. 
The extent of oxidative stress induced depends on the dose and duration of exposure 
to the stressor 205. Oxidative stress can cause modification of proteins associated with 
developing spermatozoa and cause the premature release of sperm from seminiferous 
tubules 206. Even a transient state of oxidative stress, spanning a few hours has been 
shown to bring about protein changes and stimulate a caspase-3-mediated cell death 
pathway and apoptosis 43, 207. In the reproductive milieu, oxidative stress is also linked 
to inflammation particularly since inflammatory cytokines dramatically arrest sper-
matogenesis and may lead to infertility 208. However, the most important effect is the 
ability of oxidative stress to cause DNA damage. PARP responds to all three of these 
changes that can occur in the cell as a result of oxidative damage. However, there is a 
great deal of variability in PARP activation as a result of this type of stress depending 
on the metabolic stage of the cell or its microenvironment 209-211. As a result of its 
interaction with NF-ĸβ, PARP has an important role in the inflammation process 78, 102. 
In response to DNA damage caused by oxidative species, PARP1 recruits the DNA 
repair protein XRCC1 to the sites of the damage 212. In addition to causing damage to 
DNA, oxidative species can harm histones wherein PARP activates the 20S proteosome 
involved in breaking down oxidatively damaged histones. Also, in response to 
oxidative stress caused by exposure of histones to hydrogen peroxide, a complex is 
formed by the binding of PARP, poly (ADP-ribose), and the nuclear proteosome 133, 213. 
This complex formation could be important because a condensed chromatin 
structure may protect DNA from strand breaks induced by hydroxyl radicals 197, 214.
In conditions of oxidative stress-induced necrosis in Bax-/- Bak -/- (a proapoptotic 
protein that regulates the intrinsic apoptotic pathway) mouse embryonic fibroblasts, 
there is an activation of PARP1. PARP1-catalysed poly (ADP-ribosyl)ation causes a 
depletion of ATP, which promotes the autophagy of these necrotic embryonic cells 215. 
PARP1 has been implicated in the repair of DNA damaged by estradiol in human es-
trogen-receptor-negative (ER -/- ) breast cancer cells. Treatment of these breast cancer 
cells with 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), which is itself an estrogenic 
toxicant, altered the expression of enzymes responsible for the bio-activation of 
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estrogen leading to DNA damage, PARP1 activation and DNA repair. Thus, the 
apoptosis of human ER -/ breast cancer cells was prevented by TCDD-induced 
activation of PARP1 and aided the survival of these cancer cells 216. Interestingly, 
administration of TCDD caused the expression of cDNA encoding a 75 kDa protein 
that had sequence similarity with PARP. This protein, renamed as TCDD-inducible 
PARP (TiPARP) possessed catalytic activity similar to PARP 217. However, the role of 
TiPARP on chromosome stability, DNA repair and apoptosis are yet to be elucidated. 
PARP and ageing
The ageing process also takes its toll on DNA, which can in turn, affect the fertility 
potential of a male. As discussed earlier, PARP is also involved in ageing through its 
role in immune responses, telomere maintenance, DNA repair, spindle assembly, and 
cell death 218. In a recent study, El-Domyati et al collected sperm samples from fertile 
men of various age groups and quantified the differences in PARP1 presence and 
PARP activity 199. The expression of PARP1 and its DNA repair partner, XRCC1 were 
higher in spermatocytes of older men while the Sertoli cells of these men showed 
higher poly (ADP- ribose) levels. Apoptosis was increased in older men who showed 
more active caspase-3 and cleaved PARP1 in the spermatogonia and spermatocytes. 
This general increase in PARP1 and DNA repair enzymes could be associated with this 
declining DNA integrity as a result of age 199.
Chromosomal stability is vital for the survival of an organism and chromosomal 
instability increases with the age of an organism and is considered a symptom of 
ageing. PARP is essential for chromosomal stability through its role in DNA repair. 
PARP activity may influence ageing by maintaining genomic stability through DNA 
repair, telomere maintenance, spindle stability, and cell death 210, 218-220. Under 
physiological conditions, both PARP1 and PARP2 affect telomere functioning by 
binding to telomere repeat binding factor II (TRFII ) and affecting its ability to bind to 
telomere regions 221-223. PARP1 is also found at telomere regions of DNA that is damaged 
by genotoxic agents and it may play a role in preventing damage to genomic stability 
222. PARP1 deficient mice showed greater incidence of chromosomal aberrations, 
polyploidy and telomere shortening. When PARP was reintroduced in the form of 
cDNA, they were then able to restore chromosomal integrity. 224, 225
Biological role of PARP in male fertility
PARP plays a crucial role in maintaining genomic integrity in a variety of cell types and 
perhaps nowhere is this genomic integrity more important than in germ cells. Cases 
of male infertility are associated with abnormal sperm chromatin and DNA structure. 
The problems that arise in genomic integrity of sperm come from a variety of sources 
including spermatogenesis defects, abortive apoptosis, problems with spermatid 
maturation, and oxidative stress 22, 226. Problems in spermatogenesis could include 
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double strand breaks that are not resolved after crossing over during meiosis I 22. 
Although there has not been any clear association between apoptotic markers and 
DNA fragmentation in mature male gametes, it is possible that incomplete apoptosis 
could be a cause of such DNA fragmentation 22, 227. Maturation of spermatids involves 
chromatin remodeling steps that involve necessary DNA strand breaks and thus could 
be a source of unresolved breaks. Lastly, reactive oxidative species (ROS) have been 
extensively investigated in male infertility, and in light of the activation of PARP-induced 
apoptosis pathways in oxidative stress conditions, may provide an explanation for the 
role of PARP in male fertility.
Thus, at the time of writing this review, the role of PARP in male fertility is not as well 
defined as its role in other cellular processes. However, there is enough evidence such 
as detection of PARP in the testis, during spermatogenesis, and in ejaculated 
spermatozoa to suggest that such a role exists 169, 200. Furthermore, the role of PARP as 
an important DNA repair enzyme could empower it with maintaining the genomic 
integrity of sperm. Similarly, the role of PARP in cell death pathways may have 
important implications for its role in the elimination of abnormal spermatozoa during 
the processes of spermatogenesis 228.
Potential therapeutic applications of PARP
The key role of PARP in cell death has made it an attractive candidate in cancer 
therapies 157. It is based on the simple idea that inhibiting DNA repair in malignant cells 
exposed to chemotherapy will kill off these cancerous cells due to the large amounts 
of DNA damage that will accumulate if PARP is inactivated 229. Non-malignant cells will 
not be susceptible to cell death at these low doses of chemotherapy. Thus PARP 
inhibitors could provide a means to sensitize cancerous cells to chemotherapy and be 
developed as an adjuvant to chemotherapy 230. An alternate strategy being explored 
is that of inactivating PARP through cleavage to attain the same end result, i.e., 
accumulation of damaged DNA in cancerous cells causing them to die faster 228, 231.
PARP modulation may not only prove useful in cancer therapies, but also in dangerous 
inflammatory processes. The role of PARP in inflammation especially through the 
recruitment of NF-ĸβ and through its role in responding to oxidative stress produced 
by the inflammatory processes make it a powerful target for anti-inflammatory 
therapy 157. The use of PARP inhibitors as therapeutics in conditions such as cerebral 
ischemia and other inflammation-induced conditions may be explored 159, 220. It still 
remains to be seen whether PARP can provide a therapy for male infertility. PARP 
inhibition may protect against chemically induced injury of ejaculated spermatozoa 
in vitro, but was not effective against damage induced by oxidative stress 200. It is also 
possible that PARP inhibition may have a potential role in testicular cancer as well as 
cancer that may have spread to the testes 109. Inflammatory processes as result of 
infections could also be another area to explore in terms of PARP and male fertility.
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Conclusions 
PARP homologues have diverse role(s) in spermatogenesis and in ejaculated sperm. 
PARP expression is associated with sperm maturity in proven fertile men. PARP 
inhibition may be used as an in vitro treatment in certain conditions such as oxidative 
stress and/ or chemically induced death of spermatozoa with damaged DNA. 
Therefore these spermatozoa may not have the ability to fertilize or produce healthy 
embryo as the oocyte repair system may be inadequate to correct such high DNA 
damage. PARP modulation using kinase activators or inhibitors may have a future 
beneficial role in infertile patients exhibiting sperm DNA damage. This could pave the 
way for future studies to elucidate the role of PARP in other conditions resulting in 
sperm DNA damage. Cleaved PARP, which is activated during apoptosis, could serve 
as an apoptotic marker for differentiating healthy spermatozoa from apoptotic ones. 
In addition, the anti-tumor properties of PARP could provide new strategies to 
preserve fertility in cancer patients even after genotoxic stresses like radiation. The 
possibility of using DNA damaged sperm in ART especially in ICSI needs careful 
evaluation. PARP may hold the key to a better understanding of these repair 
mechanisms inherent in spermatozoa and the importance of such mechanisms in 
producing healthy pregnancies.
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Abbreviations
AIF Apoptosis inducing factor
AMD Auto modification domain 
ADPR ADP ribose
AP Apurinic-apyrimidinic endonuclease
ART Assisted reproductive technologies
BER Base excision repair
BRCA-1 CT Breast cancer-1, human oncogene, C-Terminus
Bub3 Budding uninhibited by benzimidazoles 3
CAG Tri-nucleotide (Cytosine- Adenine- Guanine)
CD Catalytic domain
CTCF CCCTC-binding factor (zinc finger protein)
DBD DNA binding domain
DBD DNA binding domain
ERK Extracellular signal-regulated kinases
Fas-FasL Fas antigen (Fas)/Fas ligand (FasL)
H2AX One of several genes coding for histone H2A 
ICSI Intracytoplasmic sperm injection
LPS Lipopolysaccaride
MALDI-TOF-TOF Matrix-assisted laser desorption/ionization time-of-flight/ time-of-flight
MSH2 MutS homolog 2
NAD Nicotinamide adenine dinucleotide
NBS1 Nijmegen Breakage Syndrome 1
NF-ĸβ Nuclear factor kappa β
NHEJ Non-homologous end-joining
NLS Nuclear localization signal
PAR Poly (ADP-ribose)
PARG Poly (ADP-ribose) glycohydrolase
PARP Poly (ADP-ribose) polymerase
Rad54 A gene linked to chromosome 1p32, encodes for a protein known to be 
involved in the homologous recombination and repair of DNA.
ROS Reactive oxygen species
SCOS Sertoli cell only syndrome
SIRT1 Silent information regulator gene in human affect the metabolism and 
inflammation
TBP TATA-binding protein
TCDD 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
TRFI-I Telomere repeat binding factor II, I
WWE domains Domain associated with protein-protein interaction
XRCC1: X-ray repair complementing defective repair in Chinese hamster cells 1
YY1 YinYang1 
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Abstract
Objective: To examine the presence of cleaved poly(ADP-ribose) polymerase(s) 
(cPARP) in ejaculated spermatozoa and determine cPARP levels following exposure to 
chemical or oxidative stress.
Design: Prospective pilot study.
Setting: Tertiary care academic hospital.
Patient(s): Eight healthy men.
Intervention(s): Semen specimens were collected, prepared with double-density-
gradient centrifugation, and divided into control, hydrogen peroxide (H
2
O
2
), H
2
O
2
 + 
3-aminobenzamide (3-ABA), staurosporine (STS), and STS + 3-ABA treated groups.
Main Outcome Measure(s): Cleaved PARP and apoptosis markers by flow cytometry. 
Result(s): Cleaved PARP was detected in both neat and mature fractions. The cPARP 
levels were similar in both mature and immature spermatozoa. In combined mature 
and immature fractions, a higher percentage of late apoptotic sperm was seen in STS 
+ 3-ABA versus STS. Higher levels of late apoptotic spermatozoa were seen in immature 
versus mature fractions within STS and STS + 3-ABA groups. Lower levels of cPARP 
were seen in immature versus mature fractions in H
2
O
2 
and H
2
O
2 
+ 3-ABA treated 
groups. Cleaved PARP was related to levels of activated caspase-3. 
Conclusion(s): Cleaved PARP is present in ejaculated human spermatozoa. Poly 
(ADP-ribose) polymerase inhibitors may play a different role in chemical versus 
oxidative stress-induced sperm damage.
Key words: Apoptosis; flow cytometry; PARP cleavage; sperm fraction; TUNEL
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Introduction
Male factor infertility is solely responsible for about 20% of infertility cases and is 
contributory in another 30 to 40% 1, 2. The possible etiologies of male infertility include 
idiopathic causes, varicocele, extensive iatrogenic interventions, and erectile dysfunction, 
as well as defective spermatozoa 3-7. One possible cause of male infertility that has 
been studied intensely in the last decade is the integrity of DNA in the nucleus of 
mature ejaculated spermatozoa 8, 9. There are many possible causes of sperm DNA 
damage, including abortive apoptosis, oxidative stress associated with infections, 
chemical exposure, and defects of spermiogenesis associated with the retention of 
excess residual cytoplasm 10-16. The focus on the genomic integrity of the male gamete 
has been intensified by the growing concern about transmission of genetic diseases 
through intracytoplasmic sperm injection (ICSI) 17.
Apoptosis is defined as programmed cell death, which is an energy- and protein- 
dependent process that depends upon the cellular ATP level 18. Human spermatozoa 
have the ability to undergo apoptosis or apoptosis-like conditions 19-27. Absence of Fas 
protein from the spermatozoa or dysfunction has been reported 28, 29, and another 
study reported presence of Fas ligand on the mature ejaculated spermatozoa 30-32. 
Sperm DNA damage can occur at the time of, or be the result of, DNA packaging 
during spermiogenesis stages through abortive apoptosis 33-37.
Poly(ADP-ribosyl)ation is a DNA damage-dependent process that is affected by cell 
energy level. Poly(ADP-ribose) (PAR) level is controlled by the opposing actions of 
poly(ADP-ribose) polymerase (PARP) and poly(ADP-ribose) glycohydrolase (PARG), a 
major enzyme responsible for the catabolism of PAR. PAR metabolism is critical in a 
wide range of biological structures and processes. These include DNA repair and 
maintenance of genomic stability, transcriptional regulation, centromere and 
centrosomal function, mitotic spindle formation, telomere dynamics, trafficking of 
endosomal vesicles, apoptosis, and necrosis 38-41. In humans, the PARP family is 
comprised of as many as 18 distinct proteins; PARP-1 is the most expressed member 
39. PARP-1 plays a primary role in the process of poly-ADP-ribosylation. It has been 
implicated in genome maintenance, carcinogenesis, aging, immunity, inflammatory 
conditions, and neurological function 40, 42. 
Poly(ADP-ribose) polymerase 1 has a well-characterized role in DNA damage detection 
and repair. Protein ribosylation by PARP-1 is an immediate response to DNA damage 
induced by oxidants, alkylation, or ionizing radiation 40, 43. In contrast to PARP-1’s role as a 
survival factor in limited DNA damage, PARP-1  promotes cell death under conditions 
of extensive DNA damage 38. Therefore, chemical inhibition or genetic ablation of 
PARP-1 can provide protection against cell death, including ischemia-perfusion injury, 
cardiac infarction, neural cell damage, or aging 44-46. 
Poly(ADP-ribose) polymerase has been documented consistently as playing a functional 
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role in testicular germ cells 47-49. Germ cells require PARP for repair of DNA damage 50. 
Maymoun et al. detected PAR expression in germline cells 51. Its subcellular localization 
in meiotic and post-meiotic prophases demonstrated chromatin modifications 
occurring during spermatogenesis stages demonstrated chromatin modifications 
occurring during spermatogenesis. Although spermatids do not enter a prophase, 
Maymon et al. concluded that PARP expression in germline cells and its subcellular 
localization in meiotic and postmeiotic prophases demonstrate chromatin modifications 
occurring during spermatogenesis. Their results showed that PARP was localized in 
germ cell nuclei in full spermatogenesis (in round and elongated spermatid and 
primary spermatocytes). This established a key role for PAR in germ cell differentiation, 
presumably to safeguard DNA integrity 49, 51. 
Besides the established central role of PARP-1 and PARP-2 in the maintenance of 
genomic integrity, accumulating evidence indicates that PAR may modulate epigenetic 
modifications under physiological conditions. Poly(ADP-ribose) polymerase 2 exerts 
essential functions during meiosis I and haploid gamete differentiation 52. However, a 
similar role for PARP in human ejaculated spermatozoa is controversial. Whether PARP 
can repair DNA damage in mature human spermatozoa remains largely unclear. 
Oocyte repair capacity will help in the presence of sperm DNA damage. However, 
recently PARP was shown to have a role in full spermatogenesis, and we have reported 
its presence in different homologues. Poly(ADP-ribose) polymerase may protect 
the sperm DNA during the maturation/transportation processes. In addition, it may 
play a role in sperm chromatin remodulation.
Conflicting reports exist regarding the presence of whole or cleaved PARP 25, 53. 
Recently we reported the presence of PARP homologues in ejaculated human 
spermatozoa and identified these as PARP-1 (~75 kDa), PARP-9 (~63 kDa), and PARP-2 
(~60 kDa) 54. We demonstrated a positive correlation between the amount of PARP 
protein and sperm maturity, suggesting a role for PARP proteins in sperm DNA damage/
repair. 
The goal of our study was to validate the presence of cPARP in ejaculated human 
spermatozoa and determine whether the cPARP level can be modulated by chemical 
or oxidative stress cell injury in the presence or absence of PARP inhibitor. 
Materials and Methods
Sample Collection
A pilot study was conducted following Institutional Review Board approval. Following 
48 – 72 h of sexual abstinence, semen samples were collected from eight healthy 
donors, defined as a group of healthy male volunteers with sperm parameters in 
the normal range (normozoospermic) according to World Health Organization (WHO) 
77
3
cparp in sperm after induction of apoptosis
guidelines 55. These included men with proven and unproven fertility. Sample collection 
was done at the Cleveland Clinic Andrology Laboratory by masturbation into sterile 
containers. Flowchart of our experimental design of this study is shown in Figure 1.
Figure 1  Flowchart of various steps involved in processing of semen sample after collection, 
modulation and analysis for various parameters. 3-ABA, 3-aminobenzamide; cPARP, cleaved 
poly (ADP-ribose) polymerase; FACS, fluorescence activated cell sorter; PI, propodium iodide; 
TUNEL, terminal deoxynucleotidyl transferase mediated fluorescein-dUTP nick-end labeling.
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Standard Semen Analysis
After liquefaction, semen specimens were evaluated for volume, sperm concentration, 
total cell count, motility, and morphology. A 5µl aliquot of the sample was loaded on 
a Microcell slide chamber (Conception Technologies, San Diego, CA) for manual 
evaluation of concentration and motility.
Separation of Mature and Immature Sperm Population
Liquefied semen (1-2 ml) was loaded onto a 40% and 80% discontinuous PureCeption® 
density gradient (SAGE Assisted Reproduction Products, Bedminster, NJ) and 
centrifuged at 1600 rpm (400g) for 20 min at room temperature. The resulting 80% 
pellet, representing the mature fraction, and 40% cell layer, representing the immature 
fraction, were separately suspended in human tubal fluid (HTF) media (Irvine Scientific, 
Santa Ana, CA) and centrifuged at 300g for an additional 7 min to remove the remaining 
media. 
The interphase between the 40 to 80% gradient comprising the immature sperm was 
carefully aspirated into a tube, washed and re-suspended in sperm wash medium. 
This fraction consisted largely of immature, morphologically abnormal sperm with 
poor motility. Similarly, the pellet at the bottom of the 80% gradient was carefully 
aspirated into another tube, washed and re-suspended in sperm wash medium. This 
fraction consisted of morphologically normal, highly motile, mature sperm. Both the 
mature and immature sperm fractions were washed with Quinn’s sperm wash media 
(SAGE In Vitro Fertilization Inc., San Clemente, CA), and final washing was done with 
phosphate buffer saline (PBS, pH 7.4).
Induction and Modulation of Apoptotic and Oxidative Sperm DNA Damage
In vitro sperm DNA damage was induced using: 1) staurosporine (STS, 10µM ; 
Sigma-Aldrich, St Louis, MO) incubation at 37°C for 4 h 56; and 2) hydrogen peroxide 
(H
2
O
2
, 100µM; Sigma-Aldrich) incubation at 37°C for 1 h 57. PARP inhibition was 
achieved using 3-aminobenzamide (3-ABA, 1mM; Sigma-Aldrich) 58. 
Assessment of Cleaved Poly(ADP-Ribose) Polymerase (c-PARP) 
The presence of c-PARP was detected using an FITC-conjugated anti-PARP cleavage 
site-specific antibody (CSSA) kit (ApoTarget, Anti-PARP CSSA FITC apoptosis detection 
kit, BioSource International Inc., Camarillo, CA) as described earlier 59. Briefly, sperm 
pellets were washed twice with PBS by centrifugation at X300g, and the intracellular 
staining protocol was followed according to the manufacturer’s instructions. Sperm 
pellets were fixed in IC Fix™ buffer for 20 min at 4oC at concentration of 1mL IC Fix™ 
buffer per 1 x 106 sperms. Tubes were spun at X300g for 5 min; the supernatant was 
discarded, and the pellets were washed twice in PBS. Cells were re-suspended in IC 
Perm™ buffer to yield a density of 1 x 106/ 50µl. 10µl of FITC conjugated anti-PARP 
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CSSA was incubated with the treated and untreated sperm cell suspensions at room 
temperature for 30 min. Samples were washed twice in 2ml IC PermTM buffer and once 
in PBS and re-suspended in 0.5ml PBS for FACS analysis.
Terminal Deoxynucleotidyl Transferase-Mediated Fluorescein-dUTP Nick End 
Labeling Assay
Sperm DNA fragmentation was evaluated using the terminal deoxynucleotidyl 
 transferase-mediated fluorescein-dUTP nick end labeling (TUNEL) assay kit 
(Apo-DirectTM, BD Biosciences Pharmingen, San Diego, CA) as described earlier 60-63. 
Briefly, 1 x 106 spermatozoa were washed in PBS, re-suspended in 1% paraformal-
dehyde and placed on ice for 30-60 min. Subesequently, spermatozoa were washed 
again and re-suspended in 70% ice-cold ethanol.
Following a second wash in PBS to remove the ethanol, sperm pellet samples as well 
as the positive and negative controls provided with the assay kit were re-suspended 
in 50µl of the staining solution for 60 min at 37°C. The staining solution contained 
terminal deoxytransferase (TdT) enzyme, TdT reaction buffer, fluorescein-tagged 
deoxyuridine triphosphate nucleotides (FITC-dUTP) and distilled water. All cells were 
further washed in rinse buffer, re-suspended in 0.5ml of propidium iodide/RNase 
solution and incubated for 30 min in the dark at room temperature followed by flow 
cytometric analysis.
Annexin V/ Propidium Iodide Assay
To perform this assay, the Annexin-V FITC Apoptosis Detection Kit was used (BD 
Biosciences Pharmingen). A 100µl aliquot of neat, mature, and immature sperm 
fractions was re-suspended in 400μl cold reaction buffer (HEPES; N2-hydroxyethyl 
piperazine-N’2-ethanesulfonic acid) containing 2.5mM CaCl
2
. Sperm cells were labeled 
with 10μl each of annexin-V/FITC solution and propidium iodide (PI) for detecting 
apoptotic and necrotic sperm. Samples were incubated for 15 min at room temperature 
in the dark. Cells were washed with 1ml PBS, centrifuged and re-suspended in 300μl 
of reaction buffer. Flow cytometric analysis was done to quantitatively determine the 
percentage of early and late apoptotic, necrotic, and viable cells. Early apoptotic 
sperm were defined as sperm that were positive for only annexin V (annexin V+), while 
late apoptotic sperm were those that were positive for both annexin V and PI (annexin 
V+/ PI+) 64-66. 
Active Caspase-3 Staining
Assessment of active caspase-3 activity was performed using a phytoerythrin- 
conjugated monoclonal active caspase-3 antibody apoptosis kit (BD Biosciences 
Pharmingen) as established earlier 67. Briefly, sperm pellets were washed twice with 
cold PBS, re-suspended in 0.5 ml Cytofix/Cytoperm™ solution/ x 106 sperm and 
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incubated with the cytofix for 20 min on ice. Centrifugation was done at 300g; 
supernatant was aspirated and discarded. Sperm pellets were washed twice with 
0.5 ml Perm/Wash buffer™/ x106 sperm. For each test tube, 100 µl Perm/Wash buffer 
and 20 µl antibody were added and incubated for 30 min at room temperature. 
Washing was done in 1.0 ml Perm/Wash buffer followed by re-suspension in 0.5 ml of 
the buffer solution. All samples were analyzed by flow cytometry.
Flow Cytometry (FCM) Analysis
All fluorescence signals of labeled spermatozoa were analyzed by the flow cytometer 
FACScan (BD Biosciences). Approximately 10,000 spermatozoa were examined for 
each assay at a flow rate of <100 cells/sec. The excitation wavelength was 488 nm 
supplied by an argon laser at 15 mW. Green fluorescence (480–530 nm) was measured 
in the FL-1 channel and red fluorescence (580–630 nm) in the FL-2 channel. Gating was 
done to exclude debris and aggregates using 90° and forward-angle light scatter. 
The percentage of positive cells and the mean fluorescence were calculated on a 
1023-channel scale using the flow cytometer software FlowJo version 6.4.2 (Tree Star, 
Inc., Ashland, OR).
Statistical Analysis:
Data were represented as mean ± SD or median (25th -75th percentiles). We used the 
Wilcoxon signed-rank test for comparisons between groups and the Spearman 
non-parametric test for correlations. All statistical analysis was done by using 
GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA). A P 
value <0.05 was considered statistically significant.
Results
Ejaculated sperm had a semen volume of 2.85 ± 1.17 ml; concentration 80.2 ± 50.5 x 
106/ ml; median (25th and 75th percentiles) 65.9 (48.7, 136.1), respectively; and sperm 
motility (%) 64.2 ± 9.15.
Apoptotic Markers in Mature and Immature Sperm without PARP Modulation
Detectable levels of cPARP were seen in both mature and immature spermatozoa 
using the intracellular staining technique followed by detection with flow cytometry 
(Figure 2). The percentage of sperm that were positive for cPARP was comparable in 
both mature and immature sperm (Figures 3).
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PARP Modulation Experiment in the Presence and Absence of Inducer/Inhibitor 
Mature and immature sperm were exposed to PARP modulation by chemical injury 
(STS) or an oxidative stress inducer (H
2
O
2
) in the presence or absence of the PARP 
inhibitor 3-ABA. Results are shown in Tables 1 - 3 and Figures 2 and 3.
PARP Cleavage (cPARP Assay)
The cPARP-FITC fluorescence intensity in the mature fraction was higher in the 
STS-only group compared with the H
2
O
2-
only group (Figure 2B). Higher fluorescence 
intensity in cPARP+ve staining was seen in immature sperm in the STS-only group 
compared with the H
2
O
2
-only or control groups (Figure 2C). Exposure to the PARP 
inhibitor 3-ABA decreased the cPARP-FITC fluorescence intensity in the STS-only 
group compared with the H
2
O
2
-only groups (Figure 2D).
Figure 2  Overlay histograms for cPARP %+ve sperm: (A) Mature vs. immature with the 
negative control; (B) Oxidative vs. chemical stress-induced damage with unstained negative 
control in mature spermatozoa; (C) Oxidative vs. chemical stress-induced cell damage with 
unstained negative control in immature spermatozoa; (D) effect of PARP inhibition in 
oxidative or chemical stress-induced cell damage on PARP cleavage.
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DNA Fragmentation by TUNEL Assay
Immature and mature sperm exposed to STS or H
2
O
2
 alone or in the presence of 
3-ABA did not exhibit a significant difference in the percentage of TUNEL+ve sperm 
compared with the control group (Figure 3C and 3D).
We next combined the immature and mature sperm groups to examine the effect of 
3-ABA on the percentage of TUNEL+ve sperm. A higher but non-significant percentage 
of TUNEL+ve sperm were seen in both STS + 3-ABA versus STS-only groups and H
2
O
2
 + 
3-ABA-treated vs. H
2
O
2
-only groups (Table 1; Figure 3 C and 3D).
Figure 3  TUNEL %+ve in mature (A) and immature spermatozoa after chemical or oxidative 
stress-induced damage in presence or absence of PARP inhibitor; cPARP %+ve in mature 
(C) and immature (D) spermatozoa following chemical and oxidative stress-induced damage 
in presence or absence of PARP inhibitor (STS= staurosporine).
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Table 1   Measured parameters in different modulation treatments without and with  
PARP- inhibitor (3-ABA)
Parameter Mean ± SD
Median (IQR)
(n = 16) [%]  
p- valuea
TUNEL +ve%
STS Only 12.2 ± 7.2
9.0 (6.7-18.3)
0.52
STS + 3-ABA 11.6 ± 7.9
10.8 (4.1-16.3)
H
2
O
2
 Only 11.1 ± 6.9
8.8 (5.6-17.5)
0.42
H
2
O
2
 + 3-ABA 12.2 ± 9.4
10.2(4.7-18.6)
c-PARP +ve%
STS Only 48.3 ± 34.9
46.4 (15.0-85.4)
0.34
STS + 3-ABA 44.3 ± 28.7
49.2(14.7-69.2)
H
2
O
2
 Only 47.5 ± 28.2
57.3(19.2-66.4)
0.82
H
2
O
2
 + 3-ABA 48.7 ± 29.1
50.3(22.6-70.1)
Late apoptotic sperm +ve%
STS Only 34.7 ± 21.8
30.2(21.2-46.9)
< 0.001
STS + 3-ABA 75.5 ± 16.9
79.1(63.4-91.3)
H
2
O
2
 Only 90.9 ± 22.9
96.7(94.2-98.7)
0.55
H
2
O
2
 + 3-ABA 88.9 ± 24.7
97.4(95.3-98.2)
Early apoptotic sperm +ve%
STS Only 8.0 ± 5.1
8.6(2.6-13.1)
0.10
STS + 3-ABA 4.9 ± 4.7
3.7(1.4-6.4)
H
2
O
2
 Only 0.62 ± 0.55
0.64(0.10-0.91)
0.036
H
2
O
2
 + 3-ABA 0.93 ± 0.81
0.66(0.33-1.47)
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Apoptosis by Annexin V/ PI assay
Early Apoptosis Early apoptosis was detected by annexin V+ve staining of immature 
and mature sperm. Exposure to STS only or in combination with 3-ABA did not show 
a significant difference in the percentage of early apoptotic sperm in both immature 
and mature sperm compared with the control group. When both immature and 
mature sperm were combined and examined for effects of STS + 3-ABA exposure, a 
38% decrease in early apoptotic sperm percentage was seen compared with the 
STS-only group; however, this decrease was non-significant (Table 1).
Exposure to oxidative stress by H
2
O
2
 caused a significant decrease in the percentage 
of early apoptotic sperm in immature and mature sperm (0.91% ± 0.58%; p = 0.039 and 
0.33% ± 0.36%; p = 0.008) compared with the control group. Exposure to H
2
O
2
 + 3-ABA 
resulted in a significant increase in the percentage of early apoptotic sperm in 
immature (1.28 ± 0.39 %; p = 0.039) and mature sperm (0.59 ± 0.52 %; p = 0.008) 
compared with the control group. When both immature and mature sperm were 
combined, a significant increase was seen in the percentage of early apoptotic sperm 
exposed to H
2
O
2
 + 3-ABA vs. the H
2
O
2
-only group (p = 0.036; Table 1). 
Late apoptosis Immature sperm showed a higher incidence of late apoptotic sperm 
in the control, STS-only, and STS + 3-ABA groups compared with the mature sperm 
fractions. A significantly higher percentage of late apoptotic sperm was seen in the 
immature sperm in the STS-only group (P = 0.039; Table 1). Within the immature and 
mature sperm fractions, no difference was seen in the percentage of late apoptotic 
sperm in the STS-only group, while a significantly higher percentage was seen in the 
STS + 3-ABA- treated group in immature (P = 0.016) and mature (P = 0.023) sperm 
fraction compared with the control group (Figure 4).
Mature sperm fraction showed a higher incidence of late apoptosis following 
exposure to both H2O2 only and H2O2 + 3-ABA compared with immature sperm (P = 
0.016 and 0.014, respectively). Within immature and mature fractions, the immature 
fraction showed a higher incidence of late apoptotic sperm in the H
2
O
2
-only and H
2
O
2 
+ 3-ABA-exposed groups (P = 0.039 and P = 0.038; respectively; Fig. 4) compared with 
the control group. Similarly, a higher incidence of late apoptotic sperm was seen in 
the mature fraction for both H
2
O
2
-only and H
2
O
2 
+ 3-ABA-exposed groups compared 
with the control group (P = 0.008 and P = 0.008 respectively; Figure 4).
Combined immature and mature sperm fractions and STS + 3-ABA treatment showed 
a significantly higher incidence of late apoptotic sperm (P <0.001; Table 2) compared 
with STS-only groups. Exposure to H
2
O
2
 + 3-ABA showed a non-significant decrease in 
the percentage of late apoptotic sperm compared with the H
2
O
2
-only group (Table 2). 
Caspase Activation by Active Caspase-3 Assay
No significant changes in active caspase-3 level were seen in either immature or 
mature sperm exposed to STS only or H
2
O
2
 only or in the presence of 3-ABA. 
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Correlation between cPARP, TUNEL, apoptosis, and active caspase- 3 
Apoptotic markers (cPARP, TUNEL, early and late apoptosis, and active caspase-3) were 
examined for their association with chemical (STS-only and STS + 3-ABA) or oxidative 
stress (H
2
O
2
-only and H
2
O
2
 + 3-ABA) treatment (Table 2). Significant correlations were 
seen with cPARP in all treated groups (Table 2).
In the untreated group, a positive correlation (r = 0.56, P = 0.02) was observed between 
the percentages of sperm positive for cPARP and those that were positive for active 
caspase-3 in the combined (mature and immature) sperm fraction. This correlation 
became stronger in the STS-only and STS + 3-ABA-treated groups (r = 0.72, and 0.74; 
P = 0.002, and P <0.001, respectively). In the immature fraction, the percentage of 
cPARP+ve sperm showed a positive correlation with active caspase-3+ve sperm in 
STS-only (r = 0.74; P = 0.046) and STS + 3-ABA (r = 0.81; P = 0.022). Similarly, in the 
mature fraction, the percentage of cPARP+ve sperm showed a positive correlation with 
active caspase-3+ve sperm in the STS + 3-ABA-treated (r = 0.83; P = 0.015), H
2
O
2
-only 
(r = 0.74; P = 0.046) and H
2
O
2
 + 3-ABA (r = 0.73; P = 0.046) groups. 
Figure 4  Early apoptotic changes (annexin V +ve) in mature (A) and immature (B) sperm 
fractions following chemical and oxidative stress-induced damage in presence or absence 
of PARP inhibitor.
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Table 2   Correlation between each measured parameter in different modulation 
treatments without and with PARP inhibitor (3-ABA)
Treatment Untreated sperm fraction
r P
Activated Caspase-3 +ve spermatozoa 
STS Only 0.94 <0.001 S
STS + 3-ABA 0.98 <0.001 S
H
2
O
2
 Only 0.95 <0.001 S
H
2
O
2
 + 3-ABA 0.42 0.10 
TUNEL +ve spermatozoa
STS Only 0.29 0.28 
STS + 3-ABA 0.68 0.004
H
2
O
2
 Only 0.64 0.008
H
2
O
2
 + 3-ABA 0.64 0.007
Cleaved  PARP +ve spermatozoa 
STS Only 0.91 0.0001
STS + 3-ABA 0.88 0.001
H
2
O
2
 Only 0.82 0.001
H
2
O
2
 + 3-ABA 0.83 0.001
Early apoptotic sperm (annexin V only +ve spermatozoa)
STS Only 0.72 0.002
STS + 3-ABA -0.13 0.63 
H
2
O
2
 Only -0.48 0.06 
H
2
O
2
 + 3-ABA -0.20 0.46
Late apoptotic sperm (annexin V/PI +ve spermatozoa)
STS Only 0.63 0.009
STS + 3-ABA 0.37 0.16 
H
2
O
2
 Only -0.28 0.29
H
2
O
2
 + 3-ABA -0.13 0.63 
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Discussion
We have demonstrated detectable levels of cPARP in ejaculated human mature and 
immature spermatozoa by flow cytometry. Our present study puts to rest the 
controversial debate on the presence 20, 53 or absence 25, 68 of PARP.
Poly(ADP-ribose) polymerase is involved in gamete differentiation during sperma-
togenesis 51, spermiogenesis 52 and sperm chromatin remodeling 49.
Our findings are in agreement to those of Maymon et al. (2006), who reported 
increased PARP-1 expression in all types of spermatogonia in different maturation 
stages. These investigators suggested that increased PARP-1 expression may act as a 
reservoir for maintaining DNA integrity during germline differentiation. Our earlier 
study 54, in which we reported the presence of PARP homologues in mature and 
immature spermatozoa, supports this observation. Poly(ADP-ribose) polymerase 
cleavage may be involved in the DNA damage/ repair process as its incidence is seen 
to increase with progression of spermatogenesis 48. The higher, although non-signifi-
cant, levels of cPARP reported in our study in the mature sperm fraction is supported 
further by the increased band density of PARP homologues that we previously 
reported for the first time in mature sperm of proven fertile donors 54. Our present 
study findings indicate a potential role of PARP during sperm maturation and the 
sperm chromatin re-modulation processes. This observation is also supported by 
several other recent reports 49, 69, 70.
Poly (ADP-ribose) polymerase 1 plays a role in both necrotic and apoptotic cell death 
pathways as illustrated in Figure 1. Hyper-synthesis of PAR by PARP-1 in response to 
extensive DNA damage causes depletion of NAD and ATP leading to energy failure 
and cell necrosis 71. Poly(ADP-ribose) polymerase 1 can promote a caspase-indepen-
dent apoptotic pathway through apoptosis inducing factor 72. Although the 
mechanism underlying the choice between apoptosis and necrosis in response to 
genotoxic stimuli is unclear, it may be affected by cell type, stimuli type and strength, 
and duration of exposure 73. 
The present study findings support the above hypothesis of the cell death pathway(s). 
In the absence of PARP inhibition, exposure to STS-only resulted in a large increase in 
the percentage of early apoptotic sperm. This increase in early apoptotic sperm with 
STS declined following PARP inhibition. Furthermore, we obtained a > 2-fold increase 
in the percentage of late apoptotic sperm following PARP inhibition in STS-induced 
sperm injury. The increase in late apoptotic sperm with chemical exposure and PARP 
inhibition are more apparent in immature than in mature sperm fractions, suggesting 
mature spermatozoa are more protected from chemical-induced damage. This may 
explain the possible therapeutic application of PARP in selectively facilitating tumor 
cell death alone or in combination with chemotherapy 74-76 or viral infection 77, 78.
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On exposure to oxidative stress, PARP inhibition caused a significant increase only in 
the percentage of early apoptotic sperm (Table 1). Immature spermatozoa show more 
resistance to this damage compared with mature sperm, suggesting that mature 
sperm are more susceptible to oxidative stress. The oxidative stress-induced increase 
in early apoptotic sperm following PARP inhibition also suggests that over-activation 
of PARP can increase late apoptosis and necrosis. This is also evident by reports of 
DNA breaks following oxidative stress causing over-activation of PARP and promoting 
cell dysfunction/ necrosis in diabetes mellitus, stroke, and cardiovascular diseases 74, 79. 
The present study findings show cPARP to be correlated with activated caspase-3. 
PARP cleavage is catalyzed by activated caspase-3 that initiates apoptosis and prevents 
PARP-mediated DNA repair processes. Inactivation of PARP has been proposed to 
prevent depletion of NAD (a PARP substrate) and preserve ATP 80. Earlier reports have 
documented apoptosis via oxidative stress 81 and chemical induction 82 through 
 caspase-dependent and independent pathways. One of the mechanisms through 
which oxidative stress or TNF-alpha mediates cell death is activation of transient 
receptor potential cation channel, subfamily M, member 2 (TRPM2). This results in 
increased intracellular Ca++ followed by caspase activation and PARP cleavage 83. 
Spermatocyte function is reported to be affected by PARP-1 or PARP-2 automodifica-
tion 84.We hypothesized that sperm with reduced levels of cPARP might be deficient 
in post-testicular protection/ repair during exposure to a sperm damaging agent. This 
PARP-dependent mechanism may be inefficient in infertile men; hence, the sperm are 
more susceptible to damage. In our earlier study, we identified the presence of 
different PARP homologues in ejaculated sperm 54. PARP homologues have a variety 
of molecular and cellular functions. PARP-1 and PARP-2 are involved in DNA repair 
mechanisms 39, 40, 52, 73, 85. 
Collectively, mature and immature spermatozoa showed a significant decline in the 
percentage of late apoptotic sperm following PARP inhibition in chemical- and 
oxidative stress-induced sperm damage. The response of oxidative stress-induced 
damage to PARP inhibition was low compared with that of chemical damage. This 
suggests that oxidative stress-induced sperm damage may have different pathway(s) 
such as peroxidation of lipids and proteins in addition to DNA damage. This was 
evident from the increase in early apoptotic sperm seen in oxidative stress-induced 
damage even after PARP inhibition.
Our study limitation was the small sample size; however, this was a pilot study. We 
recommend additional studies with a large sample size. In addition, it will be important 
to examine DNase- induced injury to ensure direct DNA damage of sperm following 
exposure to other injurious agents. Optimizing the duration and concentration of 
exposure to these toxic agents/ PARP inhibitors is also important. Furthermore, it 
would be interesting to examine the type of PARP homologue cleaved by these 
treatments, thus opening new therapeutic applications for infertile patients. As we 
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reported in our earlier study PARP-2 may play a role in sperm damage response and 
additional studies are needed to explain role of PARP-9 54.
In conclusion, cPARP is a new apoptotic marker that can be detected in ejaculated 
spermatozoa by flow cytometry and may be related to the activation of caspase-3. 
Both immature and mature sperm show cPARP expression following chemical- or 
oxidative stress-induced damage. PARP inhibition can modulate the incidence of early 
or late apoptosis in ejaculated human spermatozoa.
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Abstract
Objective(s): To elucidate the missense GLU298ASP polymorphism within exon 7 of 
endothelial nitric oxide synthase (eNOS) in infertile men with asthenzoospermia and 
their potential contribution to sperm motility.
Methods: In this prospective controlled study conducted at our Andrology unit, we 
investigated the frequency of G894T polymorphism (Glu298Asp variant) within exon 
7 of the eNOS gene in 70 infertile men and in 60 healthy men. Sperm motion kinetics 
were assessed with computer assisted semen analysis (CASA). A single nucleotide 
polymorphism (SNP) of the eNOS gene in exon 7 (NCBI SNP cluster ID: rs1799983; 
genbank accession: NG 011992; Protein accession NP 000594 ) was determined by 
 allele-specific polymerase chain reaction followed by restriction fragment length 
polymorphism (PCR-RFLP). Sequencing analysis was used to confirm the specific 
genotype.
Finding(s): The G894T eNOS (T) allele was found at a higher frequency in the patients 
with asthenozoospermia (60%) compared to the control group (22.5%) (P = 0.02). 
In those men, the percentage of rapid motile sperm (grade a+b) was low in astheno-
zoospermic infertile men harbor homozygote’s eNOS (TT) genotyping vs.those with 
wild-type eNOS (GG) (p = 0.02) or heterozygote’s eNOS (GT) genotyping (p = 0.01). In 
the fertile men, the percentage of rapid motile sperm (grade a+b) was higher in the 
wild-type eNOS than in the eNOS (TT) (p=0.03) or eNOS (GT) genotyping (p=0.04). 
Conclusion(s): Our findings suggest that the T allele encoding for aspartic acid of the 
eNOS (Glu298Asp) gene may contribute to low sperm motility.
Key Words: eNOS, SNP, male infertility, asthenozoospermia, NO, (Glu298Asp) variant.
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Introduction
Advanced technologies increase the interest of genetic disorders in infertile men 1. 
Nowadays, there is an increased demand and use of various assisted reproduction 
techniques (ART) such as intracytoplasmic sperm injection (ICSI). In addition, ICSI 
increased our awarenss about potential genetic risks which may increase the incidence 
of hereditary genetic causes of transmission infertility or other genetic disorders in 
the offspring 2, 3. 
Oxidative stress (OS) is one of the major issues associated with impaired sperm 
motility, male infertility and ART outcome 4, 5. Nitrogen monoxide (·NO), commonly 
referred to as nitric oxide in the biochemical literature 6, is a highly reactive free radical 
gas generated in biological systems that has a variety of functions. NO is a messenger 
in a wide array of biological processes 7, 8. In addition, NO serves as a neurotransmitter 
in the nervous system as well as a mediator of endothelium-dependent relaxation; it 
also mediates both tumoricidal and bactericidal actions of macrophages 9, 10. It has 
been suggested that NO modulates sexual and reproductive functions in mammalian 
species 11-13. Lewis et al. (1996) reported for the first time that NO is synthesized by the 
human male gamete. Experimental evidence demonstrates that although excessive 
NO concentrations can cause defective sperm function, low and controlled 
concentrations of NO play an important role in the control of sperm physiology 14. 
Nitric oxide synthase (NOS; EC 1.14.13.39) enzymes produce NO by catalysing a five- 
electron oxidation of a guanidino nitrogen of L-arginine (L-Arg) 6. In mammals, 3 distinct 
genes encode for NOS isozymes; neuronal (nNOS or NOS 1, 150 KDa on chromosome 
12, 12q24.2-q24.31); cytokine inducible (iNOS or NOS 2, 130 KDa positioned on 
chromosome 17, 17q11.2-q12) and endothelial (eNOS or NOS 3), 135 KDa 15. Balligand et 
al. (1993) 16 assigned the NOS3 gene to chromosome 7 and regionalized it to 7q35-q36. 
eNOS and nNOS are isoforms of constitutive NOS and they are involved in cellular 
signaling pathways 17. Both enzymes are calcium/calmodulin dependent and they are 
rapidly activated by agonists that elevate intracellular free Ca2+18. Whereas iNOS is a 
Ca2+ independent inducibile NOS isoform 9, iNOS and nNOS are soluble and found 
predominantly in the cytosol whereas eNOS is a membrane-associated enzyme. 
Spermatozoa are the main source of NO. A constitutive NOS appears to be involved in 
sperm motility, capacitation, and acrosome reaction 19-21. Using indirect immuno-cy-
tochemistry, the eNOS protein has been localized in the cytoplasm of Leydig, Sertoli 
cells and all stages of spermatogenesis as well as to the epithelium of the epididymis 
and vas deferens 22, 23. .
A single nucleotide polymorphism (SNP) of the eNOS gene within exon 7 includes a G 
to T mutation at nucleotide position 894 of the eNOS cDNA, which causes glutamic 
acid to be replaced by aspartic acid at codon 298 (Glu298Asp) during translation of 
the eNOS enzyme. At present, this variant is associated with both coronary spastic 
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angina and myocardial infarction 24-26. There is a lack of knowledge of information in 
the literature regarding the association between eNOS genotypes and asthenozoo-
spermia—a link we believe may exist because of earlier observation on the association 
of seminal NO concentration with sperm motility. Our aim was to examine the eNOS 
gene SNP in infertile men with idiopathic asthenospermia. We examined the possible 
association(s) between the eNOS missense mutation (Glu298Asp variant) in infertile 
patients with asthenozoospermia and sperm motion kinetics.
Patients and methods
Study population
This prospective study was approved by the Institutional Review Board (IRB) of the 
Polytechnic University of Marche, Umberto I Hospital. All participants provided their 
written informed consent to participate in this study. 
Our study consisted of 70 patients who had been referred to the andrology clinic of 
the endocrinology division of the Umberto I Hospital, Polytechnic University of 
Marche, in Italyfor an infertility work-up. All of the patients were considered infertile in 
that they had a female partner with whom they had engaged in unprotected sexual 
intercourse for at least 18 months without pregnancy. A control group was enrolled as 
well. These were age-matched men (n=60), whose female partners had achieved 
pregnancy within the past 2 years. They also had normal sperm motility and other 
routine sperm parameters as per WHO guidelines 27.
Inclusion/ exclusion criteria
All subjects enrolled in our study had normal sperm morphology (> 30 %) and 
leukocy tospermia (< 1x106/mL) in their semen specimen. The patients had a sperm 
concentration > 20x106/mL, forward motility (grade a + b) < 50% and/ or grade (a) 
< 25% and viability >75%. All patients were negative for Mar-test of antisperm 
antibodies. Semen cultures were negative for microbial infection, including Chlamydia 
and Mycoplasma ureoliticum infections. The patients also had normal serum FSH, LH, 
testosterone, estradiol, and prolactin levels. There was no evidence of anatomical 
abnormalities of the genital tract, including varicocele (excluded by scrotal doppler 
sonography). There was no history of criptorchidism, testicular torsion, or genital tract 
infection. The following exclusion criteria were applied: presence of systemic diseases 
(hypertension, diabetes mellitus and hypercholesterolemia), drug treatment within the 
last 3 months before enrolment in our study, smoking, alcohol use, drug addiction or 
occupational chemical exposure. Since no possible causes for reduced sperm motility 
could be detected, our patients were diagnosed with idiopathic asthenozoospermia.
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Sperm evaluation
Two complete semen analyses were performed for the study and control populations 
according to WHO guidelines 27 to ascertain sperm motility and kinetic characteristics. 
All of these examinations were performed by the same scientist (E.B.). Briefly, 3 μL of 
liquified semen was placed into a 20 µm cellVU® chamber (Conception Technologies, 
La Jolla, CA). Two sides (A and B) were loaded for each specimen with scoring of at 
least 300 spermatozoa, up to 6 different fields per chamber side. Sperm motility was 
assessed using computer-assisted semen analysis (CASA). Sperm motion characteris-
tics were analyzed with an automated WLJY-9000 sperm analyzer (CGA Scientific 
Instruments, Florence, Italy). The following sperm kinetic characteristics were evaluated: 
sperm velocity distribution (rapid + medium, a+b, %), curvilinear velocity (VCL, μm/s), 
straight linear velocity (VSL, μm/s) and linearity (LIN, %). CASA was performed using 
low-to-normal settings and calibrated as follows: 20 frames , 4-20 frames/s, 2 track 
points for calculation of motility, 8 track points for calculation of velocity, and 0-180 
μm/s velocity range.
Determination eNOS genotyping
Genomic DNA was extracted from peripheral blood lymphocytes using the Flexigene 
DNA kit (Qiagen,Valencia, CA) as per the manufacturer’s instructions. Isolated genomic 
DNA was assessed using a Du-62 Spectrophotometer (Beckman, Fullerton, CA) at 260 
nm, which also helped to ensure that our extraction method was reliable. A SNP of the 
eNOS gene in exon 7 (NCBI SNP cluster ID: rs1799983; genbank accession: NG 011992; 
Protein accession NP 000594 ) was identified using polymerase chain reaction (PCR) 
and sequencing analysis. The specific genotype was identified with PCR followed by 
restriction fragment length polymorphism (RFLP) using the restriction enzyme MboI 
and BanII (New England, Bio Labs, Ipswich, MA) to digest mutant and wild alleles, 
respectively. Breifly, PCR was performed using 50 µL of PCR mixture Buffer (1X Tris-HCl 
Buffer,pH 8.55), 1.0 mM MgCl2, 0.8 mM dNTPs, plus 0.75 U of DNA Taq polymerase 
(Finnzyme Oy, Espoo, Finland), 150 ng of genomic DNA template, and each forward 
and reverse primers at 0.5 µM). 
Thermocycling conditions consisted of an initial denaturation for 5 minutes at 94°C; 
amplification for 35 cycles (denaturation for 30 seconds at 94°C, annealing for 30 
seconds at 62°C, and extension for 30 seconds at 72°C) followed by a final step of 
extension for 5 minutes at 72°C (2700 Thermal Cycler; Applied Biosystem, Foster, CA). 
PCR primers were generated to amplify the 248-bp fragment encompassing the 
G894T variant: forward and reverse primers were 5’-AAGGCAGGAGACAGTGG-ATG-
GA-3’ and 5’- CCCAGTCAATCCCTTTGGTGCTCA-3’, respectively 28. PCR products were 
separated on 2.5% agarose gel and visualized under UV light after ethidium bromide 
staining. The PCR product was digested using 5 U of the proper restriction enzyme at 
37 °C overnight. The guanine (G) allele at position 894, results in the presence of 
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glutamic acid (Q) amino acid at position 298, produces two fragments (163 bp and 
85 bp in length) in response to BanII restriction enzyme digestion. The thymine (T) 
allele at position 894, results in the presence of an aspartic acid (D) amino acid at 
position 298, produces two fragments (158 bp and 90 bp in length) in reposnse to 
MboI restriction enzyme digestion. The restriction digest products were analyzed by 
electrophoresis on 2.0 % agarose gels.
In some cases, sequence validation using the same primers was performed per the 
manufacturer’s instructions. Sequencing was performed using ABI Prism 310 sequencer 
(Applied Biosystem, Foster, CA).
Statistical analysis
Statistical analysis was performed using the SAS statistical package (Statistical Analysis 
System Institute, Cary, NC). The Kolmogorov-Smirnov goodness-of-fit test was used 
to determine ifthe data were normally distributed. For each biallelic marker, allele 
frequencies were calculated from genotypes in patients and control groups using the 
Hardy-Weinberg equilibrium. Deviation from Hardy-Weinberg equilibrium was assessed 
using the Chi Square test ( χ2). Results are expressed as mean ± SD, and they were 
compared with Student’s t test between the patients and controls. Values of p<0.05 
were considered statistically significant. 
Results
Screening for missense mutation (Glu298Asp variant) of eNOS gene
A descriptive comparison of our study populations is presented in table 1. Figure 1 shows 
agarose gel loaded with 3 PCR products after digestion with BanII enzyme only. 
Figure 2 (a, b, and c) shows a panel of sequencing pattern analyses of the 3 different 
genotypes of the eNOS (Glu298Asp) variant. Sequence analysis was done to confirm 
homozygote, heterozygote of mutant or wild-type genotypes.
eNOS genotypes (TT, GT and GG) were found in 31 (44.3%), 22 (31.4%) and 17 (24.3%) 
of 70 patients with idiopathic asthenozoospermia, respectively. In contrast, the eNOS 
genotypes (TT, GT and GG) were found in 9 (15.0%), 9 (15.0%) and 42 (70.0%) of 60 
control subjects, respectively. Chi Squared test showed that the genotype frequencies 
were in agreement with those predicted (not shown) by the Hardy-Weinberg 
equilibrium (Table 1). Additive and dominant effects of the eNOS (T) allele were 
significantly higher in the patients with idiopathic asthenozoospermia than in the 
control group, as shown in Table 1. 
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Table 1   Descriptive comparison of age, ejaculate volume, sperm concentration and 
hormonal levels in asthenozoospermic patients and healthy controls
Clinical parameters Asthenozoospermic group
 (n=70)
Control group 
(n=60)
P 
value
Age (years) 32.5 (27-38) 40 (30–50) >0.05
Sperm concentration (106/ml) 49.55 ± 20.61 55.21 ± 24.69 0.02
Ejaculate Volume (ml) 3.2 ± 0.9 2.4 ± 1.1 0.02
FSH (mIU/L) 3.8 ± 2.1 2.9 ±1.6 0.02
LH (mIU/L) 4.4 ± 2.0 3.7 ± 1.9 0.02
Testosterone (ng/ml) 4.7 ± 1.3 4.0 ± 1.5 0.02
Estradiol (pg/ml) 31.8 ± 10.4 35.6 ± 12.9 0.02
Prolactin (ng/ml) 9.7 ± 4.1 8.8 ± 3.9 0.02
Data represented as mean ± SD except for age presented as average (range). Comparison between 
groups was done by using student t-test. P< 0.05 was considered significant.
Figure 1  A representative agarose gel loaded with three PCR products of (Glu298Asp) 
homozygote (TT), (Glu298Asp) heterozygote (GT) and wild-type (GG) after digestion with 
Ban II, respectively. Use of PCR-RFLP analysis to screen for the missense (Glu298Asp) 
mutation; G to T substitution at nucleotide position 894 of the eNOS cDNA; we used a 
standard 100 bp marker in this run in the first lane.
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Comparison between asthenozoospermic and control groups regarding eNOS gene 
(Glu298Asp) polymorphism is also shown (Table 2). There was a significant increase in 
allelic frequency of the (Glu298Asp) variants (TT, GT) in asthenozoospermic patient 
(60%) vs.22.5% for the control groups.
Sperm motion kinetics in asthenozoospermic and control subjects groups
We examined the association between kinetic parameters (rapid motile sperm (a+b, 
%), VCL, VSL, LIN) in the asthenozoospermic patients and controls with different eNOS 
(Glu298Asp) variants (Table 3a and Table 3b). The comaprisons of sperm kinetic 
parameters between the control (n=60) and asthenozoospermic groups (n=70) are 
summarized in Table 4 irrespective to eNOS polymorphism. 
In the control group, sperm motion kinetic parameters were significantly different in 
the men with GG vs.GT alleles regarding rapid motile sperm (a+b, %) (p=0.04) and VCL 
(p=0.04) and in men with GG vs. TT alleles regarding rapid motile sperm (a+b, %) 
(p=0.03). On the other hand, asthenozoospermic patients with homozygotes eNOS 
(TT) alleles showed significantly high values in each sperm motion kinetic parameters 
(GG vs TT: rapid motile sperm (a+b, %) (p=0.02), VCL (p=0.01), VSL (p=0.02), and LIN 
Table 2   Genotype and Allele frequencies for the eNOS gene single nucleotide 
polymorphism (Glu298Asp variant) in asthenozoospermic patients and healthy 
controls 
Asthenozoospermic group
(n=70)
Control group
(n=60)
Genotypes
eNOS (GG), n (%) 17 (24,29%) 42 (70%)
eNOS (GT), n (%) 22 (31,43%) 9 (15%)
eNOS (TT), n (%) 31 (44,28%) 9 (15%)
χ2 Test 0,94 0,85
p-value 0.02
Alleles
G, n (%) 56 (40,00%) 93 (77,50%)
T, n (%) 84 (60,00%) 27 (22,50%)
p-value 0.02
Data represented as number (percentage within group) of patients. eNOS = endothelial nitric oxide 
synthase; eNOS/GG = homozygous normal; eNOS/TG = heterozygous carriers of the eNOS (Glu298Asp) 
variant; eNOS/TT = homozygous carriers of the eNOS (Glu298Asp) variant. Chi square (χ2) test was used 
to compare the observed frequencies in to those predicted frequencies (not show) by the Hardy- 
Weinberg equilibrium among patient and control study populations.
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(p=0.01). Moreover, the same sperm kinteic parameters were significantly higher in 
the heterozygotes patients (GT) than in the homozygotes (TT) patients (GT vs TT) 
regarding rapid motile sperm (a+b, %) (p=0.01), VCL (p=0.002), VSL (p>0.05) and LIN 
(p=0.002).
Table 4   Comparison of sperm motion kinetics among infertile asthenozoospermic 
patients vs. healthy controls 
Control Subjects 
(n=60) (Means ± SD)
Asthenozoospermic 
(n=70) (Means ± SD)
p-value
Sperm motility 
(grade a+b, %)
63.85 ± 7.38 32.52 ± 16.65 <0.001
Curvilinear velocity
(VCL, μm/sec)
59.55 ± 9.15 35.11 ± 9.69 <0.001
Straight linear velocity
(VSL, μm/sec)
22.00 ± 1.61 15.42 ± 2.71 <0.001
Linearity (LIN, %) 43.29 ± 5.86 33.40 ± 10.57 <0.001
Figure 2  Sequencing analysis of the G894T of exon 7 in eNOS gene with different allele 
expressions, (a) heterozygous (GT) genotyping, (b) mutant homozygotes (TT) genotyping 
and the (c) wild type homozygotes (GG) genotyping.
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Discussion
Spermatozoa are susceptible to oxidative stress (OS) damage. Sperm motility defects 
are mainly related to the OS damage 29-32. NO, a short-lived gaseous free radical, has 
been linked with oxidative stress in various biological systems 33-36. Our group showed 
significant high NO concentration in semen from asthenozoospermic infertile 
comapred to normozoospermic men. Linear negative correlationa between NO 
concentration with sperm motility has been evidenced, and kinetic characteristics 
such as VCL and VSL. Furthermore, the eNOS protein expression was higher in asthe-
nozoospermic patients than normozoospermic men 8. NO synthesized from L-arginine 
by NO synthases (NOS), is a potent mediator of biologic responses involved in several 
pathologies. Several eNOS gene polymorphisms have been associated with various 
vascular, infectious and autoimmune diseases 37.
Middendorff et al.(1997) showed that NOS enzymes and NO receptors are not only 
present in Leydig cells but also in peritubular lamina propria, Sertoli, and blood vessel 
cells, suggesting production and activity of NO in these structures 38. In vitro studies 
showed that low NO concentrations enhance sperm motility in mouse 20, hamster 21, 
human 39, 40. We hypothesized that eNOS gene polymor-phism may be asscoated with 
abnormal production of NO and oxidative stress (OS) which are associated with male 
infertility and low sperm quality 4, 8.
In this study, we used the candidate gene approach to explore whether the eNOS 
encoding gene is involved in sperm motility. For the first time, we describe the 
association between the eNOS gene and sperm motility and sperm motion kinetics. 
A nucleotide substitution at the open reading frame causes amino acid substitution 
of glutamic acid to aspartic acid at a codon in the 298th position. Therefore, we have 
only limited information about whether this missense mutation gives rise to a 
functional alteration of eNOS enzymatic activity or if it is a genetic marker associated 
with some loci. Specifically, we found that there was a statistically significant 
association between the eNOS (Glu298Asp) SNP and motility in the asthenozoosper-
mic patients. With regard to kinetic parameters, in the asthenozoospermic group, the 
patients with a wild type (GG) genotype had significantly higher values of sperm 
motion kinetics than the patients with a heterozygote (GT) or homozygote (TT) 
genotype except for VSL (Table 3). Recent reports showed involvment of the eNOS 
gene Glu298Asp polymorphism in various conditions and diseases that are associated 
with oxidative stress and/ or abnormal NO levels  such as attenuation of the 
vasodilation of in nonexercising muscle 41, advanced stages of endomertiosis 42 and 
frontotemporal lobar degeneration 24. Also, Glu298Asp eNOS polymorphism increases 
the risk ofhypotension in E coli bacteremia 43. These reports confirm our findings 
which prove our hypothesis of the possible involvment of Glu298Asp eNOS SNP in 
abnormal levels of the NO and/ or OS. 
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In effect, we found a significant difference in the frequency of the missense 
(Glu298Asp) variant of the eNOS gene between the asthenozoospermic patients and 
control group. The combined incidence of missense (Glu298Asp) eNOS mutation 
heterozygote [GT] and homozygote [TT] was 75.71% in the patients with idiopathic 
asthenozoospermia and 30.0 % in the controls. Thus, our study shows that this 
missense eNOS polymorphism (Glu298Asp variant) was significantly associated with 
asthenozoo-spermia and that its homozygote condition (TT) was statistically 
associated with compromised sperm motion kinetics parameters. 
The eNOS missense mutation (Glu298Asp variant) is not located in any functional 
consensus sequence, but computer analysis revealed that the (Glu298Asp variant) 
mutation results in a conformational change in the eNOS protein from a helix to a 
tight turn 44. The functional significance of this missense (Glu298Asp variant) of the 
eNOS gene has not yet been demonstrated, suggesting that it may affect the function 
of eNOS protein. However, X-ray diffraction by protein crystallography is still required 
to confirm the eNOS 3-dimensional structure, which will provide a better 
understanding of the molecular basis of the eNOS protein’s function. The T allele of 
this missense eNOS SNP is associated with high plasma NO levels in healthy people 45 
and with eNOS protein levels 46. The eNOS T allele may be associated with an increased 
production of NO that compromises sperm motility. Presence of T allele may be the 
cause of altered eNOS protein structure and function which increases the incidence 
of the OS induced sperm damage in infertile men leading to the asthenozoospermia 
47. The OS induced sperm damage may be related to the abnormal NO levels 8, 40 or 
due to any other possible associated polymorphism affecting genes responsible for 
important molecules such as tumor necrosis factor-alpha 1.
Our study findings may one day lead to therapies that inhibit NO activities in patients 
with low sperm motility. In addition, our study findings may provide novel diagnostic 
tools for idiopathic male infertility and asthenozoospermia. Additional studies with 
larger groups of subjects are needed to confirm our findings, to establish a genetic 
profile that may be useful in the prediction of the outcome of idiopathic infertility, 
and to establish a relationship with NOS protein activity and NO levels with sperm 
motility.
In conclusion, we report for the first time a possible role of the missense (Glu298Asp 
variant) of the eNOS gene in the impairment of sperm motility and kinetic parameters 
in infertile men. Our findings suggest that the T allele, encoding for aspartic acid, of 
the eNOS (Glu298Asp) SNP may be associated with low sperm motility.
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Abstract
Objective: To investigate sperm viability, incidence of apoptosis, and intracellular 
basal and induced reactive oxygen species (ROS) in sperm fractions.
Design: Prospective controlled study. 
Setting: Center for Reproductive Medicine at a tertiary care hospital.
Method(s): Liquefied seminal ejaculates (n = 12) prepared by density gradient 
centrifugation were reconstituted to 2 mL with PBS. Oxidative stress was induced by 
hydrogen peroxide (H
2
O
2; 
100µM). Sperm viability, intracellular ROS and incidence of 
apoptosis/necrosis in neat, immature and mature sperm fractions were assessed. 
Result(s): Before H
2
O
2 
exposure, mature spermatozoa fractions showed significantly 
lower incidence of apoptotic sperm and intracellular O
2
−• levels but higher amounts of 
intracellular H
2
O
2
 compared with neat semen. Higher levels of intracellular H
2
O
2
 were 
demonstrated in immature sperm fractions compared with neat or mature fractions. 
In all sperm fractions, intracellular H
2
O
2
 levels correlated with intracellular concentration 
of O
2
−•. Following H
2
O
2 
exposure, neat semen showed a significantly higher percentage 
of apoptosis compared with the prepared mature spermatozoa. However, no 
differences were observed in the incidence of apoptosis between immature and 
mature sperm fractions.  
Conclusion(s): There is a differential shift of both intracellular H
2
O
2 
and O
2
-• in each 
sperm fractions that may affect sperm quality. Sperm apoptosis is related to intra -
cellular H
2
O
2 
levels, which in turn are affected by intracellular O-• levels. Oxidative stress 
was not associated with increased incidence of apoptosis in immature or mature 
sperm fractions.
Key Words: Reactive oxygen species, flow cytometry, apoptosis, human spermatozoa, 
intracellular staining.
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Introduction
Oxidative stress has been implicated in male infertility 1-5. Superoxide (O
2
−•) and hydrogen 
peroxide (H
2
O
2
) are common reactive oxygen species (ROS), which are highly reactive 
and can interact with nearby molecules, inducing oxidative stress damage in cellular 
organelles and molecules 6-8. 
Physiological levels of ROS are required for normal sperm functions such as hyper-
activation, capacitation and acrosome reaction 9-11. Oxidative stress occurs in spermatozoa 
when global levels of ROS (both extra- and intracellular) exceed the available total 
antioxidant capacity. Sperm have a limited amount of cellular cytoplasm where 
scavenging enzymes are found, making sperm highly susceptible to ROS damage 10, 12, 
13. As ROS are able to readily permeate the membranes, they can cause DNA, proteins 
and lipid molecules peroxidative damage within the cell 7, 8, 14. Motile sperm have been 
shown to be activated by excessive ROS formation and undergo apoptosis-like 
changes 15-17. This insult has been linked to sperm apoptosis and male infertility 18, 19. 
Sperm preparation plays an important role for successful outcome in assisted 
reproductive techniques (ART). Double-density gradient centrifugation is a standard 
sperm selection method for ART to separate mature motile sperm with superior 
morphology. A mature sperm fraction shows fewer incidences of apoptotic sperm 
compared with ejaculated unprocessed sperm 20, 21. Oxidative sperm damage can 
occur during sperm preparation and processing for ART 22-24. 
Oxidative stress-induced sperm damage and apoptosis-like changes may occur when 
the intracellular ROS levels are in excess of the cells’ scavenging capacity 20, 25. In 
addition, H
2
O
2
 has been recommended as a local vaginal contraceptive/spermicidal 
agent 26, 27. Measurement of the intracellular ROS would, therefore, be more beneficial 
than global measurement of the seminal ROS 6, 8, 28. On the other hand, simultaneous 
selective measurement of intracellular H
2
O
2
 or O
2
−• levels may be important in 
understanding how sperm preparation affects ART success rates.
Dichlorofluorescin diacetate (DCFH-DA) and dihydroethidium (DHE) are used for 
measurement of intracellular H
2
O
2 
and O
2
-•, respectively, by flow cytometry. The 
advantages of using flow cytometry for measurement of intracellular ROS in ejaculated 
human spermatozoa have been reported recently 29-31.
In this study oxidative stress was induced following exposure to exogenous hydrogen 
peroxide (H
2
O
2
). Sperm viability and intracellular ROS levels were evaluated in seminal 
ejaculates (unprocessed) and in immature and mature sperm fractions to determine 
the basal and stimulated intracellular ROS levels and examine their relationship with 
viability and apoptosis.
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Material and methods
Sample Collection and Preparation
This study was approved by the Cleveland Clinic Institutional Review Board. Semen 
samples were collected from 12 healthy male volunteers of unproven fertility status at 
the Cleveland Clinic andrology laboratory. All samples were collected by masturbation 
after 2-3 days of sexual abstinence.
After liquefaction, sperm count, percentage motility, viability and presence of round 
cells were examined on an aliquot of the neat semen sample. The remaining aliquot 
was prepared for separating mature and immature fractions by double-density 
gradient centrifugation (PureCeption, SAGE BioPHARMA, Bedminster, NJ). Samples 
were centrifuged at 300 g for 20 minutes, and the resulting interface between the 
40% and 80% layers (immature spermatozoa) was aspirated. Highly motile mature 
spermatozoa were obtained in 80% pellet. Both fractions were re-suspended in 
human tubal fluid media (HTF, Irvine Scientific, Santa Ana, CA). 
Induction of Oxidative Stress
Oxidative stress was induced by exposing the sperm to H
2
O
2
. A 30% stock solution of 
H
2
O
2 
(Sigma Chemical Co., St Louis, MO) was diluted to 100µM and added to one mL 
of sperm suspension (stimulated ROS) and incubated for 15 min at 37oC. Another aliquot 
from the same fraction containing an equal volume of HTF served as control (basal ROS). 
Determination of ROS by Flow Cytometry
DCFH-DA, a specific probe for H
2
O
2 
and DHE, an O
2
−•-specific probe, are cell-permeable 
stains. DCFH is oxidized selectively by the free intracellular H
2
O
2
 into DCF that binds to 
DNA and emits green fluorescence. HE is oxidized by the free intracellular O
2
-• into 
ethidium bromide that binds to the DNA and emits red fluorescence 31-33. DCFH–DA 
(25 µM) and DHE (1.25 µM) (Sigma) were added to the sperm suspension and incubated 
at 25°C for 40 minutes (DCFH-DA) and 20 minutes (DHE), respectively. Aliquots were 
subsequently analyzed using a flow cytometer. Green fluorescence (DCF) was 
evaluated between 500 and 530nm, while red fluorescence (HE) was evaluated 
between 590 and 700 nm (excitation: 488 nm; emission: 525 - 625 nm in the FL2 
channel). Data were expressed as the percentage of fluorescent spermatozoa. 
Apoptotic spermatozoa were excluded by using counter nucleic acid stains. Propidium 
iodide (PI) was used as a counter stain dye for DCFH-DA; YO-PRO-1 was used as a 
counter stain dye for the HE 29. 
Apoptosis Detection 
To measure the apoptotic status of the spermatozoa, the Vybrant Apoptosis Assay 
(Invitrogen, Carlsbad, CA) was used. All samples were washed in cold phosphate- 
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buffered saline (PBS) and the cell density adjusted to ~1 × 106 cells/mL in PBS. One μL 
of the YO-PRO-1 solution (10 μM) and 1 μL of the PI solution (50 μg/mL) were added 
to 1 mL of cell suspension and incubated for 20–30 minutes. Flow cytometric analysis 
of the stained cells was done within 1 - 2 h using 488 nm excitation with green 
fluorescence emission for YO-PRO-1 (i.e., 530/30 bandpass) and red fluorescence 
emission for PI (i.e., 610/20 bandpass). Gating was performed to exclude any debris. 
Standard compensation was done using single-color stained controls. Three different 
populations can be identified by using this assay (Fig 1): viable sperm are negative for 
both PI and YO-Pro-1, apoptotic sperm are positive for Yo-pro-1 but negative for PI, 
and dead sperm show positivity for both PI & YoPro-1.
Flow Cytometry Analysis
All fluorescence signals of labeled spermatozoa were analyzed by a Becton Dickinson 
flow cytometer FACScan (Becton Dickinson, San Jose, CA) equipped with a 488 nm 
argon laser as a light source. A minimum of 10,000 spermatozoa were examined for 
each assay at a flow rate of <100 cells/ sec. 
 The sperm population was gated using 90o and forward-angle light scatter to 
exclude debris and aggregates. The excitation wavelength was 488 nm supplied by 
an argon laser at 15 mW. DCF/ YO-PRO-1 emitting green fluorescence and PI/ HE 
emitting red fluorescence (580–630 nm) were recorded in the FL-1 and FL-2 channels 
respectively. The percentage of HE/ PI positive cells and the mean fluorescence were 
calculated on a 1023-channel scale and analyzed using the flow cytometer software 
FlowJo version 7.2.2 (FlowJo, Ashland, OR).
Statistical Methods
For all quantitative measured parameters, comparisons between stimulated and 
non-stimulated neat, mature, and immature spermatozoa were performed using the 
Wilcoxon signed-rank test. Associations among quantitative variables were measured 
using Spearman’s correlation coefficients both within and across sample groups. 
P value <0.05 was considered as statistically significant
Results
Neat semen samples showed a mean (± SD) semen volume of 2.7 (±1.3) mL, sperm 
concentration of 62.4 ± 53.1 X 106 cells /mL, and motility: 66.6 ± 9.2 %. Before H
2
O
2 
exposure, mature sperm showed a significantly higher motility (72.7 ± 19.3%) when 
compared with neat sample (48.9 ± 19.7%, p = 0.014) and immature sperm (41.7 ± 
12.3%, p <0.001), respectively.
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Sperm Population Identification
When viable, apoptotic, and dead sperm were examined, three different sperm 
staining patterns were observed upon analyzing the sperm for apoptosis by using the 
Yo-Pro-1/PI assay (Figure 1 A-F). The apoptotic sperm population stained only positive 
for Yo-Pro-1. Yo-Pro-1 and PI positive cells represented the dead sperm population, 
while viable sperm showed negative Yo-Pro-1 and negative PI fluorescence. The 
percentage of each sperm population in neat, immature, and mature sperm fractions 
are shown in Figure 1 (A-F).
Sperm Apoptosis and Intracellular ROS before H2O2 Exposure:
Density gradient centrifugation selected a population of mature cells with a significantly 
lower number of apoptotic cells than were present in neat semen (p = 0.006) (Table 1). 
Mature sperm also displayed a higher percentage of DCF +ve (p <0.001) and a lower 
HE+ve % (p = 0.004) fluorescence compared with sperm in the neat semen. Immature 
sperm showed a significantly higher percentage of DCF-stained sperm when 
compared with both neat (p<0.001) and mature sperm (p = 0.05).
Sperm Viability, Apoptosis and Intracellular ROS after H2O2 Exposure:
Exposure to H
2
O
2
 significantly reduced viability and increased the percentage of dead 
sperm in neat and in immature and mature groups as shown in Figure 1. On the other 
hand, exposure to H
2
O
2
 was associated with an increase in the mean percentage of 
apoptotic sperm in neat semen and in the mature and immature sperm fractions but 
the difference was not significant (Table 1). Following H
2
O
2
 exposure, a significantly 
lower percentage of apoptosis was seen in mature vs. neat sperm fractions (p = 0.024). 
Other comparisons between immature vs. mature and neat (stimulated or non-
stimulated) showed no significant differences.  
The percentage of sperm with DCF fluorescence (intracellular H
2
O
2
) increased in both 
neat and mature sperm, but the difference was not significant in the immature sperm 
fractions (Table 1) (Fig. 2 A). Moreover, neat, immature and mature sperm fractions 
exhibited a significant increase in the percentage of sperm showing HE fluorescence 
(increase intracellular O
2
-•) (Table1) (Fig. 2B).
Correlation of Intracellular ROS with Other Sperm Parameters 
Sperm viability was inversely related to the percentage of apoptotic spermatozoa 
(mature non-stimulated r = -0.76, p = 0.006; mature stimulated r = -0.58, p = 0.047; all 
fractions; r = -0.55, p <0.001). Following H
2
O
2
 exposure, the percentage of viable 
spermatozoa was positively correlated with the intensity of DCF fluorescence in neat 
(r = 0.63, p = 0.031) and in mature sperm fractions (r = 0.59, p = 0.04).
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The percentage of apoptotic sperm was positively correlated with DCF fluorescence 
(intracellular H
2
O
2
) in neat non-exposed fractions (r = 0.60, p <0.041). We wanted to 
examine the relationship of apoptotic sperm with dead sperm. When the neat, 
immature and mature fractions (overall) were examined before and after stimulation, 
the percentage of apoptotic sperm was positively correlated with the percentage of 
dead sperm in the overall group (r = 0.52; p <0.001) and the mature sperm fraction 
(r = 0.78; p = 0.004). Following H
2
O
2 
exposure, the percentage of sperm positive for 
Figure 1  Representative flowcytometry pseudo colored dot plots for unstimulated (left) 
and stimulated (right) A-B: neat, C-D: immature and E-F: mature sperm fractions. Each 
quadrant is shown as : Lower left quadrant: viable, non-stained sperm; lower right: apoptotic 
sperm (Yo-Pro positive only); Upper right quadrant: dead spermatozoa (positive for Yo-Pro 
and PI). The numbers in parenthesis represent the percentage of sperm population in each 
quadrant. Only 3 sperm population could be identified by using Yo-Pro-1/PI for apoptosis.
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DCF showed a negative correlation with the percentage of dead sperm in neat 
(r = -0.68, p = 0.01) and in mature sperm fractions (r = -0.59; p = 0.04). Similarly, after 
exposure, the percentage of HE +ve sperm (intracellular O
2
−•) was significantly correlated 
with the percentage of DCF +ve sperm (intracellular H
2
O
2
) in the overall (r = 0.52; 
p <0.001) and mature sperm fractions (r = 0.78; p = 0.004).
Discussion
Our study aim was to evaluate the basal and stimulated intracellular H
2
O
2
 and O
2
-• 
levels in different sperm fractions and to examine their relationship with sperm 
apoptosis. We have measured basal levels of both intracellular H
2
O
2
 and O
2
-• in neat, 
immature and mature sperm fractions. Interestingly, both mature and immature 
sperm showed reduced intracellular levels of O
2
-• compared with the neat sperm. 
Higher levels of intracellular H
2
O
2
 (as represented by DCF +ve fluorescence) were seen 
in immature compared with mature or neat sperm fractions (Table 1). We report for 
the first time the shift in intracellular H
2
O
2
 and O
2
-•levels. This shift may be explained 
by the fact that conventional centrifugation increases heat generation, which may 
affect sperm quality 17, 34, 35. Avoiding sperm centrifugation for longer times and / or 
higher speed(s) or its modification may be helpful in preserving sperm quality 36. 
Figure 2  Representative flowcytometry marker histogram for stimulated neat, immature 
and mature sperm fractions. A: positive DCF fluorescence (represents intracellular H2O2) B: 
Positive fluorescence for HE fluorescence (represents intracellular O2−•). The histograms 
show the differential shift of the intracellular ROS in sperm fractions.
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We hypothesize that conventional centrifugation may increase the activity of the 
superoxide dismutase enzyme that converts the generated superoxide ion during 
centrifugation into hydrogen peroxide, which may prove fatal to sperm cells 37. This 
conversion lowers the available intracellular superoxide levels in both immature and 
mature sperm when compared with the neat unprocessed spermatozoa. However, 
mature spermatozoa may have higher catalase activity/expression 38 when compared 
with immature spermatozoa, enabling them to scavenge the generated H
2
O
2
 more 
effectively. Interestingly, despite the higher levels of intracellular H
2
O
2
 seen in the 
mature sperm fraction, the percentage of dead sperm in this fraction did not increase 
significantly even though a significant decrease was seen in the percentage of 
apoptotic sperm.  This might be explained by the fact that H
2
O
2
 is not as lethal as O
2
-• 
for cell viability. Another, more likely, explanation is the fact that mature sperm have 
the ability to protect themselves against the harmful effects of H
2
O
2.
exposure 39, 40. On 
the other hand, our finding confirms the reports of Donnelly et al. 41 that supplemen-
tation with ascorbate and alpha-tocopherol in combination protects the sperm from 
H
2
O
2
-induced sperm DNA damage by scavenging the ROS generated during sperm 
preparation.
Our study data demonstrated that mature spermatozoa fractions exhibited lower 
levels of both apoptotic and dead sperm and displayed higher percentages of viable 
sperm compared with neat semen (Table 1). These findings were in agreement with 
earlier studies from our group 30, 42, as well as with other studies where superoxide 
anions were shown to induce both caspase activation and apoptosis. From these 
results, it is also worth mentioning that acute exposure of spermatozoa to H
2
O
2
 results 
in decreased sperm viability and increased percentage of dead spermatozoa. 
Apoptosis and necrosis are different death pathways; we examined their relations to 
sperm viability. This is in agreement with the findings of Conde de la Rosa et al. 6 who 
reported that H
2
O
2
 induced cell death. It also agrees with others who evaluated the 
efficacy of H
2
O
2
 as a local vaginal contraceptive/spermicidal agent with a short time 
exposure 21, 43-45. 
We have demonstrated that intracellular H
2
O
2 
levels are related to the intracellular O
2
-• 
levels as both are end products of one reaction. Sperm motility is positively related to 
the percentage of viable sperm. When all the fractions were considered together, 
motility was inversely related to the percentage of dead or apoptotic sperm. This may 
explain why sperm motility decreases in pathologically high ROS conditions where 
there is an increase in the percentage of dead sperm. It may also explain why sperm 
preparation by density gradient separation shows higher motility due to reducing the 
percentage of apoptotic spermatozoa. As shown earlier, removal of apoptotic sperm 
improves the quality of the prepared sperm 42. 
Our study findings show that the percentage of apoptotic sperm was positively 
related to the basal intracellular levels of H
2
O
2
 in the neat sperm fraction. However, 
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under high ROS conditions (pathological or induced), intracellular H
2
O
2
 level was 
positively related to the percentage of viable spermatozoa in stimulated as well as 
neat sperm. This may be explained by the fact that induced high ROS conditions will 
increase the percentage of apoptotic/ dead sperm. In high ROS conditions 
(pathological or induced), viable spermatozoa may have the ability to adapt to 
increased H
2
O
2
 as a result of their high defense status (Figure 1). This observation may 
be important and supported by the report that shows 100% efficacy (sperm 
immobilization and loss of viability) in mating studies not earlier than 2 h of H
2
O
2
 
exposure 43. This may explain the poor efficacy of H
2
O
2
 as a local vaginal contraceptive 
for short time usage (<1 h) and is in accordance with a report 43 that 2 hours exposure 
may be appropriate to improve the H
2
O
2 
contraceptive efficiency.
In conclusion, both immature and mature sperm produce higher intracellular H
2
O
2
 
levels compared with neat spermatozoa. This probably is attributable to sperm 
processing with centrifugation. Mature spermatozoa may adapt to H
2
O
2 
generated 
during sperm preparation involving centrifugation. This may explain the presence of 
the higher percentage of viable and the lower percentage of dead/ apoptotic sperm 
in the prepared mature spermatozoa fraction. Sperm preparation may be associated 
with differential shift of both intracellular H
2
O
2
 and O
2
-• that may affect the sperm 
quality. Apoptotic changes in sperm are attributed largely to the intracellular H
2
O
2
 
levels while dead sperm are related to intracellular O
2
-• levels. Finally, intracellular ROS 
levels may affect sperm quality through their effects on sperm viability.
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Abstract
Objective: To establish cutoff value, sensitivity, specificity and intra- and inter-observer 
variability of total antioxidant capacity (TAC) in seminal plasma from healthy donors 
(controls) and infertile patients.
Design: Seminal plasma from proven fertile donors (n = 55), non-proven fertile donors 
(n = 45) and infertile patients (n = 42) were examined for TAC level  
Settings: Reproductive research center in a tertiary care hospital.
Patient(s): Infertile patients from male infertility clinic of various diagnoses  
Intervention(s): Seminal plasma TAC measurement by a colorimetric assay using the 
TAC assay kit, receiver operating curve. 
Main Outcome Measure(s): Seminal plasma TAC levels, cutoff value, sensitivity, and 
specificity. 
Result(s): Proven fertile donors showed higher TAC values (median and range): 1700 
(1440 - 2290 µM); compared to the infertile patients: 1310 (1040 - 1600 µM). The best 
cutoff to distinguish between fertile controls and infertile men was 1420 µM. At this 
threshold, specificity was 64% and sensitivity 76%. 
Conclusion(s): Total antioxidant capacity of the seminal plasma as measured by the 
colorimetric assay is a reliable and simple test for the diagnosis and management of 
male infertility. 
Key words: Seminal plasma, male infertility, oxidative stress, receiver operating characteristic 
curve, total antioxidant capacity.
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Introduction
Male factor infertility accounts for 30 to 50% of the total infertile couples seeking for 
infertility management 1. Among the couples seen for infertility, the most common 
cause of male infertility is defective spermatozoal function. It may result from testicular 
pathologies, genetic disorders, and exposure to drugs, toxins or irradiations, or 
because of oxidative stress damage 2, 3. The mechanism of action for loss of sperm 
function may be due to elevated levels of reactive oxygen species (ROS) beyond the 
available total antioxidant capacity in the semen 3-9.
Seminal plasma has a very effective antioxidant systems that can provide the 
spermatozoa with a protective environment against oxidative stress 10. This protection 
compensates for the loss of cytoplasmic sperm enzymes that occurs during maturation 
and transportation processes, which in turn diminishes the spermatozoa’s endogenous 
enzymatic and repair defenses 7, 8, 11-15. Indeed, the total antioxidant capacity of seminal 
plasma is due to the sum of enzymatic (e.g. superoxide dismutase, catalase and 
glutathione peroxidase) and non-enzymatic (e.g. ascorbate, urate, vitamin E, pyruvate, 
glutathione, taurine, and hypotaurine) antioxidants 7, 16-21.
Low level of seminal total antioxidant capacity (TAC) has a key role in male infertility 8, 22, 23. 
It is important to ensure that any measurement of seminal TAC is accurate and reliable 
and yet easy to use as a diagnostic tool in the evaluation and follow-up of male 
infertility. TAC levels have been measured by the enhanced chemiluminescence 
method earlier in patients with clinical diagnosis such as varicocele, varicocele with 
infection, vasectomy reversal as well as idiopathic infertility 9, 24, 25. In addition, using 
the ROS and TAC results, a novel score called the ROS-TAC score was also described 
earlier by us in subsets of patients with various clinical diagnosis1, 16, 25-27. This score was 
described as a better predictor of oxidative stress in patients with various clinical 
diagnosis compared to ROS or the TAC values alone. Seminal TAC can be measured as 
the total available antioxidant protection in the seminal plasma which is more 
practical and easy to perform by an enhanced chemiluminescence or the colorimetric 
assay. In contrast, measuring specific antioxidant assays are expensive and cumbersome 
in performance (High pressure liquid chromatography, and so forth) and provide 
limited information about the assessed antioxidants. Earlier we compared the 
enhanced chemiluminescence and colorimetric method to assess TAC. We reported 
that the colorimetric TAC measurement is simple, rapid, cheaper and accurate 28. 
Increase in levels of ROS without a concomitant rise in antioxidant defenses leads to 
oxidative stress. Oxidative stress is involved in the pathogenesis of male and female 
reproduction. Oxidative stress causes damage to the spermatozoa, oocyte and 
embryos. Several reports relate low seminal plasma TAC levels to male infertility as 
well as in embryo culture media from the oocytes, cumulus cell mass and spermatozoa 
used for insemination in conventional IVF. The potential cellular sources of TAC in ICSI 
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setting are the spermatozoa and the injected oocytes 8, 22, 23, 29-36. However, a definite 
cutoff or reference range in infertile patients or proven fertile subjects for a possible 
use as a diagnostic tool for infertility identification is lacking.
The objectives of our study were to [1] identify a cutoff value for seminal plasma TAC 
level that can differentiate infertile patients from fertile donors, [2] establish the 
sensitivity and specificity of the test; and [3] examine the intra- and inter-observer 
variability of the assay to establish the variability between various individuals who 
may perform the assay in a clinical laboratory setting.
Materials and methods
Subject Selection
This study was approved by the Institutional Review Board of our hospital. Infertile 
patients (n = 42 ) as well as normal healthy men (n = 100) were screened and selected 
on the basis of normal semen analysis according to the World Health Organization 
(WHO) 37 guidelines. 
Semen Collection and Preparation
Semen specimens were collected by masturbation after 48 to 72 hours of sexual 
abstinence. The specimens underwent complete liquefaction at 37oC for 20 minutes, 
and 5 µL of each specimen was loaded on a 20 µL Microcell chamber (Conception 
Technologies, San Diego, CA) where it was analyzed for sperm concentration and 
motility. Samples were classified according to the results of semen analysis as per the 
WHO (1999) 37 criteria and history of establishing a pregnancy in the past 2 years.
Donors or controls (n = 55) were further classified as proven fertile that is, who had 
initiated a pregnancy within the past 2 years and had normal semen analysis results 
according to WHO criteria. Unproven fertile (n = 45) men were those who had normal 
semen analysis results but had not established a pregnancy in the past 2 years. 
Infertile patient group (n = 42) consisted of men who had abnormal semen analysis 
and were presenting for infertility treatment and /or undergoing investigation for 
various male infertility factors. All samples were centrifuged at 1,000 X g for 10 minutes 
at 4oC. Clear seminal plasma was aliquoted and frozen at -70oC till the time of TAC 
assay. A total of 142 TAC measures were conducted: 42 for patients, 55 for fertile 
donors and 45 for donors with unknown fertility status. 
Total antioxidant assay
Seminal plasma total antioxidant measurement was done using the antioxidant assay 
kit (Cat # 709001; Cayman Chemical, Ann Arbor, MI). The Cayman chemical antioxidant 
assay was used to measure the antioxidant capacity of the seminal fluid samples. The 
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principal of the assay is the ability of aqueous- and lipid-antioxidants in the seminal 
plasma specimens to inhibit the oxidation of the 2, 2’-Azino-di-[3-ethylbenzthiazoline 
sulphonate] (ABTS) to ABTS+. Under the reaction conditions used, the antioxidants in 
the seminal plasma cause suppression of the absorbance at 750 nm to a degree which 
is proportional to their concentration. The capacity of the antioxidants present in the 
sample to prevent ABTS® oxidation was compared with that of standard - Trolox, a 
water-soluble tocopherol analogue. Results are reported as micromoles of Trolox 
equivalent. This assay measures the combined antioxidant activities of all its 
constituents including vitamins, proteins, lipids, glutathione, uric acid, and so forth.
The technique for TAC assay used in our study has been described before 38, 39. All 
seminal plasma samples were diluted 1:10 with the assay buffer before assaying to 
avoid variability due to interference by the plasma proteins or sample dilution. All 
reagents and samples were equilibrated to room temperature before beginning the 
assay. Samples as well as Trolox standards were assayed in duplicate. Trolox standards 
and reagent were prepared as per the manufacturer’s instructions at the time of the 
assay. After the plate configuration, 10 µL of Trolox standard and samples were loaded 
on to the corresponding wells of a 96 well plate. Then 10 µL of metmyoglobin and 150 
µL of chromogen were added to all standard/sample wells. The reaction was initiated 
by adding 40 µL of hydrogen peroxide (H
2
O
2
) as quickly as possible. The plate was 
covered and incubated for 5 minutes on a shaker at room temperature. Absorbance 
was monitored at 750 nm using ELx800™ Absorbance Microplate Reader (BioTek 
Instruments, Inc., Winooski, VT). 
Calculation of assay result
Determination of the reaction rate was done by calculating the average absorbance 
of each standard and sample. The average absorbance of the standards as a function 
of the final Trolox concentration (µM) was plotted for the standards curve in each run, 
from which the unknown samples were determined (Figure 1). The total antioxidant 
concentration of each sample was calculated using the equation obtained from the 
linear regression of the standard curve by substituting the average absorbance values 
for each sample into the equation:
Antioxidant (μM) =
 
Unknown average absorbance – Y-intercept
Slope
X dilution X 1000
Precision and sensitivity of the TAC assay kit
According to the manufacturer, the assay precision was: inter-assay coefficient of 
variation 3% (n = 20) and intra-assay coefficient of variation 3.4% (n = 84). The assay kit 
could measure samples containing antioxidants ranging between 44 - 330 µmoles 
without any further dilution.
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Interobserver and Intraobserver Variation
For each subject, 1-2 measurements were recorded. Two observers (RM and RS) 
conducted these measurements both from the same subjects as well as from different 
subjects. 
The inter- and intra-observer variability illustrated in Figure 1 was evaluated using a 
total of 60 TAC measurements. Two observers evaluated 8 donors and 7 patients in 
duplicate (n = 30 each). The inter observer variation was obtained by analyzing the 
differences in the results produced by the 2 observers. The intra-observer variation 
was obtained by analyzing the differences between measurements within each 
observer. 
Statistical Analysis
The difference in distributions of TAC levels between infertile patients and proven 
fertile donors was assessed using the Wilcoxon rank sum test. Summaries of the 
distributions include mean, standard deviation, median, and interquartile range (IQR). 
A receiver operating characteristic curve was used to display estimated sensitivity and 
specificity over a range of possible cutoff points for TAC as a predictor of fertility. A 
cutoff value was chosen to maximize the sum of sensitivity and specificity. A secondary 
analysis was performed in a similar fashion that added donors with unproven fertility 
to the group of donors with proven fertility for comparison to the infertile patients.
Inter- and intra-observer reliability of TAC measurement was assessed between two 
selected observers. This was calculated in a set consisting of both donors and patients 
using each observer’s measurement in duplicate. For intra-observer reliability, the 
absolute difference for each sample between the two TAC measurements, divided by 
the average of the two (denoted as “d/m”), was used as a measure of relative nearness 
of the measurements. The frequency in which the relative nearness was within set 
levels was used to describe the intra-observer reliability for each of the two observers. 
For inter-observer reliability, the two observer’s average measurements for each 
subject were treated as a pair. Differences (not in absolute value), divided by the 
averages (denoted as”d/m”), and within the pairs were computed as measures of 
relative nearness of the two observers’ TAC measurements. Frequencies within 20 % 
were then used to describe inter-observer reliability. A one- sample T-test was used to 
determine if the mean relative nearness of the two observers’ TAC measurements was 
significantly different from zero, and a 95% confidence interval (CI) for the mean was 
computed. For both intra and inter-observer reliability, tests based on a Spearman 
correlation coefficient were used to confirm no evidence of the association between 
the relative nearness and the measurement magnitudes. All analyses were performed 
using R version 2.3.1 (www.R-project.org) 40.
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Results
Receiver Operator Characteristic Curve Analysis
Proven fertile donors versus. infertile patients We have examined the association 
between TAC levels and the status of a subject, as either infertile patient or a fertile 
donor. We first considered only proven fertile donors who had normal semen analysis 
results and had fathered a child in the last 2 years. The distribution of TAC levels within 
the proven fertile and donors of unproven fertility is shown in Figure 2 and 3. 
The mean ± SD and median (IQR) values were as follows: infertile patients: 1380 ± 430 
μM, and 1310 (1040 - 1600) μM; proven fertile donors: 1830 ± 540 μM and 1700 (1440 
- 2290) μM (Figure 2). Proven fertile donors showed significant higher seminal plasma 
TAC levels compared to infertile patients groups (p<0.001). The cutoff which 
maximized the sum of the sensitivity and specificity when using TAC as a predictor of 
fertility was 1420 μM seminal plasma TAC level. The ROC curve showed 76% sensitivity 
and 64% specificity for this optimal cutoff (Figure 4).
Figure 1  A standard curve used for TAC measurement, Trolox standard concentrations are 
represented on x-axis while absorbance at the y-axis.
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Figure 2  Boxplot for seminal plasma TAC levels of the infertile patient group vs. proven 
fertile donors group.
Figure 3  ROC curve to show the best cutoff value with its sensitivity and specificity when 
used to differentiate infertile patients from proven fertile sperm donors.
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Figure 4  Box plot of seminal plasma TAC levels on the infertile patients vs. all sperm donors 
group.
Figure 5  ROC curve is used to predict the best cutoff value of seminal plasma TAC levels 
of the infertile patients vs. proven fertile sperm donors with sensitivity and specificity.
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All donors vs. infertile patients As a secondary analysis, we compared infertile 
patients to all donors (whether proven fertile or not). The TAC values in all donors 
(proven and unproven) was 1740 ± 510 μM and 1670 (1360 - 2000) μM versus infertile 
patients: 1380 ± 430 μM, and 1310 (1040 - 1600) μM; (Figure 3). The results of this 
analysis were similar to those that exclude the unproven donors. Significant difference 
in the TAC values was seen in the 2 groups when a similar cutoff value of 1420 μM was 
selected (Figure 5).
Intra- and inter-Observer variability The intra- and inter-observer differences were 
calculated using the simple difference rather than a standard deviation. Rather than 
the CV, we used a ratio of a difference to mean (d/m) to represent the relative 
difference of two TAC measurements. Next we assessed the likelihood that such 
relative differences would exceed 20% value which is unacceptable. By using this 
ratio; the mean intra-observer variability was 13.4% for observer-1 and 15 % for 
observer-2. The mean inter-observer variability between the two observers was 19 %. 
All the variability measures were in the acceptable ranges (d/m ratio <20 %).
Discussion
The link between reactive oxygen species and the male infertility has been established. 
Irrespective of the clinical manifestation and the results of semen analysis, the 
presence of abnormal ROS level plays a major role in the pathogenesis of male 
infertility 27, 30, 36, 41, 42. 
Total seminal plasma antioxidants are the most protective defensive mechanism 
available to spermatozoa against ROS. Low seminal total antioxidant capacity has 
been shown to be related to male infertility 10, 28, 35, 36. Seminal plasma antioxidant 
capacity may be influenced by a wide range of the factors such as nutrition, vitamin 
supply, age, infection, etc), therefore, it is important to accurately estimate the total 
antioxidant amount of the seminal plasma 19, 38. From the methods available for 
measuring TAC, earlier we compared the more commonly used enhanced chemilu-
minescence assay versus the colorimetric assay using for measuring TAC levels in 
seminal plasma. 
For the colorimetric assay we used the TAC kit from Randox (Randox Laboratories Ltd, 
San Francisco, CA).The measurement of total antioxidant capacity by enhanced che-
miluminescent method generally takes approximately 40-45 minutes; it requires 
stringent assay conditions as opposed to the colorimetric assay. The price of an 
average luminometer with kinetic setting averages $30,000 compared with $6,000 for 
a simple spectrophotometer. We reported that the colorimetric assay is a reliable, 
simple, rapid, and accurate assay compared with the chemiluminescence assay 28.
The main objective of our study was to examine the diagnostic value of the seminal 
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plasma total antioxidant capacity (TAC) assay in infertility clinic in terms of the 
best cutoff level, assay sensitivity and specificity using a colorimetric assay. Also we 
examined the inter- and intra-observer variability for this assay to establish the 
variability between various individuals who may perform the assay in a clinical 
laboratory setting.
It is important that the technicians are checked off for accuracy especially in routine 
bench work such as accuracy in pipetting, and so forth. In our study the two observers 
(R.M. and R.K.S.) were very experienced in routine bench work (>5 years). It is prudent 
to have more researchers validate our study. The variation is near the acceptable limit. 
This also depends on the method of calculating the variation. Here we calculated the 
ratio of the absolute difference to the average value. This is different from the 
coefficient of variation (CV), which is calculated from the ratio of standard deviation to 
the average. The d/m ratio is more sensitive to the CV. By using the CV calculations, 
the inter- and intraobserver variability was around 5%.
In our study, infertile patient group showed lower seminal plasma TAC levels compared 
to the proven fertile and the overall donor group (Figure 2 and 3). The proven fertile 
and all donors groups showed comparable seminal plasma TAC levels. We have 
established a cutoff value of 1420 micromoles of trolox; all infertile men showed TAC 
levels below this cutoff value, while proven fertile men showed TAC levels higher than 
this cutoff value. Receiver operating characteristic curve showed high sensitivity 
(76%) and specificity (64%). Inter-observer and intra-observer variation were within 
the acceptable ranges. 
Siciliano et al 21 reported similar total antioxidant status using ABTS based colorimetric 
assay in asthenozoospermic (1240 ± 200 µmoles) and oligoasthenozoospermic 
patients (1260 ± 210 µmoles) with normal viscosity compared with normozoospermic 
healthy donors (1210 ± 160 µmoles) with proven fertility 21. However significant 
differences were seen in the TAC levels in these patients with normal viscosity when 
compared to those that were hyperviscous. They concluded that impaired antioxidants 
in asthenozoospermic patients may be related to other associated pathologies such 
as hyperviscosity. Contrary to their findings, low TAC levels were seen in our infertile 
patient groups and these levels were significantly lower than in proven as well as 
unproven fertile donors. None of the samples in our study was hyperviscous. 
Fingerova et al 8 reported seminal plasma TAC level to be about 1.4 times higher than 
those in the blood serum 8. They measured the seminal plasma TAC levels by using 
Randox kit. They found significantly lower values (mean ± SD 2.15 ± 0.29 mM) in the 
infertile patients compared to the control 2.32 ± 0.33 mM; P <.02). When the range 
and median were compared there appeared to be an overlap between the patients 
and controls (patients: median and range: 2.11 (1.63 - 2.64) mM versus control: 2.48 
(1.45 - 2.66) mM. Our results agree with their finding regarding the significantly lower 
TAC values in patients compared with the controls. However the difference in our 
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cutoff value between patients and controls is more distinct compared to the values 
reported in the study by Fingerova et al. This can be attributed to the fact that in their 
study the patient and control semen analysis results were more or less within normal 
ranges according to WHO references 37. 
Lewis et al 23 compared the individual antioxidants in serum and in seminal plasma. 
They reported that in seminal plasma ascorbate, urates and thiols are the major 
antioxidant available. 23. However; Donnely et al. reported that single or combined 
supplementation of ascorbate and tocopherol is not beneficial for sperm motility 
improvement 7. Their findings suggest the importance of the TAC assay instead of 
measuring individual antioxidants which is complex & inaccurate. It may therefore be 
important to use TAC assay for monitoring and follow up for infertile patients.
Our inter- and intraobserver variability results were in agreement with our earlier work 
where we reported the actual average difference of 27.6 μM Trolox equivalent 
between observers, and inter-observer variation of 3 % (95%CI; -3.6%-9.5%) 28. Benzie 
et al 18 reported intra-assay CV of <1.0% and inter-assay CV of <3.0% using the ferric 
reducing ability of plasma (FRAP) as a measure of the antioxidant power in the 
biological fluid samples. 
Using the enhanced chemiluminescence assay for measuring TAC levels we 
demonstrated the usefulness of this assay in identifying patients with various clinical 
diagnosis 9, 24, 25. We also defined a novel ROS-TAC score and its usefulness in differen-
tiating the patients from control healthy men 1, 16, 25, 26, 43. Using the enhanced chemilu-
minescence assay we reported the TAC values in controls 1650.9 ± 532.22 1, 16, 27 and 
1653.98 ± 115.29 molar trolox equivalents 25. All infertile patients with various clinical 
diagnoses had significantly lower levels of TAC. However the enhanced chemilumi-
nescence assay probe is no longer available and the TAC measurement derived from 
the luminometer are complex and time consuming.  The equipment must be simple, 
easy to use, and cost effective. Although, enhanced chemilumenscence involves the 
luminometer, many labs also use high performance liquid chromatography (HPLC) for 
measuring vitamin E and C concentrations. This is again time consuming, requires 
specific instrumentation, and is expensive.
We therefore sought to look for an alternate, easy and accurate method for measuring 
the seminal plasma antioxidant status. We demonstrated the ease of using the 
colorimetric assay (Randox kit) versus the chemiluminescence method for TAC 
measurement 28. The accuracy, sensitivity and the specificity was comparable in the 
two methods. However, this kit is expensive, uses larger assay volumes and can be 
used only with a spectrophotometer. Our goal was to use an easy and simple 
colorimetric assay where multiple samples can be evaluated in smaller volumes 
simultaneously and therefore we looked for alternate assay kits. The assay kit used 
currently in our study is cost effective, requires smaller assay and reagent volumes 
and more importantly it can be used in a plate reader for simultaneous measurement 
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of large number of samples unlike the Randox kit. In the current study, we included 
patients and donor based on their semen analysis and fertility status only. In this 
study, our primary objective was to establish a diagnostic reference values for seminal 
plasma TAC levels in infertile patients as well as in healthy donors, and hence the 
abstinence period required was 2–3 days similar to that defined by WHO for routine 
semen analysis as recommended by WHO 37. It would be interesting to examine the 
effect of shorter abstinence period of <48 hours, as this may help decrease the 
amount of time the spermatozoa are subjected to oxidation while in the male 
reproductive tract and possibly increase the sensitivity. We recommend further 
studies to not only reproduce our results, but to establish reference values for different 
age ranges and also with certain diseases such as varicocele and infection, as well as 
conditions such as hyperviscosity and varying abstinence period. 
In conclusion, the simple colorimetric seminal plasma TAC assay used in our study can 
discriminate proven fertile from infertile patients. It may be used as a diagnostic and 
prognostic tool in the male infertility clinic. The best obtained predictive value of 
seminal plasma TAC level is 1420 μM. Therefore, we can recommend seminal plasma 
TAC measurement as a quick in-office test for the evaluation of patients with male 
infertility. 
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Abstract
Objective: To examine simultaneously the levels of superoxide (O
2
−•) and hydrogen 
peroxide (H
2
O
2
) using chemiluminescence and flowcytometry (FACS).
Design: Prospective laboratory study.
..Setting:  Reproductive research lab in a tertiary hospital...
..Subjects: Semen samples from 18 healthy male volunteers.
Interventions: Sperm preparation and measurement of ROS by chemiluminescence 
using luminol and lucigenin before and after H
2
O
2
 exposure and by flow cytometery 
using Dichlorofluorescin diacetate (DCFH-DA) for H
2
O
2 
and Dihydroethidium (DHE) for 
O
2
−•. 
Main Outcome Measures: Sperm count, motility, viability and ROS levels. 
Results: Immature sperm fractions showed significantly higher levels of ROS 
measured by either luminol or lucigenin compared to the nat and mature fraction. 
Luminol and lucigenin showed significant relationships to DCF+ve and HE+ve sperm. 
ROS levels were detectable by flowcytometery in chemiluminescence negative 
samples. Both mature and immature sperm fractions had significantly higher % of 
cells positive for H
2
O
2
 compared to neat semen (p< 0.0001 and p= 0.0055, respectively). 
On the other hand, O
2
−• positive cells in neat semen was significantly higher compared 
to mature fractions (p=0.0007) but significantly lower than that in the immature 
sperm fractions (p=0.026).
Conclusions: we recommend ROS measurement by flowcytometry on the basis 
that it requires a lower sperm count, is comparable to chemilumenscence, and has 
higher specificity for intracellular ROS in viable spermatozoa. Samples tested by 
chemilumensce negative by chemiluminescence still may have high intracellular H
2
O
2
 
generation 
Key Words: Superoxide, hydrogen peroxide, flowcytometry, chemiluminescence, 
semen analysis. 
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Introduction
The influence of oxidative stress (OS) on male fertility has been extensively studied in 
the last decade 1-3. Superoxide (O
2
−•) and hydrogen peroxide (H
2
O
2
) are the common 
form of reactive oxygen species (ROS). ROS are highly reactive and short-lived (half-life 
ranging from a few nanoseconds to milliseconds).  They can interact with nearby 
molecules and thus play a key role in inducing sperm damage 1, 4-7. ROS damage 
affects the lipid and protein content of the spermatozoa. Sperm DNA damage by ROS 
occurs by induction of high frequency of single or double DNA strand breaks. DNA 
sperm damage can be detected by terminal uridine deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) or sperm chromatin structure assay (SCSA) 8-12. Both 
extracellular and intracellular generated ROS are highly diffusible and can produce 
significant sperm DNA damage beyond the repair capacity of the growing embryo 
after fertilization 13.
Chemiluminescence using luminol or lucigenin has been the common method to 
measure ROS 14, 15. Luminol probe can measure both intra- and extracellular ROS, 
especially O
2
−•, H
2
O
2
, and OH¯ free radicals, while lucigenin can detect extracellular 
ROS, especially O
2
−• , OH¯ free radical. Consequently, both probes provide global ROS 
values but no detailed information on intracellular levels of H
2
O
2
 or O
2
−• 14, 15. 
The chemiluminescence assay has several limitations. These include [1] the need for a 
relatively high volume and sperm concentration, [2] decline of ROS with time after 
ejaculation, [3] the interference of iron and copper in the culture media, [4] the 
inability to detect a specific type of ROS, and [5] the inability to differentiate viable 
from apoptotic spermatozoa. However, reference values for standard or clinically 
useful ROS levels are lacking 16. Recently, we reported 17 the cutoff values of ROS in 
clinical patients with and without leukocytospermia. 
Recently, flow cytometry has gained popularity for semen analysis 18. Two main 
advantages of flow cytometry are the small number of spermatozoa it requires and its 
ability to measure multiple markers simultaneously 19, 20. These are particularly 
important features in patients presenting with poor sperm counts. Two specific dyes 
are available to measure intracellular ROS. Dihydroethidium (DHE) can detect intra -
cellular O
2
−• while Dichlorofluorescin (DCFH) can detect intracellular H
2
O
2
 21-24. 
The goals of this study were to [1] measure basal and stimulated ROS levels by the 
chemiluminescence method using luminol and lucigenin in different sperm fractions 
before and after exposure to hydrogen peroxide [2] measure ROS by flow cytometry 
using DCFH for H
2
O
2 
and DHE for O
2
−• [3] examine the relationship of ROS measurement 
by the two methods and [4] examine the ability of flow cytometer to detect ROS in 
samples tested negative by the chemiluminescence method. ROS levels were 
measured in neat (liquefied seminal ejaculates without any processing), and in mature 
and immature sperm fractions. 
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Materials and methods
Sample Collection and Preparation
This study was approved by the Institutional Review Board of the Cleveland Clinic. 
Semen samples were collected from 18 healthy donors by masturbation after sexual 
abstinence of at least 48 hours. Of these, three were proven fertile and had fathered 
a child in the last 2 years and 15 were of unproven fertility. Samples with leukocyto-
spermia (>1 x 106 White Blood Cells/mL) were excluded. 
A portion of the neat semen samples (liquefied seminal ejaculates without any 
processing) was separated for performing routine semen analysis as per WHO 
guidelines 25 and also for the assessment of basal and stimulated ROS levels. To 
separate mature and immature sperm, liquefied semen was subjected to double 
density (40% and 80%) gradient centrifugation (PureCeption®, SAGE BioPHARMA, 
Bedminster, NJ) and centrifuged at 300 g for 20 minutes26. The resulting interface 
between the 40% and 80% layers (immature spermatozoa) was aspirated and 
resuspended in human tubal fluid media (HTF, Irvine Scientific, Santa Ana, CA). 
The resulting 80% pellet (mature, highly motile spermatozoa) was aspirated and 
resuspended in HTF. The resulting 80% pellet (mature, highly motile spermatozoa) was 
aspirated and resuspended in HTF. In addition, we also examined the effect of sperm 
concentration (range, 2.5, 5.0, 10.0, and 20 X 106 sperm/ mL) on ROS measure ment by 
chemiluminescence using both luminol and lucigenin (Figure 1).
Induction of Artificial OS Measurement of ROS
Basal levels (unstimulated) of ROS were measured in the absence of an exogenous 
inducer of OS. Stimulated ROS levels were measured by inducing OS in the presence 
of 50 µL of freshly prepared H
2
O
2
 (100 µM) to each milliliter of semen specimen and 
incubating for 15 minutes at 37oC. ROS levels was measured by the conventional 
 chemiluminescence assay using luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione; 
Sigma Chemical Co., St Louis) and lucigenin (bis-N-methylacridinium nitrate, Sigma 
Chemical Co as probes.  Test samples consisted of luminol (10 µL, 5 mM) or Lucigenin 
(4µL, 200 mM) and 400 µL of sperm suspension. Negative controls were prepared by 
replacing sperm suspension with phosphate buffered saline. Chemilumin-escence 
was measured for 15 minutes using a Berthold luminometer (Autolumat LB 953; 
Bad-Wildbad, Germany). Results were expressed as unadjusted ROS X 106 counted 
photon (cpm)  or adjusted ROS as X 106 cpm/ 20 x 106spermatozoa 15.
Determination of reactive oxygen species by flow cytometry
DCFH can detect intracellular H
2
O
2
 and DHE can detect intracellular O
2
−• 19. DCFH- 
diacetate (DA, 25 µM) and Hydroethidium (HE) (1.25 µM) obtained from Sigma (Sigma, 
St. Louis, MO) were added to the sperm suspension and incubated at 25°C for 40 
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minutes for DCFH-DA and 20 minutes for HE. Each aliquot was analyzed using flow 
cytometer equipped with 488 nm argon laser as a light source (Becton Dickinson 
FACScan, San Jose, CA). Green fluorescence (DCFH) was evaluated between 500 and 
530nm, while red fluorescence (HE) was evaluated between 590 and 700 nm 
(excitation: 488 nm; emission: 525 - 625 nm in the FL2 channel). Data were expressed 
as the percentage of fluorescent spermatozoa. Apoptotic spermatozoa were excluded 
by using counter stain dye for nucleic acid. We used propidium iodide (PI) as a counter 
stain dye for DCFH and Yo-Pro-1 as a counter stain dye for the HE (Figure 1). 
Flow Cytometry Analysis
All fluorescence signals of labeled spermatozoa were analyzed by the flow cytometer 
FACScan (Becton Dickinson). A minimum of 10,000 spermatozoa were examined for 
each assay at a flow rate of <100 cells/sec. The sperm population was gated using 
90-degree and forward-angle light scatter to exclude debris and aggregates. The 
excitation wavelength was 488 nm supplied by an argon laser at 15 mW. PI red 
fluorescence (580–630 nm) in the FL-2 channel. The percentage of PI positive cells and 
the mean fluorescence was calculated on a 1023-channel scale and analyzed using 
the flow cytometer software FlowJo version 6.4.2 (FlowJo, LLC, Ashland, OR)
Statistical Methods
With respect to quantitative measures, comparisons between stimulated and 
non-stimulated samples within neat, mature, and immature were performed using 
the Wilcoxon signed-rank test.  Pairwise comparisons of neat, mature, and immature 
within stimulated and non-stimulated samples were also performed using the 
Wilcoxon signed-rank test.  Associations among quantitative variables were measured 
using Spearman correlation coefficients both within and across sample groups.  Linear 
regression models were used to assess associations, with interaction terms used to 
test for differences in slopes of relationships for different levels of sample concentration 
(above and below 5), i.e. effects of concentration on the relationships. Log-transfor-
mations (after an addition of 0.1 to avoid undefined values) were applied to skewed 
variables including Lucigenin, Luminol, DCF, and HE, when performing the regression 
analyses.  Samples classified as positive or negative for adjusted Lucigenin or adjusted 
Luminol were compared with respect to quantitative sperm quality measures using 
linear models with generalized estimating equations (GEE) to account for correlation 
among samples from the same donor. Analyses were performed using R version 
2.3.127. 
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Results
The medians (25th, 75th percentile) for neat semen samples were volume 2.9 mL (1.5, 3.9); 
concentration 42.4 X 106/ mL (34.4, 60.4); and percent motility 65.7% (59.3, 70.9). Medians 
and 25th and 75th percentiles of all other parameters are shown in Table 1. 
ROS by chemiluminescence
The ROS levels in unstimulated and stimulated matched (n = 13) as well as unmatched 
samples (n = 18) showed significant differences in neat, immature, and mature sperm 
fractions by both luminol and lucigenin as well as by DCF and HE. Neat samples were 
assessed with HE for superoxide anion. 
Nonstimulated (basal; n = 18) ROS Luminol and lucigenin did not show significant 
differences in basal levels of ROS (either adjusted or nonadjusted) in nonstimulated 
neat, mature, or immature sperm fractions (Table 1). Immature sperm fractions 
showed significantly higher levels of basal or adjusted ROS as measured by luminol 
compared with neat spermatozoa fractions (P=.03). A higher, although nonsignificant, 
level was seen in immature versus mature sperm (P=.25). No significant differences 
were seen in adjusted ROS levels by lucigenin in neat versus mature and immature 
sperm fractions (P=.48 and .67, respectively).
Stimulated ROS (n = 13) significantly higher levels of ROS (both unadjusted and 
adjusted) as measured by luminol were seen in neat versus mature (P=.003 and .009, 
respectively) and in neat versus immature sperm fractions (P=.005 and .003, 
respectively). No significant differences in levels of ROS (unadjusted and adjusted 
ROS) with lucigenin were observed between neat versus mature (P=.023, and .21, 
respectively) and between neat versus immature sperm fractions (P=.05, and .009, 
respectively).
Intracellular ROS by Flow Cytometry
ROS levels by flow cytometry in nonstimulated and stimulated neat, immature, and 
mature sperm by DCH and HE are shown in Figures 2 and 3. 
Nonstimulated (Basal; n = 18) ROS The proportions of sperm cells stained for DCF 
(H
2
O
2
) and HE (O
2
−•) were significantly higher in immature sperm fractions compared with 
mature fractions (P=.021 and .003 respectively). Both immature immature and mature 
sperm fractions had a significantly higher percentage of sperm positive for H
2
O
2
 
compared with neat semen (P<.001 and P=.003, respectively). On the other hand, the 
percentage of HE (O
2
−•)-positive sperm in neat semen was significantly higher 
compared with mature fractions (P<.001) but lower, although nonsignificant, in 
immature sperm fractions (P=.08; Figs. 2 and 3).
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Stimulated ROS (n = 13) Both H
2
O
2
 (DCF+ve) and O
2
−• (HE+ve) levels) were increased in 
neat (P<.001 and .021, respectively), mature (P=.009 and .002, respectively), and 
immature (P=.24 and .002, respectively) sperm fractions. Also, mature sperm fraction 
showed higher poststimulation levels of both H
2
O
2
 (DCF+ve) and O
2
−• (HE+ve) compared 
with the neat (P=.14 and .2, respectively) and immature (P=.69 and .26, respectively) 
sperm fractions (Figs. 2 and 3).
Figure 1  A representative flowchart for this study experimental steps and the chronologic 
methodology.
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Figure 2  Show comparison of semen specimen in different processing and treatment 
regarding; A: level of intracellular H
2
O
2
 (DCF +ve) spermatozoa percentage, B. level of 
intracellular O
2
−• (HE+ve sperm percentage)
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Correlation of ROS by Flow Cytometry and Chemiluminescence
The percentage of DCF+ve sperm showed significant correlation with unadjusted 
luminol (r = 0.57, P<.001), adjusted luminol (r = 0.62, P<.001), unadjusted lucigenin 
(r = 0.51, P<.001), and adjusted lucigenin (r = 0.56, P<.001). The percentage of HE+ve 
sperm had significant correlations with unadjusted luminol (r = 0.40, P<.001), adjusted 
luminol (r = 0.32, P=.003), unadjusted lucigenin (r = 0.57, P<.001), and adjusted 
lucigenin (r = 0.49, P<.001; Table 2).
Adjusted ROS values by chemiluminescence increase the correlation with the 
intracellular H
2
O
2
 level as measured by DCF. However, this correlation with the 
intracellular O
2
-• by HE decreases with adjusted ROS values in the chemiluminescence 
results for the same specimen. DCF+ve sperm is also correlated with percentage of 
HE+ve sperm in a given sample (r = 0.38, P<.001).
When we examined the effect of low and high sperm concentration after log 
transformation, regression analysis showed no significant effect of concentration on 
correlation of ROS by flow cytometry and chemiluminescence (Table 2).
Evaluation of the Sperm Concentration on Chemiluminescence Results
No effect of sperm concentration (2.5–20 x 106 sperm/mL) was seen in ROS levels by 
luminol (unadjusted P=.15; or adjusted P=.07) or lucigenin (P=.53). The Spearman 
correlation showed significant negative dependence of the adjusted (r = 0.887, P<.001) 
or log-adjusted lucigenin (r = 0.887, P<.001) on sperm concentration.
Basal Intracellular ROS Level Measured by Flow Cytometry
The basal levels of H
2
O
2
 and O
2
  / in neat semen of both proven and unproven donors 
(n = 18) were higher (7.9 ±10.3 and 3.4 ± 2.5). Proven fertile men (n = 3) showed lower 
basal ROS levels in the neat samples with both DCF (5.0 ± 4.1) and HE (3.4 ± 1.6).
Comparison of ROS negative samples by flowcytometry
When all aliquots (stimulated and unstimulated) were analyzed, 13 aliquots tested 
negative by luminol (ROS ≥ 0 cpm/20 X 106 sperm), and 74 tested positive by luminol 
(ROS ≥ 0.2 cpm/20 X 106 sperm; cutoff established by our lab). In contrast, both DCF 
and HE were able to detect ROS in all luminol-negative samples. Positive luminol 
samples showed significantly higher levels by DCF (33.9 ± 2.7; P =.0002) and HE (6.58 
± 0.98; P =.006) compared with luminol-negative aliquots (14.5 ±  4.6 for DCF and 3.02 
± 0.80 for HE-positive samples; Fig. 4). 
Similarly, when we compared 44 lucigenin-negative and 43 lucigenin-positive aliquots 
by flow cytometry, both DCF and HE were able to detect ROS in lucigenin-negative 
samples. Lucigenin-positive aliquots showed significantly higher levels by DCF (41.7 ± 
3.8; P<.0001) and HE (9.57 ± 1.50; P < .0001) compared with aliquots that tested 
negative by lucignin (20.6 ± 2.5 for DCF and 2.6 ± .42 for HE-positive samples; Fig.4)
154
chapter 7
Discussion
In our study, we validated that flow cytometry is as useful and accurate as the chemi-
luminescence assay for the measurement of ROS in human semen. Furthermore, by 
using both DCF and HE probes, we can simultaneously measure the two main types 
of ROS generated intra-cellularly, namely, H
2
O
2
 and O
2
−•. The increase in ROS values 
detected by both DCF and HE probes after exposure to H
2
O
2
 confirms their ability to 
specifically measure H
2
O
2
 and O
2
−•. This is in agreement with Guthrie and Welch 19, 
who reported that these probes can selectively measure H
2
O
2
 and O
2
−•. The significant 
relationships between DCF and luminol (H
2
O
2
) and HE and lucigenin (O
2
−•) additionally 
Figure 3 Dotplot histograms showing the simultaneous measurements of Upper: intra -
cellular hydrogen peroxide and intracellular superoxide in A. neat, B. immature and C. mature 
spermatozoa. For hydrogen peroxide (Upper): Lower left quadrant represents viable, 
non-stained sperm, while lower right shows viable sperm with high intracellular H
2
O
2
 Upper 
left quadrant shows apoptotic sperm. Upper right shows apoptotic sperm with high 
intracellular H
2
O
2
. For Superoxide (Lower): Lower left quadrant represents viable, nonstained 
sperm, while lower right shows apoptotic sperm. Upper left quadrant shows viable sperm 
with high intracellular O
2
−• and upper right shows apoptotic sperm with high intracellular O
2
−•. 
The numbers in parenthesis represent the sperm population in each quadrant
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validate these probes for sperm ROS measurements. Another important finding that 
we are reporting for the first time is that intracellular H
2
O
2
 can be detected using flow 
cytometry even in aliquots that test negative by chemiluminescence.
Flow cytometry is highly reproducible technology that allows simultaneous 
measurement of multiple parameters in a selected cell population. Recently, it was 
shown to accurately measure sperm count and other parameters such as anti-sperm 
antibodies as well as sperm DNA damage 28. Similar data have been reported on the 
assessment of sperm concentration, apoptosis, and leukocyte concentration using a 
multi-parameter flow cytometry for a simultaneous rapid and accurate evaluation of 
sperm parameters 20. In addition, other investigators described the flow cytometry 
method for measuring intracellular ROS in semen samples from animals using both 
DCF and HE stains 19, 21, 29 or HE only 30. De Iuliis validated the use of HE as a probe 
together with flow cytometry to measure OS and compared this with other methods 
Figure 4  Flow cytometry histograms showing the intracellular ROS measured by DCH for 
H
2
O
2
 could be detected in chemiluminescence negative specimen; A and B: luminol 
negative and positive samples C-D: lucigenin negative and positive samples.
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such as high pressure liquid chromatography (HPLC) and chemiluminescence for the 
investigation of intracellular O
2
−• production 30. While there are reports on normal ROS 
levels detected by chemiluminescence in fertile men, similar data on intracellular ROS 
using HE as a probe together with flow cytometry are lacking 17.
In our study, we demonstrated that specific intracellular ROS (O
2
−• and H
2
O
2
) levels can be 
measured simultaneously in human spermatozoa with flow cytometry using DCF and HE 
probes. Our results showed that neat, mature, and immature spermatozoa had different 
levels of intracellular ROS. Oxidative sperm damage occurs when the intracellular ROS 
levels exceed the available antioxidant capacity of the cells. OS may cause damage to the 
sperm DNA, proteins, and lipids, leading to male factor infertility 31-33. ROS is produced 
both by leukocytes and abnormal spermatozoa 30, 34, 35. Therefore, measuring the 
intracellular ROS is valuable in determining the source of excess ROS compared with 
measuring global intra- and extracellular ROS using chemiluminescence.
We are reporting for the first time the basal levels of the intracellular ROS for neat, 
immature, and mature sperm fractions. We observed a shift in the pattern of O
2
−• and 
H
2
O
2
 levels in neat semen and in immature and mature sperm fractions prepared by 
double-density gradient centrifugation. This has not been reported earlier in the 
literature as largely global (intra- and extracellular) ROS levels were measured. Taking 
into account the advantages of flow cytometry, this might be a useful method for 
accurate studies on ROS in infertile men. In addition, it will provide more information 
on the specific ROS levels selectively in viable spermatozoa.
Measuring ROS levels using flow cytometry has many advantages such as [1] speed, 
[2] accuracy, and [3] reproducibility. In addition, our study demonstrated that flow 
Cytometry detected intracellular ROS levels even in samples that tested negative by 
chemiluminescence. The clinical implication of our finding is that samples that would 
otherwise have tested negative for ROS chemiluminescence may still be compromised, 
with sperm damage resulting in impaired fertilization potential.
Another significant advantage of using flow cytometry to measure ROS levels is that 
semen samples with very low sperm count (oligozoospermia) can be accurately 
evaluated. There is evidence that sperm count is declining 36, and more men with very 
low sperm counts (with sperm concentration <5 X 106/ mL) are opting for assisted 
reproductive technologies such as IVF/intracytoplasmic sperm injection 36, 37. Flow 
cytometry provides a reliable means of assessing ROS production at such low 
concentrations
We previously reported that chemiluminescence may be accurate and reliable but 
only in samples with sperm concentration >1 million/mL 12, 15. Its sensitivity declines 
significantly even in specimen with sperm concentrations <5 million/mL 14, 15. In this 
current study, we performed measurements by luminometer using sperm samples with 
low concentration and found similar values for specimen with sperm concentrations 
of 2.5 and >5 X 106/mL.
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Our findings showed that using adjusted ROS values improves the relationships of 
lucigenin and luminol with the intracellular H
2
O
2
 level, but it may weaken such a 
relationship with the intracellular O
2
−• level. This shows that adjusting sperm 
concentration is critical for intracellular H
2
O
2
, which is the main free radical detected 
by the luminometer 38. One of our study limitations was the relatively small sample 
size. We are planning a large-scale study using both fertile and infertile specimens, 
including those from oligozoospermic men, to compare both technologies in terms 
of sensitivity and specificity and to identify the best cutoff value for each probe.
In conclusion, we have standardized ROS measurement using the flow cytometry 
specific probes for simultaneous detection of both intracellular O
2
−• and H
2
O
2
 
selectively in viable human spermatozoa. We are reporting for the first time the basal 
levels of the intracellular ROS for neat, immature, and mature sperm fractions. Flow 
cytometry and chemiluminescence may be comparable in specimens producing 
high levels of ROS; however, flow cytometry is superior in samples generating low 
levels of ROS and in low-concentration (oligospermic) semen specimens. Use of 
adjusted ROS levels is useful in ROS measurement by chemiluminescence. Luminol 
and lucigenin results are related to intracellular H
2
O
2
 and O
2
−• levels, confirming their 
global affinity to any free radical. Specimen testing negative by chemiluminescence 
assay may still have the ability to produce intracellular H
2
O
2
, which can be easily 
detected by flow cytometry. 
Acknowledgement: We acknowledge the Andrology clinical and research laboratory, 
and Lerner flow core staff in enrolling the donors and patients for the study. Authors 
also acknowledge the help provided from Hussein Abdelrazik, MD and Maria Bykova, 
Diploma specialist in chemiluminescence. 
158
chapter 7
References
1. Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Current opinion in 
obstetrics & gynecology. Jun 2006;18(3):325-332.
2. Aitken RJ. Sperm function tests and fertility. International journal of andrology. Feb 2006;29(1):69-75; 
discussion 105-108.
3. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human 
reproduction. Fertility and sterility. Apr 2003;79(4):829-843.
4. Agarwal A, Prabakaran S, Allamaneni S. What an andrologist/urologist should know about free radicals and 
why. Urology. Jan 2006;67(1):2-8.
5. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction (Cambridge, 
England). Oct 2001;122(4):497-506.
6. de Lamirande E, Gagnon C. Impact of reactive oxygen species on spermatozoa: a balancing act between 
beneficial and detrimental effects. Human reproduction (Oxford, England). Oct 1995;10 Suppl 1:15-21.
7. Saleh RA, Agarwal A, Kandirali E, et al. Leukocytospermia is associated with increased reactive oxygen 
species production by human spermatozoa. Fertility and sterility. Dec 2002;78(6):1215-1224.
8. Alvarez JG, Sharma RK, Ollero M, et al. Increased DNA damage in sperm from leukocytospermic semen 
samples as determined by the sperm chromatin structure assay. Fertility and sterility. Aug 2002;78(2):319-329.
9. Saleh RA, Agarwal A, Nelson DR, et al. Increased sperm nuclear DNA damage in normozoospermic infertile 
men: a prospective study. Fertility and sterility. Aug 2002;78(2):313-318.
10. Erenpreiss J, Hlevicka S, Zalkalns J, Erenpreisa J. Effect of leukocytospermia on sperm DNA integrity: a 
negative effect in abnormal semen samples. Journal of andrology. Sep-Oct 2002;23(5):717-723.
11. Marchetti C, Obert G, Deffosez A, Formstecher P, Marchetti P. Study of mitochondrial membrane potential, 
reactive oxygen species, DNA fragmentation and cell viability by flow cytometry in human sperm. Human 
reproduction (Oxford, England). May 2002;17(5):1257-1265.
12. Sharma RK, Pasqualotto AE, Nelson DR, Thomas AJ, Jr., Agarwal A. Relationship between seminal white blood 
cell counts and oxidative stress in men treated at an infertility clinic. J Androl. Jul-Aug 2001;22(4):575-583.
13. Aitken RJ, De Iuliis GN. Origins and consequences of DNA damage in male germ cells. Reproductive 
biomedicine online. Jun 2007;14(6):727-733.
14. Agarwal A, Allamaneni SS, Said TM. Chemiluminescence technique for measuring reactive oxygen species. 
Reprod Biomed Online. Oct 2004;9(4):466-468.
15. Kobayashi H, Gil-Guzman E, Mahran AM, et al. Quality control of reactive oxygen species measurement by 
luminol-dependent chemiluminescence assay. Journal of andrology. Jul-Aug 2001;22(4):568-574.
16. Aitken RJ, Baker MA, O’Bryan M. Shedding light on chemiluminescence: the application of chemilumines-
cence in diagnostic andrology. Journal of andrology. Jul-Aug 2004;25(4):455-465.
17. Athayde KS, Cocuzza M, Agarwal A, et al. Development of normal reference values for seminal reactive 
oxygen species and their correlation with leukocytes and semen parameters in a fertile population. Journal 
of andrology. Jul-Aug 2007;28(4):613-620.
18. Shai S, Roudebush W, Powers D, Dirnfeld M, Lamb DJ. A multicenter study evaluating the flowcytometric-
based kit for semen analysis. Fertility and sterility. Apr 2005;83(4):1034-1038.
19. Guthrie HD, Welch GR. Determination of intracellular reactive oxygen species and high mitochondrial 
membrane potential in Percoll-treated viable boar sperm using fluorescence-activated flow cytometry. 
Journal of animal science. Aug 2006;84(8):2089-2100.
20. Perticarari S, Ricci G, Granzotto M, et al. A new multiparameter flow cytometric method for human semen 
analysis. Hum Reprod. Feb 2007;22(2):485-494.
21. Soh N. Recent advances in fluorescent probes for the detection of reactive oxygen species. Analytical and 
bioanalytical chemistry. Oct 2006;386(3):532-543.
22. Fridovich I. Editorial commentary on “Superoxide reacts with hydroethidine but forms a fluorescent product 
that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of 
superoxide” by H. Zhao et al. Free radical biology & medicine. Jun 1 2003;34(11):1357-1358.
159
7
chemiluminescence and flow cytometry for testing ros
23. Zhao H, Kalivendi S, Zhang H, et al. Superoxide reacts with hydroethidine but forms a fluorescent product 
that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of 
superoxide. Free radical biology & medicine. Jun 1 2003;34(11):1359-1368.
24. Bonini MG, Rota C, Tomasi A, Mason RP. The oxidation of 2’,7’-dichlorofluorescin to reactive oxygen species: 
a self-fulfilling prophesy? Free radical biology & medicine. Mar 15 2006;40(6):968-975.
25. World Health Organization WHO. WHO laboratory manual for the examination of human semen and 
sperm-cervical mucus interaction. 4th edition ed. Cambridge: University Press, Cambridge, UK.; 1999.
26. Ollero M, Gil-Guzman E, Lopez MC, et al. Characterization of subsets of human spermatozoa at different 
stages of maturation: implications in the diagnosis and treatment of male infertility. Human reproduction 
(Oxford, England). Sep 2001;16(9):1912-1921.
27. Team RDC, ed R: A language and environment for statistical computing. Vienna, Austria: R Foundation for 
Statistical Computing; 2006.
28. Eustache F, Jouannet P, Auger J. Evaluation of flow cytometric methods to measure human sperm 
concentration. Journal of andrology. Jul-Aug 2001;22(4):558-567.
29. Robinson JP, Bruner LH, Bassoe CF, Hudson JL, Ward PA, Phan SH. Measurement of intracellular fluorescence of 
human monocytes relative to oxidative metabolism. Journal of leukocyte biology. Apr 1988;43(4):304-310.
30. De Iuliis GN, Wingate JK, Koppers AJ, McLaughlin EA, Aitken RJ. Definitive evidence for the nonmitochondrial 
production of superoxide anion by human spermatozoa. J Clin Endocrinol Metab. May 2006;91(5):1968-1975.
31. Agarwal A, Saleh RA. Role of oxidants in male infertility: rationale, significance, and treatment. Urol Clin 
North Am. Nov 2002;29(4):817-827.
32. Aitken RJ, Buckingham DW, West KM. Reactive oxygen species and human spermatozoa: analysis of the 
cellular mechanisms involved in luminol- and lucigenin-dependent chemiluminescence. Journal of cellular 
physiology. Jun 1992;151(3):466-477.
33. Griveau JF, Le Lannou D. Reactive oxygen species and human spermatozoa: physiology and pathology. Int 
J Androl. Apr 1997;20(2):61-69.
34. Saleh A, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. Journal of 
Andrology. 2002;23:737-752.
35. Sikka SC. Role of oxidative stress and antioxidants in andrology and assisted reproductive technology. J 
Androl. Jan-Feb 2004;25(1):5-18.
36. Lackner J, Schatzl G, Waldhor T, Resch K, Kratzik C, Marberger M. Constant decline in sperm concentration 
in infertile males in an urban population: experience over 18 years. Fertil Steril. Dec 2005;84(6):1657-1661.
37. Keel BA. How reliable are results from the semen analysis? Fertil Steril. Jul 2004;82(1):41-44.
38. Peris SI, Bilodeau JF, Dufour M, Bailey JL. Impact of cryopreservation and reactive oxygen species on DNA 
integrity, lipid peroxidation, and functional parameters in ram sperm. Mol Reprod Dev. Jul 2007;74(7):878-892.

Chapter 8
Semen characteristics and sperm DNA 
fragmentation in infertile men with 
low and high levels of seminal reactive 
oxygen species 
Reda Mahfouz, MD, Rakesh Sharma, PhD, Aparna Thiyagarajan, MS, 
Vaishali Kale, MS, Sajal Gupta, MD, Edmund Sabanegh, MD and 
Ashok Agarwal, PhD, HCLD
Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio, USA
Presented in abstract form at 34th annual meeting of American Society of 
reproductive medicine, October 17-21 Atlanta.
Research support provided by the Glickman Urological and Kidney Institute, 
Cleveland Clinic
Fertil Steril. 2010 Nov;94(6):2141-6. Epub 2010 Feb 1.
162
chapter 8
Abstract
Objective: Little is known about the clinical and laboratory findings in high reactive 
oxygen species (ROS) conditions. Our aim was to examine sperm motility, total 
antioxidant level (TAC), DNA fragmentation and medical history in infertile men with 
high seminal ROS. 
Design: Prospective study. 
Settings: Tertiary care hospital. 
Patients: Infertile men (n=101) 
Interventions: Group I (n = 57) included men with seminal ROS (<250 RLU/sec/X 106 
sperm) while group II (n = 44) included men with seminal ROS levels (≥250 RLU/sec/X 
106 sperm).
Main Outcome Measures: Seminal ROS, TAC, sperm DNA fragmentation, ROS/TAC 
score were measured.
Results: Group II had high incidence of sperm DNA fragmentation than group I (p = 
0.036). The odds ratio of 1.25 for elevated ROS levels corresponded to >10% greater 
DNA fragmentation in our patients (95%CI 1.01 - 1.53). Group II showed poor motility 
(p = 0.001), a higher incidence of leukocytospermia (p = 0.001) and higher ROS-TAC 
scores (p<0.001) compared with group I. ROS was negatively correlated with sperm 
curvilinear velocity (VCL) (r = -0.24, p = 0.021), linearity (r = -0.24, p = 0.017) and sperm 
motility (r = -0.31, p = 0.002). Sperm motility was correlated with %TUNEL+ve sperm 
(r = -0.39, p<0.001). 
Conclusions: An increase in seminal ROS levels by 25% was associated with a 10% 
increase in sperm DNA fragmentation. Sperm motility was affected by seminal ROS 
and sperm DNA fragmentation. 
Keywords: sperm motility, sperm motion kinetics, male infertility, sperm DNA fragmentation, 
oxidative stress, reactive oxygen species, total antioxidant capacity
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Introduction
Basal levels of ROS are essential for physiological sperm functions 1, 2. However, high 
seminal ROS levels lead to oxidative stress (OS), which in turn can reduce sperm 
motility, viability and fertilizing potential and increase sperm DNA fragmentation 
rates 3-7. Some authors report high ROS levels to be an independent marker for male 
factor infertility 3. 
Introducing seminal ROS assay in clinical andrology laboratory services may help 
clinicians in accurate diagnosis of their patients such as idiopathic cases or other 
diagnostic conditions associated with oxidative stress induced sperm damage 6, 8-10. 
New OS scores (such as ROS-TAC score) have been added to easily diagnose infertile 
patients with OS, however seminal ROS still remains the main parameter for measuring 
OS 11. High levels of seminal ROS may be an important indicator of further deterioration 
of sperm quality in men with OS. 
In a preliminary study (unpublished data) we observed all seminal ROS values in the 
healthy donors (proven and unproven healthy) were < 250 relative light units (RLU)/ 
secondX106 sperm. We therefore took this cutoff to differentiate infertile men with 
values > 250 RLU/sec/ X106 sperm and categorize these patients with high seminal 
ROS that are vulnerable to OS induced sperm damage. The objective was to compare 
infertile men with normal and high levels of ROS in seminal ejaculates (as determined 
from unpublished data from our group) and examine their sperm parameters and 
clinical information. 
Materials and methods
Subjects Selection
This prospective study was approved by the Institutional Review Board of our hospital. 
Our patient population consisted of 101 infertile patients who attended our fertility 
clinic between 2008 and 2009 for male factor fertility. All patients underwent semen 
analysis according to World Health Organization guidelines 12. 
Semen Collection and Preparation
Semen specimens were collected and analyzed as per WHO 1999 guidelines. Briefly, 5 
µL of liquefied specimen was loaded on a 20 µL Cell-Vu® chamber (Millennium 
Sciences, Inc., New York, NY). Leukocytospermia was confirmed (using the Endtz test) 
in any specimen showing round cells > 0.2 X106 white blood cells/mL of semen 13, 14. 
Sperm motion characteristics such as linearity (%) and curvilinear velocity (VCL, µm/
sec) were examined by computer assisted sperm analysis (CASA, IVOS version 10, 
Hamilton Thorne, Inc., Beverly, MA) 15.
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The remaining seminal ejaculate was divided into 3 aliquots for further use. One aliquot 
was used to measure seminal ROS levels. The second aliquot was used to assess DNA 
damage via the TUNEL (terminal dUTP nick-end labeling) assay. Spermatozoa were 
fixed and kept in 70% ethanol at -20oC for the TUNEL assay. The third aliquot was 
centrifuged at 1,000 X g for 7 minutes, and clear seminal plasma was aliquoted and 
stored at -70oC for the measurement of the total antioxidant capacity (TAC). 
Measurement of reactive oxygen species (ROS)
Seminal ejaculates that had not undergone any additional processing (neat samples) 
were used for ROS measurement by chemiluminescence assay. Luminol (5-amino-2, 
3-dihydro-1, 4-phthalazinedione; Sigma Chemical Co., St Louis, MO) was used as a 
probe. A 100 mmoL/ L stock solution of luminol was prepared in dimethyl sulfoxide. 
For the analysis, 10 µL of the working solution (5 mM) was added to 400 µL of a neat 
sperm sample 16, 17. Chemiluminescence was measured for 15 minutes using a 
luminometer (Autolumat LB 953; Berthold Technologies, LLC, Oak Ridge, TN). The 
results were expressed as RLU/ sec/106 sperm. 
Patients were divided into 2 groups based on their ROS levels. Group 1 consisted of 
patients with normal levels of seminal ROS (< 250 RLU/sec/ X106 sperm; n = 57), which was 
used as a control group, and group 2 consisted of patients with high levels of seminal ROS 
(> 250 RLU/sec/ X106 sperm; n = 44). This cutoff point was derived from an unpublished 
study performed by our group that showed all seminal ROS values in healthy donors 
(proven and unproven healthy) were < 250 relative light units (RLU)/ secondX106 sperm. 
Total antioxidant (TAC) assay
The TAC of the seminal plasma samples was measured using an antioxidant assay kit 
(Cayman Chemical Company, Ann Arbor, Michigan). Its principle is based on the ability 
of aqueous- and lipid-based antioxidants in seminal plasma to inhibit oxidation of the 
ABTS® (2,2’-Azino-di-[3-ethylbenzthiazoline sulphonate]) to ABTS® • +. Under the 
reaction conditions used, the antioxidants in the seminal plasma suppress absorbance 
at 750 nm to a degree that is proportional to their concentration. The capacity of the 
antioxidants in the sample to prevent ABTS® oxidation was compared with that of 
Trolox, a water-soluble tocopherol analogue, and the results were reported as 
micromolar trolox equivalents 18.
Calculation of ROS-TAC score
The principal component (PC) was used to calculate the ROS-TAC score for all patients. 
This was derived from their seminal ROS and seminal plasma TAC values 19 with some 
modifications. 
ROS-TAC = 50 + (10/ 0.99672)*[-0.707* StdLogROS + 0.707* StdTAC]
Where
165
8
sperm dna fragmentation in infertile men
LogROS = Log10 (ROSRLU + 5)
StdLogROS = Standardized Log ROS = (LogROS - 2.3814)/(1.2357)
StdTAC = Standardized TAC = (TAC - 1976.56)/ (641.68) 
Sperm DNA fragmentation 
Sperm DNA fragmentation was evaluated with the terminal deoxynucleotidyl trans-
ferase-mediated fluorescein-dUTP nick end labeling (TUNEL) assay using Apo-DirectTM 
kit (Pharmingen, San Diego, CA) as established earlier 20, 21. Briefly, 1 to 2 million 
spermatozoa were washed in phosphate buffered saline (PBS), resuspended in 3.7 % 
paraformaldehyde with adjustment of the concentration to 1-2 X 106 sperm/ mL and 
placed on ice for 30 to 60 minutes at 4oC. Thereafter, spermatozoa were again washed 
to remove the paraformaldehyde and then re-suspended in 70% ice-cold ethanol. 
Specimens were kept at -20oC until the run time. In addition we also included an 
internal set of samples which were tested negative or positive for DNA damage with 
each run. Following a second wash in PBS to remove the ethanol, sperm pellets were 
re-suspended in 50 µL of the freshly prepared staining solution for 60 minutes at 37°C. 
According to the manufacturer’s instructions, the staining solution contains terminal 
deoxytransferase (TdT) enzyme, TdT reaction buffer, fluorescein isothiocynate tagged 
deoxyuridine triphosphate nucleotides (FITC-dUTP) and distilled water. All specimens 
were further washed in rinse buffer to remove the unbound reaction solution, 
re-suspended in 0.5 mL of propidium iodide/RNase solution and incubated for 30 
minutes in the dark at room temperature. Flow cytometric analysis was then 
performed. The percentage of positive cells (TUNEL+ve) was calculated on a 
1023-channel scale using the flow cytometer software (FlowJo Mac version 8.2.4, 
FlowJo, LLC, Ashland, OR) 22.
Review of medical charts and related parameters
A complete medical history and clinical examination were performed for every 
patient. Their medical charts were reviewed for age, body mass index (BMI), primary 
or secondary infertility and duration of infertility. A history of antioxidant and/or 
antibiotic prescription use was also verified.
Statistical Analysis
The differences in distributions of OS-induced damage markers and patient charac-
teristics between patients with ROS levels below vs. above 250 RLU/ sec/106 sperm 
were assessed using Wilcoxon rank sum and Chi-square tests. Summaries of the 
distributions–mean, standard deviation, median, and interquartile ranges (IQR)—
were examined. Spearman correlations were used to assess associations between 
ROS levels and other measured parameters. Statistical significance was considered 
when p <0.05. All analyses were performed using R version 2.3.1 (www.r-project.org) 23. 
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Results
OS-induced sperm damage markers
There were no significant differences between group I (normal seminal ROS levels) 
and. group II (high seminal ROS levels) regarding seminal plasma TAC levels (p = 0.43). 
However, group I had a significantly higher ROS-TAC score (p<0.001) than group II. 
Table 1   Clinical and semen parameters in infertile men with high or physiological 
seminal ROS values 
Variable Group I
(ROS<250)
(n=57) (56.4%)
Group II
(ROS≥250)
(n=44) (43.6%)
P-value
Age (years) 36.53 ± 7.07 37.33 ± 8.25 0.77
Height (cm) 177.69 ± 8.73 179.08 ± 9.70 0.49
Body weight (kg) 90.98 ± 17.43 92.46 ± 16.79 0.44
Body mass index (BMI) 28.81 ± 4.96 28.42 ± 3.94 0.99
Infertility Type: 0.51
Primary 33 (61.1%) 24 (54.5%)
Secondary 21 (38.9%) 20 (45.5%)
Infertility duration (years) 2.18 ± 2.04 2.38 ± 2.28 0.68
Abstinence time (days) 3.45 ± 1.33 3.79 ± 1.68 0.32
Semen pH 7.63 ± 0.25 7.65 ± 0.22 0.71
Ejaculate volume (mL) 2.88 ± 1.45 3.26 ± 1.68 0.35
Sperm Motility (%) 62.56 ± 22.87 45.21 ± 28.22 0.001
Curvilinear velocity (VCL) µm/sec 42.00 ± 8.21 37.76 ± 12.28 0.005
Linearity (%) 49.45 ± 9.24 46.15 ± 9.77 0.026
WHO normal Morphology (%) 15.33 ± 10.69 14.30 ± 10.99 0.63
Strict criteria normal sperm (%) 2.82 ± 3.24 2.24 ± 2.54 0.41
Total antioxidant capacity (TAC) 
(µmol trolox equivalent/ml)
2022.81 ± 696.68 1916.78 ± 565.55 0.43
ROS-TAC score 53.96 ± 8.46 26.05 ± 10.02 <0.001
Sperm TUNEL+ve % 22.97 ± 19.12 33.83 ± 25.80 0.055
Results are presented as mean ±  standard deviation (SD), frequency (%). Associations with categorical 
variables were assessed by chi-square tests. Associations with quantitative and ordinal variables were 
assessed by Wilcoxon rank sum tests.
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There was a higher incidence of sperm DNA fragmentation expressed as %TUNEL+ve 
in group II (p = 0.036) (Table 1). The odds ratio of elevated ROS corresponding to a 
10% greater DNA fragmentation was estimated to be 1.25 (95% CI 1.01 to 1.53).
Semen parameters
Abstinence time (p = 0.32), ejaculate volume (p = 0.35), semen pH (p = 0.71), and 
normal sperm morphology by WHO (p = 0.63) and strict Kruger criteria (p = 0.41) were 
comparable between the 2 patient groups. 
The percentage of motile sperm (p = 0.001), VCL µm/sec (p = 0.005), and linearity 
(p = 0.026) were all lower in group II (Table 1). The incidence of leukocytospermia was 
higher (73.9%) in group II (Table 2) vs. group I (26.1%; p = 0.004).
Patient-related parameters
There were no significant differences between infertile patient groups with regards to 
patient age, height, weight, or BMI. No significant differences were observed in 
infertile men in the two groups in regards to duration or type of infertility (Table 1).
Antibiotics were prescribed in 11 (19.3%) patients in group I vs. 15 (34.1%) of patients 
group II (p = 0.1) Antibiotics were recommended for a comparable duration (1 to 3 
months) in both patient groups (p = 0.7). Antioxidant supplementation was recommended 
Table 2   Incidence of leukocytospermia with antibiotic and antioxidant prescription 
within infertile patient groups
Variable Group I
(ROS<250)
(n=57) (56.4%)
Group II
(ROS≥250)
(n=44) (43.6%)
P-value
Leukocytospermia (ENDTZ test) 
(x106/ml
0.05 ± 0.15 0.64 ± 1.39 0.001
Antibiotic prescription 0.10 
No 46 (80.7 %) 29 (65.9 %)
Yes 11 (19.3 %) 15 (34.1 %)
Antioxidant supplementation 0.041
No 40 (71.4%) 22 (51.2%)
Yes 16 (28.6%) 21 (48.8%)
Results are presented as mean ± standard deviation (SD), frequency (%). Associations with categorical 
variables were assessed by chi-square tests. Associations with quantitative and ordinal variables were 
assessed by Wilcoxon rank sum tests.
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for 16 (28.6%) patients in group I vs. 21 (48.8%) patients in group II (p = 0.04). Antioxidant 
supplementation were recommended for a longer duration (up to 4 months) in group II 
vs. group I (p = 0.03) (Table 2). 
Correlation studies
As a secondary analysis, spearman correlation showed positive correlations between 
seminal ROS levels and the Endtz test (r = 0.41, p<0.001) and with sperm DNA 
fragmentation (%TUNEL+ve) (r = 0.21, p = 0.06). ROS levels were negatively correlated 
with VCL (r = -0.24, p = 0.021), linearity (r = -0.24, p = 0.017) and sperm motility 
(r = -0.31, p = 0.002). Sperm motility showed negative correlation with %TUNEL+ve 
(r = -0.39, p<0.001; Figure 1). Negative correlations were observed between seminal 
Figure 1  Plots showing ROS relationship with A: sperm curvilinear velocity (VCL) B: linearity 
C: total motile sperm and D: percentage of TUNEL+ve sperm.
A
C
B
D
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ROS values with ROS-TAC score (r = -0.71, p<0.001). The ROS-TAC score was negatively 
correlated with levels of ROS in all patients (r = -0.7, p<0.001), group 1 patients with 
seminal ROS> 250 (r = -0.39, p = 0.013), and in group 2 patients with seminal ROS <250 
(r = -0.30, p = 0.03) (Figure 2).
Discussion
Our understanding of semen characteristics and patient characteristics associated 
with high seminal ROS generation is poor. Therefore, our study aimed to compare 
sperm DNA fragmentation, OS markers, and other routine infertility parameters in 
Figure 2  Plots showing the relationship of ROS-TAC score with A: ROS levels in overall 
patients group B: seminal ROS levels in patients with high ROS >RLU/ sec/106 sperm (group 1) 
and C: patients with low ROS <250 RLU/ sec/106 sperm (group 1).
A
C
B
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men with normal vs. high seminal ROS generation. In this study, we only enrolled 
infertile patients who were seeking medical help for male factor related fertility issues. 
The patients’ ages, infertility type/duration, and BMI had no effect on seminal ROS 
values. The two patient groups were comparable in terms of abstinence, semen pH, 
ejaculate volume, percentage of normal morphologically spermatozoa, and seminal 
TAC. These findings agree with previous findings suggesting that routine sperm 
parameters overlap between infertile and  fertile men 24, indicating that seminal ROS 
is an independent parameter for male infertility 3. The patient groups had comparable 
levels of seminal plasma TAC. However, the ROS-TAC score demonstrated OS 
conditions in the infertile men with high seminal ROS levels. This agrees with our 
earlier reports recommending seminal ROS measurement as a routine test for infertile 
men 25 and the use of the ROS-TAC score over the use of just ROS or TAC o in these 
patients 19, 26. 
Infertile men with high seminal ROS levels had a lower percentage of motile sperm, 
VCL, and linearity 27. This can be explained by the disturbance of the energy supply 
that may occur following a disturbed mitochondrial membrane potential, which in 
turn causes high levels of ROS to be released into the cytoplasm and depletion of the 
energy supply that affects both sperm motility and kinetics.
Our study provides evidence for OS-induced sperm DNA damage in infertile men 
with high seminal ROS levels. Infertile men may have high sperm DNA fragmentation 
that can be explained by the presence of additional risks factors with OS-associated 
conditions such as varicocele or other lifestyle issues as reported earlier 1, 28-30. 
Although several recent reports have attempted to define levels of sperm DNA 
fragmentation in infertile men, additional studies are needed before the tests that 
measure this parameter can be recommended for routine clinical use in infertile men 
31, 32. Seminal plasma TAC was comparable in both groups of our study, despite the 
difference in seminal ROS levels. This may be related to whether or not multivitamin/
antioxidants supplements were prescribed. Furthermore these findings also indicate 
that seminal TAC may vary during this compensatory phase in an attempt to scavenge 
the increasing levels of ROS. In an earlier study, we reported TAC cutoff values, in this 
study all patients had seminal plasma TAC levels within normal reference range 18. This 
finding confirms the above assumption which indicates infertile men with TAC levels 
below 1420 µM trolox equivalent/ mL may have depleted antioxidant capacity and 
are therefore more vulnerable to OS-induced damage. With seminal TAC below 1420 
µM trolox equivalent/ mL, OS-induced sperm damage may occur even with low 
seminal ROS values. This again points to the importance of calculating the ROS-TAC 
score for these patients as it is more reflective of the actual OS status. Furthermore, 
our current study findings also point to the need to develop new OS markers and 
scores (such as ROS-TAC) that are more sensitive and account for more than one 
parameter of OS status. This also is in agreement with a previous report 8. 
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The high incidence of leukocytospermia in the infertile men with high seminal ROS 
levels may represent an additional cause of low sperm quality. Antibiotic supplemen-
tation may not be effective in normalizing ROS generation or protect against further 
deterioration in sperm quality. Doxycycline has been reported to induce sperm 
damage with in vitro treatment 33, 34. Moreover, the negative relationships of seminal 
ROS with sperm motility and its kinetics in all patients confirm that sperm damage 
occurred as a result of high ROS generation in these infertile men. 
Our study showed a positive relationship between seminal ROS and leukocytosper-
mia and sperm DNA fragmentation. We recommend examining infertile patients for 
leukocytospermia and for sperm DNA integrity in order to improve their clinical 
management.
Because our study was limited to diagnose the presence or absence of ROS, we 
recommend follow up studies to develop new antibiotic/antioxidant strategies for 
these patients. Also, we did not further classify our patients based on their clinical 
diagnoses. We recommend more studies on specific clinical diagnosis and specific 
age groups to identify the seminal plasma reference values in those specific groups. 
In conclusion, infertile men with high seminal ROS levels have high incidence of 
sperm DNA fragmentation. An increase of seminal ROS by 25% may be associated 
with a 10% increase in sperm DNA fragmentation. The percentage of total motile 
spermatozoa was negatively related to seminal ROS and sperm DNA fragmentation. 
The ROS-TAC score was better than ROS or TAC values alone thereby differentiating 
infertile men with OS from those without OS. Novel OS markers should be developed 
to help better identify infertile men with DNA damage. Newer strategies are required 
for male infertility oxidative stress management. We recommend establishing 
reference values for diagnostic/ prognostic use of oxidative stress markers in 
andrology that may lead to more optimal treatments for infertile men with OS-induced 
sperm damage. 
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Abstract
In a longitudinal study over a period of 21 months, we demonstrated that seminal 
ROS levels are independent of sperm concentration, motility or abstinence duration 
within a healthy sperm donor, although some variations were observed in ROS levels. 
We suggest that fluctuation in seminal ROS values may be related to physiological or 
transient changes in spermatogenesis.
Key words: Semen analysis; Reactive oxygen species; variability; Male infertility. 
Capsule:
ROS levels are independent of sperm concentration, motility and abstinence period 
in normal, healthy proven fertile man. At physiological level ROS value do not affect 
sperm parameters.
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Reactive oxygen species (ROS) generated by spermatozoa play an important role in 
normal physiological processes such as sperm capacitation, acrosome reaction, 
oocyte fusion and stabilization of the mitochondrial capsule in the mid-piece 1, 2. ROS 
produced by spermatozoa and leukocytes are scavenged by various antioxidants in 
the seminal plasma. Uncontrolled production of ROS that exceeds the antioxidant 
capacity of the seminal plasma leads to oxidative stress (OS), which is harmful to 
spermatozoa 1. In addition, ROS is an independent marker of male factor infertility. 
ROS measurement by chemiluminescence method is highly sensitive and accurate 
method with low intra-observer, intra-observer variability 2-4 
Levels of ROS have been correlated with semen parameters, in all these studies a 
single ejaculate from each subject was examined at a single time point (2, 3). However, 
longitudinal studies describing the association of ROS levels with semen parameter 
within a fertile man are lacking. Our aim was to conduct a longitudinal study and 
monitor within individual variations in ROS levels and correlate this with semen 
parameters.
This study was approved by the Cleveland Clinic Institutional Review Board. A single 
normal healthy proven fertile man provided 36 semen samples over a period of 21 
months (From October 2006 to June 2008) with an abstinence of 1 to 10 days.
Following complete liquefaction at 37o C for 20 minutes, 5 µL of each specimen was 
loaded on a 20 µL Microcell chamber (Conception Technologies, San Diego, CA) and 
analyzed for sperm concentration and motility according to World Health Organization 
(WHO, 1999) guidelines 5. Seminal smears were stained with Diff-Quick (Baxter Health - 
care, McGraw Park, Ill), and sperm morphology was assessed using WHO criteria (5). 
The presence of white blood cells (WBC) in the specimen was detected by the Endtz 
test 2. Briefly, 20 µL volume of liquefied specimen was placed in a 0.5 mL sample cup; 
20 µL of tyrodes buffer and 40 µL of benzidine solution were added. The mixture was 
vortexed and allowed to sit at room temperature for 5 min. Peroxidase-positive WBCs, 
which stain dark brown, were counted in all 100 squares of the grid in a Makler 
chamber under the 20X bright-field microscope. The results after correction for 
dilution were recorded as the number of WBCs counted x 106/ mL. 
 Seminal ejaculates that had not undergone any additional processing (neat 
samples) were used for ROS measurement by chemiluminescence assay using luminol 
(5-amino-2, 3-dihydro-1, 4-phthalazinedione; Sigma Chemical Co., St Louis, MO). A 100 
mmoL/ L stock solution of luminol was prepared in dimethyl sulfoxide (DMSO). For 
the analysis, 10 µL of the working solution (5 mM) was added to 400 µL of neat sperm 
sample. Chemiluminescence was measured for 15 min using a Berthold luminometer 
(Autolumat LB 953; Bad-Wildbad, Germany). Results were expressed as X 10 6 counted 
photons per minute (cpm)/ 20 x 106 sperm 4. ROS levels >0.0185 were considered as 
positive based upon our lab cutoff value. Data analysis and correlation studies were 
done by JMP software version 7.0 for windows. P <0.05 was considered significant.
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Sperm concentration (Mean ± SD) was 106.3 ± 36.3X 106/ mL and motility 71.6 ± 7.96 
%. ROS levels ranged from 0.00 to 0.06 X 106 cpm/ 20 X 106 sperm. The mean ROS 
level was 0.0122 ± 0.0137 units (95% CI = 0.0169). Coefficient of variance for sperm 
concentration, motility and ROS were 30%, 10% and 110 % respectively. Correlation 
analysis demonstrates no significant correlation between ROS levels and sperm parameters. 
The fluctuations in sperm motility, concentration and ROS are demonstrated in figure 1. 
A complete semen analysis including the presence of round cells, white blood cells 
and sperm morphology was evaluated only during first visit and it was within normal 
range according to the WHO criteria.
Semen analysis is one of the important clinical laboratory tests to evaluate male 
infertility and intra individual variations in the semen parameters have been reported 
6. Reports from our center show that measurement of ROS level should be included in 
routine semen analysis 2, 7, 8. Previously, we have reported that ROS cutoff value of 
0.0185 X 106 cpm/20 X 106 sperm is highly predictive of infertility 2. However, monitoring 
Figure 1  Variations in concentration, motility and ROS (reactive oxygen species) in 36 semen 
samples provided by a single fertile donor over a period of 21 months.
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ROS level in a fertile man and studying correlation between ROS level and sperm 
parameters are extremely important before oxidative stress profile can be included to 
evaluate infertile men. 
In this study over a period of 21 months, we did not find any significant (positive or 
negative) correlation of ROS levels with sperm concentration and motility over a 
period of time within a given individual. No significant correlation of motility and 
concentration with ROS suggest that ROS is an independent marker of fertility in 
healthy fertile donor. 
In the current study on a single healthy man, incidence of ROS positive seminal 
ejaculates was 13.8% (5 of 36 samples). In spite of positive ROS (5 samples), all (36) 
samples tested for Endtz test were negative (this means absence of any detectable 
peroxidase positive leukocytes in these examined specimens) 3. In all these instances, 
sperm motility and concentration were not correlated with increased levels of ROS. 
Previously, we reported sperm motility and concentration are inversely correlated 
with ROS levels in infertile men. On the other hand, previous studies have linked ROS 
in various physiological processes of spermatozoa (i.e. sperm capacitation, acrosome 
reaction, oocyte fusion, and stabilization of the mitochondrial capsule in the 
midpiece). Therefore, we suggest that levels of ROS may rarely fluctuate within a 
fertile man but they do not affect the sperm concentration and motility. This may be 
possible due to the presence of adequate antioxidant defense mechanisms in this 
healthy individual. These fluctuations in ROS might also be due to physiological 
process. Previous reports also suggested, there might be seasonal variation in ROS 
level in semen 9, 10. Based on these, we suggest that fluctuation in ROS value may be 
physiological or due to transient sub-clinical infection, transient abnormalities in 
spermatogenesis such as retention of cytoplasm or periodic presence of abnormal 
spermatozoa in semen.
In conclusion, we demonstrated that within a normal, healthy individual, although 
variations in the ROS levels are seen over an extended period, ROS levels are 
independent of concentration, motility and abstinence period. Our results present 
seminal ROS variation in a healthy individual of proven fertility that is different from 
the sperm concentration or sperm motility variation. This variation may be 
physiological, seasonal or life style related causes. However, we measured morphology 
and leukocyte counts in only first specimen of fertile donor. We did not measure 
morphology and leukocyte counts in subsequent specimens. So, further studies 
on many fertile donors over a long period of time are necessary to explore this 
phenomenon.
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Studies presented in this thesis were performed within outlines of a more extensive 
research project aimed to improve the role of reproductive laboratory in diagnosis 
and follow up treatment in male infertility caused by oxidative stress (OS) or apoptosis. 
Accurate diagnosis and follow up in male infertility will help avoiding any undesired 
outcome that may result from the use of damaged spermatozoon on embryos. As 
assisted reproductive technologies (ART) overcome the natural selection barrier, 
especially when intracytoplasmic sperm injection (ICSI) fertilization is used, we should 
be aware not to inject damaged (unhealthy) sperm which may harbor excess damage 
beyond the oocyte repair capacity 1. 
The use of damaged spermatozoa may result in abnormal fertilization2, low embryo 
quality 3, implantation failure 3, early pregnancy loss 4, or possibility of an increased risk 
of childhood diseases for those born after ICSI 5. Moreover, ART quality has been 
intensified over the last decades by the growing concern about transgenerational 
genetic mutations through ART especially ICSI5. Therefore, the current suboptimal 
ART success rates may be attributed, at least in part, to the presence of apoptotic 
damage in sperm or in embryo post fertilization as a result of absence of natural sperm 
selection barriers 6.
This hypothesis has generated a motivation to develop new protocols for clinical 
andrology/ reproductive laboratories based on OS or apoptosis markers in male 
infertility. This approach represents an inevitable evolution of human fertility laboratory 
diagnostic services that expand to include novel molecular characteristics in addition 
to routine sperm parameters.
1. Routine sperm parameters, OS and apoptosis
Routine sperm parameters provide the basic diagnostic and prognostic tools for 
infertile men to identify those who suffer from defective spermatogenesis7. However, 
routine parameters show overlapping of sperm parameters between fertile and 
infertile individuals 8. Interestingly enough world health organization (WHO, 2010) has 
lowered their cutoff values on sperm concentration over the last decades, but still 
they fail to discriminate male (sub) fertility. There is a poor correlation between routine 
semen analyses with fertility potential in infertile patients with border-line routine 
sperm parameters or in idiopathic infertility 8, 9. 
There is a continuous effort to optimize the laboratory protocols aiming to predict the 
men’s fertility potential and to diagnose accurately infertile men. Reports related 
oligo- astheno- and terato-zoospermia (OAT) to OS and / or abortive apoptotic induced 
sperm damage 10-12. High reactive oxygen species (ROS) generation is present in 
ejaculates from infertile men with defective spermatogenesis, suggesting that ROS 
level plays a different role in conditions associated with defective spermatogenesis 
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such as production of immature sperm with morphologically abnormal (chapter 3, 5 
and 7) or as in astheno-zoospermia (chapter 4) 13, 14. Seminal ROS is now considered 
as an independent marker for male infertility (chapter 9) 15. Although reports showed 
reference values of seminal ROS in physiological or pathological conditions, accurate 
interpretation of the seminal ROS lab values requires understanding of the overtime 
variability of seminal ROS16, 17. Seasonal changes may affect sperm parameters as 
explained by several physiological, genetic or environmental factors. Life style and 
environ-mental factors may affect the sperm parameters in infertile or even in healthy 
men18, 19.
There is an increased demand for novel assays aiming to accurate detection of sperm 
pathologies and so help explaining more cases of the non-diagnosed idiopathic male 
infertility. Several observational and interventional studies showed that OS induced 
sperm damage are a major cause of defective spermatozoa function seen in infertile 
men. OS-induced sperm damage includes oxidation of molecular proteins, lipids and/ 
or DNA components of the spermatozoa, oocyte or even of the developing embryos 
4, 20. These findings support our observations of the presence of high ROS levels, either 
one or both intra- and extra-cellular (chapters 4 -7), in ejaculated spermatozoa may 
be responsible for unhealthy male gametes with an induced damage beyond oocyte 
repair capacity and hence ART failure (chapter 8)21. 
Searching for better diagnostic tools, we reported for the first time comparison of 
luminometer and flow cytometry as tools for measurement of intra- cellular hydrogen 
peroxide and superoxide levels in basal and induced ROS conditions (chapter 7). In 
support of the abortive apoptosis theory, which was proposed as an origin of sperm 
DNA damage, possible biological roles of PARP in ejaculated spermatozoa has been 
reviewed in chapter 2. We have also reported that the presence of cleaved PARP, a 
marker of apoptosis, in ejaculated human spermatozoa was related to infertility and 
highly expressed in immature ones. Cleaved PARP (chapters 2 and 3) is an early 
marker of apoptotic damage, which is stimulated mainly by damaged DNA. Expression 
of PARP1 and its homologues was reported earlier 22, in agreement to our findings, 
which showed differential expression of PARP(s) with sperm damage conditions, 
mainly OS or chemical induced injuries. OS induced sperm damage was reported in 
infertile men who showed low total antioxidant capacity (TAC) in seminal plasma 
(chapter 6)23, 24. 
We reported the diagnostic criteria of seminal TAC clearly in chapter 6 and recommended 
seminal TAC as a simple non-invasive clinical assay which can differentiate infertile 
patients from healthy or proven fertile men. There is substantial evidence from a 
number of interventional and observational studies that OS is a major causative factor 
in the increased level of DNA damage observed in spermatozoa25, 26. It has been found 
that ROS production is mainly produced by mitochondria through energy production 
cascades. Defective cell energy system in progenitors prevents proper chromatin 
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remodeling inducing abnormal maturation, morphological changes or abnormal 
sperm motility with DNA damage26. 
2. Clinical Implications of OS/ Apoptosis in Andrology lab
Seminal ROS levels are predictive for sperm DNA damage in infertile patients with 
abnormal high ROS levels produced mainly by abnormal spermatozoa and leukocytes 
in semen specimen27. In physiological conditions, seminal plasma plays a protective 
role for healthy spermatozoa 28. However, in pathological conditions, seminal plasma 
fails to neutralize free radicals which are permeable, produced in large amount by 
abnormal spermatozoa (defective spermatogenesis) or by non-sperm cells (e.g. 
leukocytes) associated with conditions such as urogenital tract infections or 
malignancy29, 30. 
Seminal plasma, with low antioxidants and/ or high free radicals, in infertile men may 
be an additional source of damage to the  healthy sperm resulted from accumulated 
ROS from leakage of abnormal cells that predominate in pathological conditions in 
semen specimens (chapter 6). Choice of proper tool, to detect accurately the levels of 
intracellular ROS, may be critical in certain patient specimens whenever false negative 
results should be avoided (chapter 7). Minimal detection limits is determined with 
right technology applied to proper specimen31. Sperm pathologies associated with 
OS and apoptosis may be due to genetic defects as seen in chapter 4 with idiopathic 
astheno-zoospermia or repeated ICSI failure report21. Maturation defects and 
environmental factors may be prominent even in infertile men without obvious 
genetic disorders (chapters 8). Variability over time of seminal ROS may reflect the 
net results of interactions between microenvironment and genetic in the male 
reproductive system (chapter 9). Over time changes should be a requirement for 
proper lab reporting of diagnostic and therapeutic services for patients in infertility 
centers.
Removal of seminal plasma may be enough in some pathological conditions such as 
presence of anti sperm antibodies, high ROS levels, or cytokines32. The importance of 
our findings is basically diagnostic for infertile couples with idiopathic infertility or 
with repeated ART failure. Proper diagnosis and successful prediction in ART outcome 
are essential to improve financial and psychological consequences on the infertile 
couples. Novel molecular and biologic assays should aim to offer them the possibility 
to understand accurately the origin of their infertility. A therapeutic potential 
application would be the selection of healthy spermatozoa not only based upon 
conventional sperm parameters but also based upon the molecular sperm markers. 
Our work (chapters 1-10) shaded the light for better understanding of male infertility 
and added values for andrology lab evaluation that covers both conventional and 
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molecular parameters which are important for infertile couple management 9. Our 
findings may be critical in sperm processing and sorting for reproduction laboratory. 
Through our work (chapter 2-9), we developed new assays and potential scores to be 
more able to personalize ART lab’s services and to optimize diagnostic or prognostic 
management of infertile couples. Our work findings would also be important in 
improving the lab procedures to avoid any possible iatrogenic damage, such as long 
contact of healthy mature sperm with leukocytes or cellular debris. This thesis will 
optimize some lab services such as cryopreservation and processing through optimal 
use of antioxidants in vitro for reproductive tissues.
Seminal ROS is a novel parameter and still not standardized. Therefore, each lab 
should set up its own cutoff levels. Multiple studies reported various cutoff values in 
their patients’ specimens using different diagnostic criteria or using different method 
with variation in sensitivity, units and limitations. However, lacking of variability of this 
marker over the time is critical to interpret accurately follow up of serial seminal ROS 
level. In chapter 9, we have investigated the variation of seminal ROS levels in a 
healthy individual over a longitudinal study for 21 months. ROS is an independent 
parameter from sperm concentration or sperm motility observed with time15. Sperm 
immaturity is associated with apoptosis or OS induced damage to DNA or plasma 
membranes. Induced sperm damage may result in fluctuation in patient’s sperm 
motility and/ or sperm concentration. Changes in sperm quality overtime were 
reported to be due to seasonal or unexplained as noticed in lowering WHO reference 
values from 1980s to 201033. Life style plays a critical role, as reported by Smits et al 
2009 who reported low concentrations of folate in seminal plasma may be detrimental 
for sperm DNA stability34. Reports showed exposure to environmental conditions 
during work in some occupations or pollution may impact the fertility potential of the 
exposed men 35. Moreover, special attention for food supplementation has been 
suggested for infertile couple treated with ART36. 
Interestingly enough, report shows OS induced DNA damage may be different in OS 
induced or apoptotic DNA damage37. Figure 1 shows the extensive DNA damage in 
apoptosis induced compared to OS induced nuclear damages after incubation with 
H
2
O
2
 (100µM) or chemical (Actinomycin D 10 ng/mL) injuries. L-carnitine supplemen-
tation at proper (0.3 mg/mL) or improper (0.6 mg/mL) high concentrations affect the 
extent of DNA damage in treated vs. untreated mouse embryonic cells 37. Moreover, 
presence of additional OS, from improper antioxidants supplementation, to apoptosis 
causes more extensive nuclear damage. This may indicate that OS induced DNA 
damage may be limited exposed foci which will expand later following activation of 
apoptotic pathways inducing extensive DNA damage (Figure 1 A).OS/ apoptotic 
damage may affect extensively the status of spermatogenesis in men with improper 
antioxidant treatments. Reports showed the importance of antioxidant supplementa-
tion before and after surgery may be helpful to restore spermatogenesis status 
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normally38, 39. In-vitro study, antioxidants should be titrated (Figure 1B) and optimized 
to avoid iatrogenic sperm damage (Figure 1B, from un-published work).
3. Molecular assays and ART
Currently, routine sperm parameters used for ART are mainly based upon sperm 
concentration, motility and morphology. However, there is a possibility to use sperm 
containing varying degrees of damage spermatozoa especially DNA damage 
(chapters 8). In support of the impact of paternal DNA status on probability to 
optimize ART outcome and to achieve healthy live births, a study showed an 
association of sperm aneuploidies and apoptotic induced damage in infertile men 
with recurrent pregnancy loss40. It is therefore much likely that failed ART cycles and 
high miscarriage rates can be minimized by the use of spermatozoa with intact 
normal genomic status. Absence of natural selection in ART may increase the 
possibility of using apoptotic DNA damaged spermatozoa beyond the repair capacity 
of oocyte or the growing embryonic cells yielding finally to failed cycle due to low 
embryo quality and increased miscarriage rates 41. 
This assumption is reinforced by Dada et al (2010) in describing a case report, where 
high ROS is associated with nuclear as well as mitochondrial DNA damage that may 
cause repeated failure even with normal karyotyping status (46, XY) 21. Likewise, high 
ROS in embryo culture is detrimental for prediction of the embryo quality and 
pregnancy outcome following both ICSI/ IVF cycles in human reproduction laboratory42. 
OS-induced DNA damage may be one of the main causes of embryo fragmentation 
that can be avoided by the use of embryo culture media supplemented with proper 
dosage of antioxidants. Antioxidants protection, against OS-induced DNA damage in 
spermatozoa and embryos, is dose dependant and requires more studies for 
optimization and individualization (Figure 1) 37. Direct and indirect evidences about 
the role of antioxidants supplementation along with environmental/ life style 
concerns are rapidly growing and may in the near future be applicable to all men 
requiring ART especially with progressive decline in sperm quality43.
4.  Potential application for OS/ apoptosis in diagnostic lab
a) Novel Assays/ prognostic multi-marker scores: 
We support the use of seminal plasma TAC, seminal ROS assay and/ or Terminal de-
oxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay for measurement of 
indirect or direct OS and DNA damage for diagnosis in infertility clinics. Combination 
of more than one assay will results in increase in specificity and/ or sensitivity for 
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these new prognostic scores. Such new scores may include: direct/ indirect OS score; 
it is formulated to cover the ratio between seminal plasma TAC levels (indirect OS, 
Chapter 6) with seminal ROS levels (direct OS, chapters 5, 7-9). 
These scores will be more informative than any individual assay in the evaluation of 
sperm integrity as of adding values of their components. Indirect OS/ sperm DNA 
fragmentation score is a second approach which can be calculated using the 
percentage of TUNEL+ve sperm and seminal TAC levels. Direct OS/ sperm DNA damage 
score can be calculated using values of seminal ROS and % TUNEL+ve. A comprehensive 
score for DNA damage consists of direct OS/ indirect OS/ sperm DNA fragmentation. 
The proposed multivariable score may be more specific and/ or more sensitive for 
evaluation of infertile men. If the prevalence of infertility is known or estimated within 
a particular testing population, which varies within different communities, then these 
multi-parameter score results could be used to estimate positive and negative 
predictive values (PPV and NPV) for such a population. The following equation uses 
the estimated sensitivity and specificity for demonstrating any prediction method of 
choice: 
Estimated PPV= 
(Sensitivity x Prevalence)/ 
(Sensitivity x Prevalence) + [(1 - Specificity) x (1 - Prevalence)]
Estimated NPV= 
 [Specificity * (1 – prevalence)]/
(1 - Sensitivity) x Prevalence) + [Specificity x (1 - Prevalence)]
 
For example if we consider prevalence of infertility is 5% in community A while it is 
20% in community B. Suppose sensitivity and specificity for global semen ROS are 
90% and 55% as a screening assay. Estimated PPV/ NPV will be 10/99 for community A 
and 33/96 for community B respectively. Similarly, in case of a specific assay such as 
sperm DNA damage test, if sensitivity is 60% and specificity is 95%, the estimated PPV/ 
NPV will be 37/98 for community A and 73/89 for community B respectively.
b) Optimizing ART Options/ Risk Reduction: 
Proper use of our novel markers (presented in Chapters 3-8) or proposed multi-marker 
scores (mentioned above) could be helpful for management of infertile men with OS 
and apoptosis. Our work showed examining for OS/ apoptosis may be critical to help 
in both diagnosis and prognosis of infertile men for successful outcome of ART 44.
c) Therapeutic/ Diagnostic Tools: 
For spermatozoa: in unpublished data, we observed that protection against OS/
apoptosis may be beneficial only if we use optimal dose of it. L-Carnitine in high 
concentrations may have an adverse outcome, observed through a dose-dependent 
decrease in sperm motility and viability (Figure 1B). Sperm motility and viability can 
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be improved only with optimal conditions usage that may vary within individuals. 
Such conditions should consider the antioxidant dosage as well as the cell concentration. 
Cellular function may be affected by the basal ROS values and/ or extent of DNA 
breaks. Optimal spermatozoa function requires basal ROS levels, which is impaired 
when basal ROS is depleted by using high antioxidants concentrations 39.
Figure 1  Nuclear DNA fragmentations differ in chemical induced apoptosis from OS induced 
damage [A]. Cellular response is different indicating differences in the affected pathways in 
both kinds of cellular injuries. The protective mechanism of antioxidant is effective only in 
optimal concentration at which the disturbed cellular pathways could be restored. Optimal 
antioxidant concentrations should be titrated according to cell concentration as well as 
different antioxidant concentrations [B-1]. Confirmation of the protective antioxidant treatment 
may be evaluated in-vitro to examine sperm quality improvement before processing to 
prevent any iatrogenic damage [B-2]. Data represented in this figure was from unpublished 
experiments.
A
B-1
B-2
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d) Advantages and limitations of our approach
Application of our clinical pathology approach in fertility labs will improve ART 
outcome and pregnancy achievement of healthy live births 45. The more accurate 
diagnosis the lighter burden will be upon the infertile couples. It would also improve 
the health services provided by infertility clinics. Therefore the use of our clinical 
pathology approach could result in significantly higher embryo quality and development 
with limited failure ART cycles 46. Our approach is still in need to be applied and 
validated in different clinical settings. Different clinical diagnosis may require additional 
modifications for optimizing our novel markers and proposed scores for personalizing 
reproductive medicine in infertility clinics.
e) Future directions
Our clinical pathology approach for studies included in this thesis will serve as a basis 
for future projects to validate its clinical significance on large scale ART services such 
as IUI, IVF or ICSI. It will help in better understanding of natural achievement of 
pregnancy and hence to overcome recurrent pregnancy failure. Developing novel 
scores which cover infertile couple’s clinical and lab parameters would be easily 
applied in the light of molecular and routine investigations discussed in this thesis. 
General conclusions
Based on the results presented in this thesis, we can conclude that: 
Ø	A rise in sperm DNA damage should be expected in conjunction with immaturity 
of male gametes. Immature spermatozoa are rich in cytoplasmic and nuclear enzymes 
that may play a critical role in high ROS generation. Therefore we could easily observe 
OS-induced sperm damage and apoptotic like changes in ejaculated spermatozoa in 
patients with defects in spermatogenesis maturation. 
Ø	Novel markers (such as intracellular ROS, cleaved PARP, sperm apoptosis markers, 
seminal plasma TAC levels and eNOS SNP mutation) have been described in this thesis 
for the first time in human ejaculated spermatozoa. Theses markers may provide 
critical values in improving diagnostic and therapeutic managements for infertile 
couples serviced in reproduction lab and infertility clinics.
Ø	Our work shaded the light upon comparisons between the diagnostic tools and/ 
or markers to facilitate the selection and hence personalized services for the infertile 
couples based on their accurate diagnosis and follow up. Intracellular ROS assay more 
sensitive, selective and specific than global seminal ROS measurement by chemilumi-
nescence. Intracellular hydrogen peroxide is related to apoptosis and maturity of 
spermatozoa. Seminal ROS is an independent parameter that may fluctuate even in 
healthy based upon the maturation or disease stages.
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Ø	OS induced sperm damage may be involved in multi pathologies affecting ejaculated 
human spermatozoa; however, it may be solely responsible in inducing sperm DNA 
fragmentations. So at least 10% of sperm DNA damage may be preventable through 
following our work’s guidelines.
Ø	Interpretation, potential application and recommendations based upon this 
thesis have been discussed and explained for andrology lab guidance as well as for 
future studies perspectives aiming to optimize infertility clinic services. 
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summary
Summary
There are many potential causes of male gametes’ damage, including abortive 
apoptosis, oxidative stress (OS) associated with infections, environmental exposure or 
life style conditions, as well as spermatogenesis defects which associated with 
retention of excess residual cytoplasm and hence defective spermatozoa function. 
Reports linked presence of apoptotic characteristics and OS induced damage in 
human spermatozoa, resulting in fertilization failure of both in-vivo (natural or 
intrauterine insemination, IUI) and in-vitro fertilization (IVF). In addition OS induced 
damage may compromise the quality and development of early embryogenesis and 
hence affect the outcome of assisted reproductive technologies (ART). The importance 
of an accurate diagnosis of male gamete damage / early embryo quality has been 
intensified by the growing concern in the transmission of genetic diseases to the 
developing embryos through ART, especially with intra-cytoplasmic sperm injection 
(ICSI). The current suboptimal ART success rates may be attributed, at least in part, to 
the use of damaged sperm for oocyte insemination, inducing embryo damage as a 
result of absence of natural sperm selection barriers.
This hypothesis has motivated us to develop new diagnostic protocols to achieve an 
accurate diagnosis for male infertility based on OS or apoptosis-like markers in 
spermatozoa. Such approach represents the inevitable evolution of the reproductive 
laboratory diagnostics towards molecular parameters in addition to routine 
examination of cellular characteristics in spermatozoa.
ART provides solutions to infertile couples’, especially in cases of male factor and 
unexplained infertility conditions. Nowadays, infertility is considered as a disease 
rather than an isolated condition of reproductive failure. Infertility affects 10-15 % of 
couples who are seeking for parenthood where male and female partners contribute 
equally (50%) in infertility causes. Managing infertile couples is expensive and has an 
unusual psychological burden. There is an increasing demand for new assays and 
parameters to monitor evaluate and improve ART outcome. Routine investigations 
may not be adequate to serve purposes of understanding the origin of male and 
female infertility. In addition, stress that merge with conditions such as modernization, 
life style and environmental changes, gene mutations and chromosomal abnormalities 
can disturb the highly refined biochemical events associated with spermatogenesis 
and/ or embryogenesis. This can ultimately lead to an abnormal chromatin structure 
which is incompatible with fertility 1. Sperm nuclear chromatin abnormalities/ DNA 
damage could occur at the time of, or be the result of, faulty DNA remodeling at 
spermiogenesis 2. Or, alternatively, it could be the result of free radical induced 
damage 3 or a consequence of apoptosis 4. Sperm processing techniques are essential 
in ART. Spermatozoa may get iatrogenic damage during preparation. Such damage is 
mainly detected through new assays for apoptosis and OS. 
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Our thesis work focused on introducing new markers for sperm evaluation in addition 
to the evaluation of other parameters which may be valuable for clinical application 
in the reproduction laboratory. Our work results may help to improve the performance 
of reproduction laboratory and the IVF/ ICSI outcome in general. The studies in this 
thesis are grouped together into 3 parts: 1) Sperm maturity, apoptosis and OS induced 
damage conditions; 2) Novel markers for OS and apoptosis; 3) applications of apoptotic 
markers in infertility. Finally, the clinical application of our work are described and 
discussed with different possible limitations and precautions regarding accurate 
diagnosis and patient selection.
In Chapter 1, includes an overview of spermatogenesis with special empahsis on the 
origin of both apoptosis and OS in male germ cell pathologies. Conventional and 
possible future diagnostic approaches to improve reproduction lab services are 
presented. An overview of the clinical aspects of male infertility is given, which can 
serve as a diagnostic and therapeutic tool for infertile couples.
The second part of this thesis comprises the exploration of novel OS/ apoptotic 
markers expressed in male gametes in relation to external or internal sperm features 
such as sperm motility, viability, maturation status and sperm chromatin which 
constitute the main selection parameters for spermatozoa.
In Chapter 2: sperm immaturity may compromise the individual’s fertility potential 
and even embryo quality after fertilization. Immature spermatozoa may be affected 
by oxidative stress conditions and/ or apoptotic changes during spermatogenesis 
and hence negatively disturbing the quality of male gametes. Poly ADP-ribose 
polymerase protein (PARP), has been recently found to be present in ejaculated 
spermatozoa. This protein plays an important role in DNA damage repair through 
maturation stages of human spermatozoa and in different pathological conditions. 
We have explored possible PARP roles that may be target for future therapeutic and 
diagnostic application in ART.
In Chapter 3: we studied levels of cleaved poly (ADP-ribose) polymerase (cPARP) in 
ejaculated human spermatozoa after induction of OS- or chemical- induced damage. 
Response of sperm to the injurious agents may be controlled by the extent of DNA 
damage and/ or ATP levels which reflect mainly mitochondrial function. Semen 
specimens were collected from eight healthy sperm donors, prepared with double-
density-gradient centrifugation, and divided into aliquots: untreated (control), 
hydrogen peroxide (H2O2), H2O2 & 3-aminobenzamide (3-ABA), staurosporine (STS), 
and STS & 3-ABA respectively. Cleaved PARP was detected in both neat and mature 
fractions. The cPARP levels were similar in both mature and immature spermatozoa. In 
combined mature and immature fractions, a higher percentage of late apoptotic 
sperm was seen in STS + 3-ABA vs STS. Higher levels of late apoptotic spermatozoa 
were seen in immature versus mature fractions within STS and STS + 3-ABA groups. 
Lower levels of cPARP were seen in immature versus mature fractions in H
2
O
2 
and H
2
O
2 
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+ 3-ABA treated groups. Cleaved PARP was related to levels of activated caspase-3. 
Cleaved PARP was detected in both neat and mature fractions. This suggests that 
cleaved PARP is present in ejaculated human spermatozoa. Poly (ADP-ribose) 
polymerase inhibitors may play a different role in chemical vs. OS-induced sperm 
damage.
In Chapter 4 we report a single nucleotide polymorphism (SNP) of endothelial nitric 
oxide synthase (eNOS) gene (Glu298asp variant) in infertile men with astheno-zoo-
spermia. We investigated the frequency of G894T polymorphism (Glu298Asp variant) 
within exon 7 of the eNOS gene in 70 infertile men and in 60 healthy men. Sperm 
kinetics were assessed with computer assisted semen analysis (CASA). A single 
nucleotide polymorphism (SNP) of the eNOS gene in exon 7 was determined by al-
lele-specific polymerase chain reaction followed by restriction fragment length 
polymorphism (PCR-RFLP). Sequencing analysis was used to confirm the specific 
genotype. The G894T eNOS (T) allele was found at a higher frequency in patients with 
asthenozoospermia (60%) compared to control group (22.5%). In those men, the 
percentage of rapid motile sperm (grade a+b) was low in asthenozoospermic infertile 
men harbor homozygote’s eNOS (TT) genotyping vs. those with wild-type eNOS (GG) 
or heterozygote’s eNOS (GT) genotyping (p = 0.01). In the fertile men, the percentage 
of rapid motile sperm (grade a+b) was higher in the wild-type eNOS than in the eNOS 
(TT) (p=0.03) or eNOS (GT) genotyping (p=0.04). Our findings suggest that the T allele 
encoding for aspartic acid of the eNOS (Glu298Asp) gene may contribute to low 
sperm motility. Whenever defective enzymes involved in pathways generating free 
radicals such as H2O2, O
-● or NO, abnormal levels of these free radicals will compromise 
spermatozoa functions. Unexplained asthenozoospermia may get benefited from 
genetic screening for genes of certain enzymes involved in OS. 
In Chapter 5: we have examined routine and molecular markers of OS/ apoptosis in 
ejaculated spermatozoa. We studied sperm viability, apoptosis, and intracellular 
reactive oxygen species (ROS) levels in human spermatozoa within immature and 
mature sperm fractions. Basically mature spermatozoa showed significantly lower 
incidence of apoptotic sperm and intracellular O
2
−• levels but higher amounts of 
intracellular H
2
O
2
 compared with neat semen. Therefore we were able to conclude 
that there is a differential shift of both intracellular H
2
O
2 
and O
2
-• in each sperm fractions 
that may affect sperm quality. Sperm apoptosis is related to intracellular H
2
O
2 
levels, 
which in turn are affected by intracellular O-• levels.
In section 3 we focused on applying some of our novel markers for OS/ apoptosis in 
andrology and ART. We have applied our bench work in-vitro studies to clinical 
applications for patient benefits. The clinical value of the seminal plasma total 
antioxidant (TAC) assay for clinical lab use requires examining it in infertile versus 
healthy sperm donors was investigated in Chapter 6.  ROC curve analysis was used to 
define new cutoff, sensitivity, specificity and ranges of the seminal plasma TAC in our 
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patients and control populations. Proven fertile donors showed higher TAC values 
(median and range): 1700 (1440 - 2290 µM); compared to the infertile patients: 1310 
(1040 - 1600 µM). The cutoff to distinguish between fertile controls and infertile men 
was 1420 µM. At this threshold, specificity was 64% and sensitivity 76%. These 
observations suggest that seminal plasma TAC as measured by the colorimetric assay 
is a reliable and simple test for the diagnosis and management of infertile men. 
In Chapter 7: we evaluated chemiluminescence for specific/ selective estimation of 
the intracellular ROS, the most common tool for seminal ROS measurement with flow 
cytometry. Semen samples from 18 healthy male volunteers were subjected to sperm 
preparation and measurement of ROS by chemiluminescence using luminol and 
lucigenin before and after H2O2 exposure and by flow cytometry using dihydroethid-
ium (DHE) for O
2
-•  and dichlorofluorescin diacetate (DCFH-DA) for H
2
O
2
. Seminal ROS 
values detected by luminol and lucigenin showed significant relationships to 
intracellular ROS as detected by %DCF+ve and %HE+ve spermatozoa. Intracellular ROS 
levels were detectable by flow cytometry in chemiluminescent negative samples. 
Both mature and immature spermatozoa had significantly high percentages of cells 
positive for H
2
O
2
. On the other hand, the percentage of O
2
-• +ve cells in un-processed 
semen was significantly higher compared to mature but significantly lower than in 
the immature sperm fractions. Therefore, we recommend ROS measurement by flow 
cytometry on the basis that it requires a lower sperm count, is comparable to chemi-
lumenscence, and has higher specificity for intracellular ROS in viable spermatozoa. 
In Chapter 8: we have explored the clinical and laboratory findings in infertile men 
with high or low seminal ROS conditions. We examined sperm motility, seminal 
plasma TAC, DNA fragmentation and medical history in 101 infertile men. Group I (n = 
57) included men with seminal ROS (<250 RLU/sec/X 106 sperm) while group II (n = 44) 
included men with seminal ROS levels (≥250 RLU/sec/X 106 sperm). Group II had high 
incidence of sperm DNA fragmentation than group I. The odds ratio of 1.25 for 
elevated ROS levels corresponded to >10% greater DNA fragmentation in our patients 
(95% CI 1.01 - 1.53). Group II showed poor motility, a higher incidence of leukocyto-
spermia and higher ROS-TAC scores compared with group I. ROS was negatively 
correlated with sperm curvilinear velocity (VCL) (r = -0.24), linearity (r = -0.24) and 
sperm motility (r = -0.31). Sperm motility was negatively correlated with %TUNEL+ve 
sperm (r = -0.39). Therefore we concluded that a rise in seminal ROS levels by 25% was 
associated with a 10% increase in sperm DNA fragmentation. Sperm motility was 
affected by seminal ROS and sperm DNA fragmentation. 
Follow up of a healthy sperm donor is reported in Chapter 9; in a longitudinal study 
over a period of 21 months, we demonstrated that seminal ROS levels are independent 
from sperm concentration, motility or abstinence duration within a healthy sperm 
donor, although some variations were observed in ROS levels. Our hypothesis is that 
fluctuation in seminal ROS values may be related to physiological or transient changes 
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in spermatogenesis. Therefore, ROS level is a unique additional parameter to semen 
analysis which is not affected by the abstinence period.
The main conclusions from this work are: 1) OS/apoptotic measures may compromise 
the male gametes. OS/apoptotic measurements may vary with stages of sperm 
development and/ or disease conditions within infertile patients for certain clinical 
diagnosis. 2) Novel markers and assays may be required for OS/ apoptotic 
measurements that could be applicable to offer additional accurate services for 
andrology laboratory and infertility clinic. 3) Flow cytometry is a powerful clinical 
pathology tool for andrology laboratory through providing a series of diagnostic 
services for clinical and research activities. 4) Although routine examination may be 
critical for infertile men, examination for DNA damage may be mandatory to explain 
sperm pathologies, or repeated ART failures. 5) OS may be responsible for at least 10% 
of sperm DNA damage in infertile men. OS may be also related with different 
pathologies such infection,  genetic disorders or idiopathic infertility.
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Samenvatting
Er zijn talrijke mogelijke oorzaken voor de beschadiging van mannelijke gameten, 
zoals ‘abortive’ apoptose, oxidatieve stress (OS) door infecties, milieufactoren of de 
lifestyle-situatie dan wel fouten in de spermatogenese die gepaard gaan met het 
vasthouden van het overtollige resterende cytoplasma en derhalve een slecht functi-
oneren van de spermatozoa.  In rapporten werd een verband gelegd tussen de aan-
wezigheid van apoptotische kenmerken en door OS gerichte schade aan humane 
spermatozoa, met als gevolgd een mislukte bevruchting van zowel in-vivo (natuurlijke 
of intra-uteriene inseminaties/IUI) als ook in-vitro-fertilisatie (IVF). Bovendien kan een 
door OS veroorzaakte beschadiging de kwaliteit en de ontwikkeling van de embryo’s 
compromitteren en kan derhalve invloed hebben op het resultaat van geassisteerde 
voortplantingstechnieken (Assisted Reproductive Technology, ART). Het belang van 
de juiste diagnose van de schade van het mannelijke gameet en de kwaliteit van 
vroege embryo’s wordt nog verder benadrukt door de toenemende ongerustheid 
over de mogelijke overdracht van genetische aandoeningen door ART, vooral door 
intracytoplasmatische sperma injectie (ICSI). Het tegenwoordige suboptimale succes-
percentage van ART kan minstens ten dele worden toegeschreven aan het gebruik 
van beschadigd zaad bij de inseminatie van oöcyten, met als gevolg abnormale 
embryo’s door het ontbreken van natuurlijke zaadcel selectiebarrières.
Deze veronderstelling heeft ons gemotiveerd om nieuwe diagnoseprotocollen te 
ontwikkelen om een juiste diagnose van mannelijke infertiliteit te stellen, gebaseerd 
op OS of apoptose markers in spermatozoa. Een dergelijke aanpak betekent de onver-
mijdelijke ontwikkeling van de diagnostiek in laboratoria naar zowel moleculaire 
parameters als ook routinematig onderzoek van andere cellulair kenmerken in 
spermatozoa.   
ART biedt oplossingen voor paren met fertiliteitproblematiek, vooral in het geval van 
mannelijke subfertiliteit en onverklaarde oorzaken voor de subfertiliteit. Tegenwoor-
dig wordt subfertiliteit als een “ziekte” beschouwd, niet als een op zichzelf staand 
mislukken van de voortplanting. Subfertiliteit komt voor bij 10-15% van alle paren met 
kinderwens. De oorzaken ervan zijn evenredig (met telkens 50%) verdeeld over 
mannen en vrouwen. Het begeleiden van subfertiele paren brengt hoge kosten met 
zich mee en betekent een bovengemiddelde psychologische belasting. Er bestaat 
steeds meer behoefte aan nieuwe testen en nieuwe referentiekaders voor het in kaart 
brengen, evalueren en verbeteren van de resultaten van ART. Routineonderzoek is 
vaak niet meer afdoende om de oorzaken van mannelijke en vrouwelijke subfertiliteit 
te begrijpen. Bovendien kan stress in combinatie met factoren zoals de modernise-
ring, leefstijl, veranderingen van het milieu, genmutaties en chromosomenafwijkin-
gen de zeer gevoelige biochemische processen verstoren die gekoppeld zijn aan 
spermatogenese en/of embryogenese. Dit kan uiteindelijk leiden tot een afwijkende 
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chromatinestructuur die onverenigbaar is met vruchtbaarheid.1 Kernchromatine 
afwijkingen c.q. beschadigingen van het DNA van het zaad zouden zich kunnen 
voordoen ten tijde van of zouden het resultaat kunnen zijn van een foutieve opbouw 
van het DNA tijdens de spermiogenese2. Ze zouden ook het resultaat kunnen zijn van 
door vrije radicalen veroorzaakte beschadigingen3 of een gevolg van apoptose.4 
Zaad opwerkingstechnieken zijn cruciaal bij ART. De spermatozoa kunnen tijdens de 
bewerking iatrogene beschadigingen oplopen. Deze beschadigingen worden voor-
namelijk gedetecteerd door middel van nieuwe testen voor apoptose en OS. 
Het werk van ons proefschrift is gericht op het introduceren van nieuwe markers voor 
de evaluatie van het zaad, naast andere parameters die waardevol zouden kunnen 
zijn voor de klinische toepassing in voortplantingslaboratoria. Onze resultaten kunnen 
er mogelijk aan bijdragen door resultaten van de geassisteerde voortplanting en de 
resultaten van IVF/ICSI in het algemeen te verbeteren. In dit proefschrift, de uitkomsten 
van onze onderzoek zijn onderverdeeld in drie delen: 1) rijpheid van het zaad, 
apoptose en door OS veroorzaakte schade; 2) nieuwe markers voor OS en apoptose; 
3) toepassingen van apoptotische markers in infertiliteit diagnosis. Tenslotte wordt de 
klinische toepassing van ons werk beschreven en bediscussieerd in het licht van de 
verschillende mogelijke beperkingen en voorzorgmaatregelen voor wat betreft de 
juiste diagnose en patiëntselectie. 
Hoofdstuk 1 bevat een overzicht van de spermatogenese met speciale nadruk op de 
oorsprong van zowel apoptose als OS bij mannelijke kiemcelpathologie. Conventio-
nele en mogelijke toekomstige diagnostische  methodes om de dienstverlening van 
laboratoria voor geassisteerde voortplanting te verbeteren worden gepresenteerd. Er 
wordt een overzicht gegeven van de klinische aspecten van mannelijke infertiliteit 
dat kan dienen als diagnostisch en therapeutisch instrument voor onvruchtbare 
paren. 
Deel 2 van dit proefschrift bestaat uit onderzoek naar nieuwe OS- en apoptotische 
markers die zich uiten in mannelijke gameten met betrekking tot uitwendige of 
inwendige zaadkenmerken, zoals de motiliteit van het zaad, de vitaliteit, de rijpings-
graad en het chromatine, die de voornaamste selectieparameters voor spermatozoa 
vormen.  
In Hoofdstuk 2 rapporteren wij dat de onrijpheid van het zaad het vruchtbaarheids-
potentieel van het individu en zelfs de kwaliteit van de embryo na de bevruchting 
kan compromitteren. Onrijpe spermatozoa kunnen door oxidatieve stress en/of apop-
totische veranderingen gedurende de spermatogenese worden aangetast, en kunnen 
derhalve de kwaliteit van de mannelijke gameten verstoren. Recent werden poly-
ADP-ribose-polymerase-proteïnes (PARP) in geëjaculeerde spermatozoa gevonden. 
Dit proteïne speelt een belangrijke rol bij het herstellen van beschadigingen van het 
DNA door de rijpingsfases van humane spermatozoa en onder  verschillende patho-
logische condities. We hebben de mogelijke rol van PARP onderzocht die een doel-
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stelling zou kunnen zijn voor toekomstige therapeutische en diagnostische toepas-
singen in ART. 
In Hoofdstuk 3 hebben we de niveaus van “cleaved”poly-(ADP-ribose)-polymerase 
(cPARP) in geëjaculeerde humane spermatozoa na de inductie van OS of chemisch 
geïnduceerde beschadigingen onderzocht. De respons van het zaad op de agenten 
die beschadigingen veroorzaken zou gecontroleerd kunnen worden door de omvang 
van de DNA-schade en/of de niveaus van het ATP, die voornamelijk het mitochondri-
ale functie weerspiegelen. Zaadmonsters van acht gezonde zaaddonoren werden 
verzameld, opgewerkt met gradient centrifugeren en verdeeld in aliquoten: respec-
tievelijk onbehandeld (controle), waterstofperoxide (H
2
O
2
), H
2
O
2
 & 3-aminobenzamide 
(3-ABA), staurosporine (STS) en STS & 3-ABA. Cleaved-PARP werd zowel in de oor-
spronkelijke als in de opgewerkte fracties gedetecteerd.  De cPARP-niveaus in de rijpe 
en de onrijpe spermatozoa waren soortgelijk. In gecombineerde rijpe en onrijpe 
fracties werd een hoger percentage apoptotisch zaad in STS + 3-ABA versus STS 
gezien. Hogere niveaus van ‘late apoptotische spermatozoa werden gezien in onrijpe 
tegenover rijpe fracties binnen de STS and STS + 3-ABA -groepen. Lagere niveaus van 
cPARP werden gezien in onrijpe tegenover rijpe fracties in met H
2
O
2 
en H
2
O
2 
+ 3-ABA 
behandelde groepen. Cleaved-PARP is gerelateerd aan niveaus van geactiveerde 
caspase-3. Cleaved-PARP werd zowel in oorspronkelijke als in rijpe fracties gedetec-
teerd. Dit suggereert dat c-PARP in geëjaculeerde humane spermatozoa aanwezig is. 
Poly-(ADP-ribose)-polymerase-remmers zouden mogelijk een andere rol kunnen 
spelen bij chemisch geïnduceerde tegenover OS-geïnduceerde schade van het zaad. 
In Hoofdstuk 4 wordt de aanwezigheid van een enkel nucleotide polymorfisme 
(SNP) van een endotheel-nitraatstikstofoxide-synthase (eNOS)-gen (Glu298asp 
variant) in onvruchtbare mannen met astenozoöspermie gemeld. Wij onderzochten 
de frequentie van G894T-polymorfisme (Glu298Asp variant) binnen exon 7 van het 
eNOS-gen bij 70 onvruchtbare mannen en bij 60 gezonde mannen. De zaadkinetiek 
werd beoordeeld door middel van een door de computer ondersteunde zaadanalyse 
(CASA). Een singel nucleotide polymorfisme (SNP) van het eNOS-gen in exon 7 werd 
nader bepaald door een allele-specifieke polymerase-chain reaction (PCR-RFLP), 
gevolgd door ‘restriction fragment length polymorphism’. Een sequentieanalyse 
werd gebruikt om het specifieke genotype te bevestigen. De G894T eNOS (T)-allel 
werd vaker gevonden bij patiënten met astenozoöspermie (60%), vergeleken met de 
controlegroep (22,5%). Bij deze asthenospermie mannen, een lage percentage snel 
progressive zaad (graad a+b) werd gevonden, zijn homozygote eNOS (TT)-genotype-
ring in vergelijking met controle mannen met het wild-type eNOS (GG)  of hetero-
zygote eNOS (GT)-genotyping (p = 0.01). In de vruchtbare mannen,het percentage 
snel motiel zaad (graad a+b) hoger bij het wild-type eNOS dan bij de eNOS (TT) 
(p=0.03) of de eNOS (GT) genotypering (p=0.04). Onze bevindingen suggereren dat 
de T-allele-codering voor aspartiaan zuur van het eNOS (Glu298Asp)-gen tot een lage 
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zaadmotiliteit zou kunnen bijdragen. Wanneer er gebrekkige enzymen betrokken zijn 
bij trajecten die vrije radicalen als H
2
O
2
, O -• of NO genereren, dan zullen abnormale 
niveaus van deze vrije radicalen de spermatozoafuncties schaden. Onverklaarde 
 astenozoöspermie zou profijt kunnen hebben van genetische screening van de 
genen van bepaalde enzymen die bij OS betrokken zijn. 
In Hoofdstuk 5 hebben we de routine en de moleculaire kenmerken/markers van OS 
en apoptose in geëjaculeerd zaad onderzocht. We hebben de vitaliteit van het zaad, 
de apoptose en de intracellulaire niveaus van de reactive oxygen species(ROS) in 
humane spermatozoa in onrijpe en in rijpe zaadfracties onderzocht. Zaadmonsters 
van twaalf gezonde donoren werden verzameld en opgewerkt met dichtheidsgradi-
ent centrifugatie.  Rijpe spermatozoa toonden een significant lagere incidentie van 
apoptotisch zaad en intracellulaire O2-niveaus, maar grotere hoeveelheden intra-
cellulaire H
2
0
2
, vergeleken met het oorspronkelijke zaad. Wij hebben wij kunnen 
concluderen dat er in iedere zaadfractie een differentiële verschuiving van zowel in-
tracellulaire H
2
O
2 
als ook O
2
−•  plaatsvindt die de kwaliteit van het zaad kan beïnvloeden. 
Zaad apoptose is gerelateerd aan de intracellulaire H
2
O
2
 - niveaus, die op hun beurt 
door de intracellulaire O
2
−• - niveaus worden beïnvloed. 
In sectie 3 hebben we ons gericht op het toepassen van onze nieuwe markers voor 
OS/ apoptose op de andrologie lab en ART. We hebben ons in-vitro-onderzoek 
klinisch toegepast in het belang van de patiënt. De klinische validatie van de semen 
plasma-totaaloxidantanalyse (TAC) assay voor het klinische laboratorium is noodzake-
lijk in het fertiliteitsonderzoek. Dit is onderzocht in Hoofdstuk 6. Er werd gebruik 
gemaakt van een  ROC-curve analyse om de nieuwe cut-off waardes, de sensibiliteit, 
de specificiteit en ranges van het seminal-plasma-TAC bij onze patiënten en bij 
 controlepopulaties te definiëren. Bewezen vruchtbare donoren toonden hogere 
TAC-waarden (mediaan en range): 1700 (1440 - 2290 µM); vergeleken met de onvrucht-
bare patiënten: 1310 (1040 - 1600 µM). De cutoff waarde voor vruchtbare controleper-
sonen (of onvruchtbare mannen) was 1420 µM, met een specificiteit 64% en een van 
sensibiliteit 76%. Deze bevindingen suggereren dat het seminale-plasma-TAC, zoals 
het wordt bepaald bij colorimetrische analyse, een betrouwbare en simpele test is 
voor de diagnose van onvruchtbare mannen. 
In Hoofdstuk 7 hebben we de chemiluminescentie voor de specifieke/selectieve 
schatting van het intracellulaire ROS geëvalueerd, voor de meting van seminale ROS 
met flowcytometrie. Zaadmonsters van gezonde mannelijke vrijwilligers werden 
onderworpen aan zaadbewerking en meting van het ROS door middel van chemilu-
minescentie, waarbij luminol and lucigenin werden gebruikt vóór en na de bloot-
stelling aan H2O2  en met flowcytometrie voor dihydroethidium (DHE) voor O2
-•  en 
 dichlorofluorescinediacetaat (DCFH-DA) voor H
2
O
2
. De seminale ROS-waarden 
toonden significante relaties met intracellulaire ROS (%DCF-positieve and %HE- 
positieve spermatozoa). De intracellulaire ROS werden gemeten met flowcytometrie 
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in chemiluminescentienegatieve zaadmonsters. Zowel de rijpe als ook de onrijpe 
spermatozoa hadden significant hogere percentages van H
2
O
2
-positieve cellen. 
Anderzijds was het percentage O
2
-• - positieve cellen in onbewerkt zaad significant 
hoger in vergelijking met de rijpe zaadfracties, maar significant lager dan dat in de 
onrijpe zaadfracties.  Derhalve adviseren wij een  ROS-meting  door middel van flow-
cytometrie aan, gebaseerd op het feit dat men daarvoor een kleinere hoeveelheid 
zaad nodig heeft,  dat deze vergelijkbaar is met chemiluminescentie, en dat deze een 
hogere specificiteit voor intracellulair ROS in levensvatbare spermatozoa heeft. 
In Hoofdstuk 8 hebben we de klinische bevindingen en de laboratoriumuitslagen 
van onvruchtbare mannen met hoge of lage seminale ROS onderzocht. We hebben 
de motiliteit van het zaad, het seminale-plasma-TAC, de DNA-fragmentatie en de 
medische voorgeschiedenis van 101 onvruchtbare mannen onderzocht. In groep I 
(n = 57) waren mannen opgenomen met seminale ROS waarden <250 RLU/sec/X 106 
zaad, in groep II (n = 44) mannen met een seminale ROS-waarde ≥250 RLU/sec/X 106 
zaad. Groep II had een hogere incidentie van DNA-fragmentatie van het zaad dan 
groep I. Verhoogd ROS-waarde had een odds ratie van 1.25 (95% CI 1.01 - 1.53) in 
patiënten met >10% hogere DNA-fragmentatie. Groep II toonde een slechte motiliteit, 
een hogere incidentie van leukocytospermie en hogere ROS-TAC-scores vergeleken 
met groep I. ROS was negatief gecorreleerd aan de curvilineaire snelheid van het 
zaad (VCL) (r = -0.24), de lineariteit (r = -0.24) en de motiliteit van het zaad (r = -0.31). 
De motiliteit van het zaad was negatief gecorreleerd aan %TUNEL- positief zaad 
(r = -0.39). We kunnen concluderen dat een toename met 25% van het seminale ROS 
gekoppeld is aan een toename met 10% van de DNA-fragmentatie van het zaad. 
De motiliteit van het zaad werd beïnvloed door het seminale ROS en door de DNA- 
fragmentatie van het zaad. 
De follow-up van een gezonde zaaddonor wordt in Hoofdstuk 9 beschreven. In een 
lange-termijn-onderzoek over een periode van 21 maanden hebben wij aangetoond 
dat het seminale ROS-waarde onafhankelijk is van de zaadconcentratie, de motiliteit 
en de duur van de onthouding, alhoewel er wel wat variaties van de ROS-waarden 
werden waargenomen. Onze hpothese is dat een schommeling van de seminale 
ROS-waarden mogelijk gerelateerd zou kunnen zijn aan fysiologische veranderingen 
of aan veranderingen in de spermatogenese. De ROS-waarde zelfs is bij gezonde 
individuen een unieke additionele parameter voor de zaadanalyse die niet wordt 
beïnvloed door de onthoudingsperiode. 
De belangrijkste conclusies van onze studie zijn: 1) OS/apoptose kunnen de 
mannelijke gameten compromitteren. Metingen van de OS/apoptose kunnen variëren 
door verschillende stadia van de zaadontwikkeling en/of omstandigheden van ziekte 
bij onvruchtbare patiënten.  2) Nieuwe markers voor metingen van de OS/ apoptose 
kunnen een waardevolle toevoeging zijn in de diagnose van mannelijke onvrucht-
baarheid en kunnen additionele informatie voor behandeling bieden. 3) Flowcytome-
210
samenvatting
trie is een krachtig instrument voor andrologische laboratoria voor klinische diagnos-
tische testen diensten en onderzoeksactiviteiten. 4) Routinematig onderzoek kan 
cruciaal zijn voor sommige onvruchtbare mannen, DNA-schade onderzoek is van 
belang bij herhaaldelijk mislukken van ART. 5) OS kan verantwoordelijk zijn voor 
tenminste 10% van de DNA-schade van het zaad bij onvruchtbare mannen. OS kan 
ook worden gerelateerd aan andere aandoeningen, zoals infecties, genetische aan-
doeningen of idiopathische onvruchtbaarheid.
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